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                                                   ABSTRACT 
 
 
 
 
Multiple System Atrophy (MSA) and Pure Autonomic Failure (PAF) are contrasting models 
of Chronic Autonomic failure. PAF primarily involves the post-ganglionic autonomic nervous 
system, whilst in MSA the pre-ganglionic structures are impaired. My central hypothesis is 
that this underlying neuropathological difference between MSA and PAF will lead to 
differing cardiovascular responses.  
 
I will assess the cardiovascular effects of known pressor and vasomotor stimuli (mental 
arithmetic, cold pressor test, isometric exercise, water ingestion, inhaled CO2 and inspiratory 
gasp) in MSA and PAF. Neurohormonal aspects will be explored by comparing the 
cardiovascular effects of the α2-adrenoceptor agonist clonidine with serum noradrenaline 
levels in these groups, as well as comparing supine antidiuretic hormone (ADH)  levels after 
head up tilt and correlating these with supine blood pressure (BP). As well as contrasting the 
cardiovascular responses, I will use the water ingestion studies to examine effects on 
orthostatic hypotension, a common complication of both MSA and PAF. 
 
To measure cardiovascular responses during these studies I have used the Portapres II device 
to obtain continuous, non-invasive, beat-to-beat measurements of BP and heart rate (HR). 
Subsequent Model flow analysis using Beatscope software has then been used to calculate 
further cardiovascular indices, including cardiac output (CO), stroke volume (SV) and total 
peripheral resistance (TPR). In addition, intermittent BP and HR measurements have been 
obtained with an automated sphygmomanometer (Dinamap). Finally, peripheral vasomotor 
responses have been recorded by means of the Laser Doppler perfusion meter.  
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                                       Chapter 1: General Introduction 
 
 
 
    1.1:  The Autonomic Nervous System in Health and Disease 
 
 
The term “Autonomic Nervous System” was first coined by Langley over a century ago. It is 
an extensive neural network, innervating every organ in the body and plays an important role 
in regulation of a number of vital bodily functions such as the control of blood pressure (BP) 
heart rate (HR), sweating, digestion, micturition and sexual function. The autonomic nervous 
system (ANS) may be broadly divided into sympathetic and parasymapthetic divisions, each 
with important central (cerebral and spinal cord) and peripheral components. The ANS can be 
impaired either secondary to other conditions such as diabetes, or as a primary, idiopathic, 
process resulting in autonomic failure (AF) such as multiple system atrophy (MSA) and pure 
autonomic failure (PAF). The clinical consequences in these disease states are related to the 
underlying autonomic damage, and clinical investigations are based around different 
components of the ANS. 
 
          Historical Background concerning the Autonomic Nervous System   
  
Langley and Gaskell revolutionised understanding of the autonomic nervous system with their 
work at the end of the nineteenth century. Gaskell was especially important in recording the 
anatomical layout of the autonomic nervous system; together with Langley he traced the 
outflow of preganglionic nerves from the spinal cord and described  fundamental differences 
in the layout of the sympathetic and parasympathetic autonomic nervous systems [Gaskell 
1916; Langley 1921]. Langley went on to describe the contrasting action of different tissues 
to adrenaline. He speculated that the reason for these differences to the same stimulus resulted 
from different types of “receptor substances” on the affected tissues [Langley 1921]. Elliot, a 
student of Langley, noted that both the adrenaline secreting (chromaffin) cells of the adrenal 
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medulla and the postganglionic sympathetic neurons were derived from the same ectodermal 
sympathoblasts. He proposed that postganglionic sympathetic nerves may produce their 
effects by secretion of adrenaline (although he believed that this was not made in the nerve 
terminals but rather sequestered from adrenaline released by the adrenal glands). He went on 
to suggest that both postganglionic parasympathetic nerves and spinal motor nerves 
innervating skeletal muscle both secreted similar substances, two decades before 
acetylcholine (Ach) was shown to a neurotransmitter common to these nerves.  Henry Dale 
(who followed Elliot as Research Fellow to Langley) noted that Ach had many similarities in 
action to those of the parasympathetic nervous system (Dale coined the terms sympathetic and 
parasympathetic nervous systems). Although he correctly postulated the presence of an 
endogenous cholinesterase which rapidly degraded Ach, he did not suggest that Ach was 
secreted by the parasympathetic nervous system. It was Dale’s close friend Loewi who finally 
deduced that a transmitter substance was released from the nerves to result in the effect. His 
classic 1921experiment on isolated frog hearts proved that this was the case. In this study he 
compared two frog hearts, the first with intact sympathetic and parasympathetic nerves, and 
the second with the nerves cut. He demonstrated that in the innervated heart electrical 
stimulation of the parasympathetic nerve led to a reduction in HR, and stimulation of the 
sympathetic nerve caused an increase in HR. He then showed that, if Ringers solution used to 
perfuse the first heart during stimulation of the parasympathetic nerve was then applied to the 
second, denervated heart, a reduced HR resulted. Similarly, when the sympathetic nerve of 
the first heart was stimulated, the perfusing Ringers solution, if applied to the denervated 
heart resulted in increased HR. Loewi originally described the substances as Vagusstoff and 
Acceleransstoff  [ Loewi 1921 ]. Follow-up work both by Loewi and Dale confirmed that 
Vagsstoff was in fact Ach, and Dale went on to show that Ach also was released by motor nerves 
supplying skeletal muscle as well as in other areas of the parasympathetic ANS, such as from 
gastric branches of the vagus [Dale & Feldberg, 1934]. Feldberg went on to show that Ach was 
also released as a neurotransmitter at the autonomic ganglia and from the splanchnic sympathetic 
nerves innervating the adrenals [Feldberg and Gaddum 1934]. 
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.  
 
 
                    Organisation of the Autonomic Nervous System  
 
 
The ANS is classically thought of as comprising two broadly antagonistic divisions, with  
sympathethetic system activation resulting in increased BP, HR, sweating, pupillary dilation 
and blood flow to skeletal muscle (“fight or flight”). By contrast, parasympathetic activation 
leads to reduced BP and HR, pupillary constriction and enhanced digestion  Whilst it is true 
that sympathetic activation usually occurs in conjuction with parasympathetic inhibition  (and 
vice versa), the two divisions may work in complentary fashion.  As well as its two major 
divisions, the ANS may also be divided into afferent and efferent components. Afferent 
components allow feedback control, especially important for the rapid adjustments to changes 
in the cardiovascular systems.  Such afferent signals include chemo- and mechanoreceptors in 
the heart atria and ventricles as well as in the aortic arch and carotid sinus. Signals travel in 
the vagus and glossopharyngeal nerves to the brain stem where synapses with the vasomotor 
centres can result in rapid changes in BP regulation by increasing or decreasing sympathetic 
and parasympathetic nervous activity. Thus a transient increase in BP is detected by 
mechanoreceptors in the wall of the aortic arch and the carotid sinus, resulting in a reflex 
inhibition of the tonic sympathetic outflow, and enhancement of the parasympathetic ANS 
leading to reduced peripheral vasoconstriction, reduced HR and reduced cardiac contractility. 
Although the ANS is often considered to be largely autonomous system, higher cerebral 
centres can strongly influence it. For example, mental stress results in cortical and limbic 
activation and thence to activation of the sympathetic nervous system. This is capable of 
eliciting an integrated physiological response.  Thus there is an increase in BP and cutaneous 
vasoconstriction (via NA release from postganglionic sympathetic nerves), increased HR (via 
both parasympathetic withdrawal and adrenaline release), increased blood flow in skeletal 
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muscle (via adrenaline release), and increased sweating (via Ach release from postganglionic 
sympathetic nerves). 
 
 
                                            Neurotransmitters and the ANS 
 
The major neurotransmitters involved are noradrenaline (NA) and acetylcholine (Ach). Both 
are involved centrally as well as peripherally. In the periphery Ach is the principal 
neurotransmitter at synapses in the ganglia for both sympathetic and parasympathetic 
divisions, acting as an agonist on nicotinic receptors on the postganglionic neurone. 
Postganglionic nerves differ, with the principle substance being Ach in the parasympathetic, 
and NA in the sympathetic nervous system (an important exception being sympathetic 
postganglionic nerves innervating the sweat glands where Ach is the principle 
neurotransmitter). The adrenal gland is a special case, being an endocrine gland intimately 
involved in the sympathetic nervous system response. It is innervated by preganglionic nerves 
which release Ach. When released the Ach causes release of adrenaline from the adrenal 
medulla into the blood stream. Other neurotransmitters are increasingly being recognised in 
both the sympathetic and parasympathetic nervous systems. Endorphins, substance P and 
calcitonin-gene related peptide are examples which are known to be released in varying 
amounts as co-transmitters in different sites within the ANS.  
 
The substances thus released by the postganglionic ANS nerves and the adrenal gland 
produce their varying effects by acting as agonists on various ligand-gated receptors 
throughout the body. The type and number of these receptors in a particular tissue will be an 
important factor in determining the final effect at that tissue. Thus adrenaline results in 
bronchodilation in the airways and vasodilatation in skeletal blood vessels because of β2 
adrenoreceptors on smooth muscle, but causes tachycardia in the heart because of greater 
concentrations of β1 receptors on cardiac pace maker myocytes. NA has much greater affinity 
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for α than β-adrenoceptors, thus NA results in greater vasoconstriction (via α1 receptors on 
blood vessel smooth muscle) than adrenaline, but does not cause tachycardia.  
 
 
 
                                                   ANS Dysfunction 
 
The ANS may be damaged by a variety of insults, including co-existing diseases (such as 
diabetes or amyloidosis), trauma (including spinal cord injury and damage resulting from 
surgery), toxins and drugs. Chronic Autonomic Failure (CAF) represents 3 different disease 
states where AF occurs without a clear cause (primary). These 3 disease states are MSA, PAF 
and Parkinson’s disease (PD) with AF [Mathias & Bannister 2002]. Whilst both major 
divisions of the ANS are affected in these 3 conditions, the lesion site differs between them. 
In PAF the lesion site is peripheral and postganglionic. Symptoms and signs are largely 
confined to the ANS, and the prognosis is generally good if the BP is well managed. By 
contrast, in MSA there is central, preganglionic impairment of the ANS with functional and 
morphological sparing of the postganglionic, peripheral autonomic nerves [Matthews 2002, 
Dotson et al 1990]. Unlike in PAF, additional features unrelated to the ANS are common. 
Parkinsonism and cerebellar dysfunction are frequently seen in MSA.  
 
The final disease state comprising CAF is that of PD with AF. This group has both pre-and 
postganglionic impairment of the ANS. The degree of impairment appears heterogeneous. For 
these reasons I have studied the clearly differentiated disease states of MSA and PAF.  
 
All 3 groups with CAF exhibit symptoms and signs of AF. These can be as varied as the 
organs that the ANS innervates. Thus problems can range from urinary or gastrointestinal 
tract dysfunction to sweating abnormalities or visual impairment.  Subjects frequently have 
symptoms related to the cardiovascular system (CVS), most commonly orthostatic 
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hypotension (OH), which can develop with pre- or postganglionic lesion site damage and thus 
is common to both MSA and PAF. OH not only is among the most limiting of autonomic 
symptoms of MSA and PAF, but also is an important background to many of the studies 
outlined in this thesis, and as such will now be considered in more detail here. 
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ORTHOSTATIC HYPOTENSION AND ITS MANAGEMENT 
 
Orthostatic hypotension (OH or postural hypotension) is defined as a drop in blood pressure 
(BP) after standing for 3 minutes of greater than 20mmHg Systolic OR 15mmHg Diastolic 
[Mathias & Bannister 1999]. Although these values can provide a useful guide, it is important 
to make sure that treatment is not just based on BP readings, but also takes into account 
symptomatology. The fundamental problem of OH is that there is a reduced perfusion 
pressure to organs and tissues. Often the most marked effect of this is when the cerebral 
circulation is compromised, causing symptoms varying from “light-headedness” or 
“dizziness” to visual impairment or loss of consciousness. Other areas commonly affected 
include the neck and shoulder musculature. If perfusion to these muscles is compromised a 
claudication type pain (termed “coathanger pain” after the area affected) can develop 
[Mathias & Bannister 1999]. Importantly all the above symptoms rapidly subside if the 
patient lies flat as the perfusion is restored. This is an important point to elicit from the history 
to help in the differential diagnosis. It is also important in immediate treatment of these 
patients; if the patient loses consciousness but is unable to resume a lying posture (e.g. 
propped against a wall in a small toilet or being held up by well meaning friends) then 
irreversible effects of underperfusion may ensue. OH can cause problems after any length of 
stand. Indeed, in some patients the problem is so severe that even sitting upright is impossible. 
Other factors such as eating meals high in carbohydrate, dehydration or exercise may further 
exacerbate the disorder.  
 
In essence any condition that compromises the circulating blood volume or reduces the ability 
to prevent pooling of blood in the lower extremities on upright stance can result in OH. 
Dehydration (or blood loss), vasodilatation (as seen in systemic infections) and certain 
medications (anti-hypertensives and anti-Parkinsonian medication) are often factors in OH. 
The major group affected are the elderly, in whom more than one of these factors may be 
important in the aetiology. The most severely affected patients tend to be those in whom there 
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is autonomic failure (AF). This can be primary (in conditions such as Pure Autonomic 
Failure, PAF, Multiple System Atrophy, MSA) or secondary (diabetes, amyloid and others) 
[Mathias & Bannister 1999].  The autonomic nervous system is important in regulation of the 
blood pressure in all positions. Because of this, in patients with AF, problems can also arise 
when lying flat. When supine, AF patients tend to be unable to prevent a rise in blood 
pressure, leading to various degrees of supine hypertension, which may be severe enough to 
require treatment in its own right, and certainly has to borne in mind when trying to treat the 
OH component. In such cases where medication is used to increase the blood pressure, the 
ideal is to use agents which have their main action during the day to help combat postural 
hypotension whilst not exacerbating supine hypertension at night.  
 
 
 
 
NON-PHARMACOLOGICAL TREATMENTS OF ORTHOSTATIC HYPOTENSION 
 
Various methods exist to help combat OH before resorting to drugs. These are often enough 
to control symptoms, and should still be considered in conjunction with drugs even in the 
more severe cases.  
 
 
1) AVOIDANCE: as explained above some factors will tend to exacerbate OH. Medication 
should always be considered as a possible factor in OH, but it is often not practical to stop 
these or reduce the dose. More readily adjustable factors include exercise and eating meals 
(especially early in the day) high in carbohydrate. Exercise could be tailored to coincide with 
the patient’s “best” times of the day (usually later in the day). Moderate exercise should be 
encouraged, but where this still appears to be causing a problem then the patient and relatives 
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should be aware of this. Supervised exercise or ensuring physical support is at hand (such as 
carrying a fold-up chair) should be considered. 
 
Food high in carbohydrate appears to cause exacerbation of OH via an insulin-mediated 
mechanism. Symptom diaries may help the patient find the ideal meal composition. Usually it 
is breakfast and lunch which cause most problems. For these meals sugar and complex 
carbohydrates (such as rice, bread, potato, and pasta) should be kept to a minimum. The daily 
nutritional requirements can then be made up in the evening meal.  Alcohol can also 
exacerbate symptoms (initially through vasodilatation, and subsequently due to increased 
diuresis). Finally, a special case exists for those whose postural hypotension is caused by 
diabetic autonomic failure. In these patients hyperglycaemia leads to increased diuresis with 
the risk of dehydration, which will tend to worsen OH.  
 
2) FLUID INTAKE: It is important that patients are taking an adequate fluid intake to 
prevent dehydration. Detailed enquiries of the exact number of cups etc consumed in a day 
are often helpful. This is especially important in cases where fluid losses are likely to be 
increased such as with increased exercise, hot weather, pyrexia, vomiting and diarrhoea. In 
one special group at risk of OH, namely renal dialysis patients, it is important to remember 
that fluid intake will be tightly regulated by their renal physicians. A more specific technique, 
explored in this thesis is the drinking of specific volumes of water for rapidly improving OH 
& its symptoms. 
 
3) MECHANICAL AIDS: BED TILT, CHAIRS, CROSS LEGS, STOCKINGS, And 
SUITS: A variety of simple manoeuvres can be learnt by patients to improve OH. These 
‘physical countermeasures’ include crossing the legs whilst standing or squatting. Such 
methods probably work by increasing vascular resistance or venous return [Ten Harkel et al 
1994]. In our experience, however, most patients with significant OH will have discovered 
some of these techniques themselves before seeking medical attention. Counter pressure 
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support garments may be applied to the legs [Sheps et al 1976] or even to the abdomen 
[Tanaka et al 1997]. However, these measures are often uncomfortable for the patient and 
may worsen peripheral pooling of blood on standing if they are subsequently not used.  Head-
up tilt of the patient’s bed at night helps increase extracellular fluid volume [Bannister et al 
1969]. This occurs both because renal perfusion pressures are lowered, reducing nocturnal 
diuresis, and because head-up tilt helps activate the renin-angiotensin system, causing fluid 
retention [Bannister 1977].  
 
 
 
PHARMACOLOGICAL TREATMENTS OF ORTHOSTATIC HYPOTENSION 
 
If the above non-pharmacological steps are insufficient to overcome the problems of OH, then 
drug therapy can be considered. It is important to remember that the above steps should not be 
abandoned if drug therapy is instituted, as they may still have a valuable role to play in 
combination with medication. Drug treatments for OH may be broadly divided into those 
which promote fluid volume expansion and those which cause vasoconstriction of resistance 
arterioles and capacitance veins. 
 
 
I) drugs promoting fluid retention: 
 
a) Fludrocortisone: Fludrocortisone (Florinef;  9-alpha flurohydrocortisone) is the most 
commonly used drug to alleviate OH, being first reported to alleviate OH in 1959 [Hickler et 
al 1959]. It is usually initiated at a dose of 100µg at night.  It is a synthetic mineralocorticoid 
and as such promotes sodium and water retention in a similar way to aldosterone. Studies 
have shown that there is indeed an increase in orthostatic cardiac output in AF patients treated 
with fludrocortisone [van Lieshout et al 2000]. There may be additional components to its 
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action. The fluid-retaining actions also seem to apply to the vessel walls themselves, and it 
has been shown that the pressor effects of amines in healthy subjects are increased by 
fludrocortisone [Tobian & Redleaf 1958; Schmidt et al 1966]. Fludrocortisone does not have 
direct pressor action but may increase both α- and β-adrenoceptors in AF patients [Bannister 
et al 1981; Davies et al 1982]. This enhancement of adrenergic pressor activity rather than the 
fluid retention may be the major factor in the treatment of OH in AF at therapeutic doses 
[Davies et al 1979]. 
 
Fludrocortisone is usually fairly well tolerated if the total daily dose is no greater than 200µg. 
However, a significant number of patients will need to discontinue this drug because of side-
effects. A study of 64 patients with OH found that 33% had had to discontinue fludrocortisone 
within 5 months of starting, most of these because of hypertension, cardiac failure or 
peripheral oedema [Hussain et al 1996]. It is interesting that although 24% of these patients 
developed hypokalaemia, in no case was the fludrocortisone stopped because of this. These 
side-effects help to emphasis that it is important to take into account the underlying condition 
causing OH. Whilst diabetic patients are prone to develop both OH and heart failure, patients 
with primary autonomic failure (such as MSA and PAF) are unlikely to develop cardiac 
failure, but are especially vulnerable to supine hypertension, which can be exacerbated by 
fludrocortisone. 
 
Liquorice (containing glycyrrhizic acid) increases blood pressure, sodium and fluid retention 
by a mineralocorticoid action. The mechanism involves inhibition of the enzyme 11 (beta)-
hydroxysteroid dehydrogenase which normally converts cortisol to cortisone [Sigurjonsdottir 
et al 2001; Quaschning et al 2001]. Cortisol but not cortisone has a marked mineralocorticoid 
action resulting in enhanced sodium and water retention. Although we have encountered 
patients who have found that taking liquorice improves their OH symptoms, there are marked 
risks of hypokalaemia which can be severe and occur at low doses [Olukoga et al 2000; 
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Stormer et al 1993; Cumming et al 1980] . For these reasons self medication with liquorice is 
probably best avoided unless regular checks of potassium levels are made.   
 
 
b) DDAVP:  DDAVP (desmopressin) is a synthetic vasopressin analogue.  Vasopressin is an 
agonist at both V1 and V2 receptors, causing vasoconstriction (of arterioles and venous 
capacitance vessels), and fluid retention (by action on the renal tubules) respectively. DDAVP 
however, is a selective agonist at V2 receptors, and so promotes fluid retention without 
vasoconstriction. These points allow DDAVP to be given at night to reduce nocturia in AF 
patients without exacerbating supine hypertension. Thus, extravascular and intravascular 
volumes will be less depleted, and so OH is improved, especially in the early morning when 
OH is normally at its worst [Mathias et al 1986]. DDAVP is normally taken at night by tablet 
or intranasal spray at a dose of 200µg orally or 20µg intranasally.  The major complication is 
that of hyponatraemia, which can develop soon after initiation, and so it is important to 
monitor serum sodium levels when commencing DDAVP [Mathias et al 1986, Mathias & 
Young 2003].   
 
c) NSAIDS. Non-steroidal anti-inflammatory drugs (NSAIDS) are known to promote sodium 
retention, and thus fluid retention. There are likely to be several mechanisms, including 
reduction of prostaglandin dependant chloride reabsorption and increased sodium re-uptake in 
the renal tubules [Oats et al 1988a; Oats et al 1988b]. This fluid retention manifests as clinical 
oedema in up to 5% of all patients on NSAIDS [Whelton & Hamilton 1991]. In autonomic 
failure other factors, such as increased sensitivity to angiotensin II and noradrenaline, may 
contribute towards a pressor effect [Davies et al 1980]. Studies have suggested a possible role 
for NSAIDS in OH. Interestingly the type of NSAID used may be important, with 
indomethacin appearing to have the most promising results, being even more effective than 
fludrocortisone in treating postural hypotension in Shy-Drager patients in one small study. 
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The significant morbidity associated with chronic NSAID use  tends to limit the use of these 
agents [Kochar & Itskovitz.1978; Bjarnason & Macpherson 1989; Pirson et al 1986] 
 
 
 
 
II) drugs enhancing vasoconstriction 
 
a) Ephedrine. Ephedrine is an orally active alkaloid with agonist action at both α and β 
adrenoreceptors [Hardman & Limbird 2001; Parfitt 1999]. Pressor effects occur both through 
activation of α1 receptors on resistance vessels, and via β1 receptor action causing increased 
heart rate. This lack of specificity of action means that ephedrine is contraindicated in patients 
with tachyarrhythmias and increases the risk of myocardial damage in susceptible individuals 
[Cockings & Brown 1997]. Ephedrine crosses the blood brain barrier, and insomnia and 
restlessness are well recognised side-effects [Hardman & Limbird 2001; Parfitt 1999]. 
Ephedrine has been shown to improve OH in AF, but as it also increases supine blood 
pressure, it is best to avoid taking in the hours before bed time [Davies et al 1978]. It has a 
half life of between 3-6 hours, and so is normally taken 3 times daily, with each dose being 
15mg-45mg [Parfitt 1999]. 
 
b) Noradrenaline. Noradrenaline has been recently shown to be of value in PAF and MSA 
with OH refractory to other treatment [Oldenburg et al 2001; Kribben et al 1998]. In these 
cases patient-controlled ambulatory noradrenaline infusion via a port-a-cath system has been 
shown to dramatically improve control of OH, although such invasive treatment would clearly 
require careful patient selection. Attempts have been made to enhance endogenous 
noradrenaline concentrations in sympathetic ganglia using a combination of tyramine (which 
releases catecholamine from pre-synaptic storage vessels) and monoamine oxidase inhibitors 
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(which enhance this action of tyramine). Such an interaction has been shown to improve 
control of OH but this effect may be marginal and associated with marked exacerbation of 
supine hypertension [Nanda et al 1976; Davies et al 1978].  
 
c) Midodrine. Midodrine (2’,5’-dimethoxyphenyl-beta-glycinamide-ethanol hydrochloride) 
is an oral agent leading to peripheral vasoconstriction by activation of α1 adrenergic receptors 
on veins and arterioles [Wright et al 1998; McClellan 1998]. Its actions are mediated by the 
active metabolite desgymidodrine, which is produced by hydrolysis of midodrine in the 
circulation. Maximal effect is reached 1 hour after taking midodrine. It has been shown to 
cause a significant increase in standing BP in patients with OH caused by a number of 
mechanisms [McClellan et al 1998; Young & Mathias 2004]. The risks of supine blood 
pressure in patients with OH associated with AF can be greatly reduced if the final daily dose 
is taken at least 4 hours before going to bed because of the short half life of midodrine, and a 
TDS regime is usually employed with individual doses between 2.5mg to 12.5mg [Wright et 
al 1998; McClellan 1998]. Although there is considerable experience of the use of midodrine 
over the past decade it is still not formally licensed for the treatment of OH in the UK. Side-
effects are usually mild, most commonly involving piloerection, parasesthesia, scalp pruritis, 
cutis anserina (‘Goose bumps’), formication and altered taste and smell perception 
[McClellan et al 1998; Young & Mathias 2004]. Overall midodrine is well tolerated and has 
been shown to be more effective than ephedrine in the treatment of OH [Fouad-Tarazi et al 
1995; Low et al 1997; McClellan et al 1998]. 
 
d) Octreotide:  Octreotide is a synthetic analogue of somatostatin, and like this endogenous 
compound it causes vasoconstriction of the splanchnic vascular bed, reduction of secretion of 
gastroenteropancreatic hormones, including insulin, and reduction of secretion of anterior 
pituitary hormones such as growth hormone [Battershill & Clissold 1989]. Octreotide has a 
longer half life (1.5 hours) than somatostatin, but has the disadvantage of requiring 
subcutaneous injection, reaching peak plasma values 30 minutes after injection [Parfitt 1999]. 
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Postprandial exacerbation of OH can be a debilitating problem for patients, especially those 
with AF. The mechanism is thought to involve enhanced insulin release and dilation of the 
splanchnic vasculature after meals rich in carbohydrates [Mathias 1997]. Octreotide has 
indeed been shown to improve post-prandial hypotension, especially when used in 
combination with midodrine [Armstrong & Mathias 1991; Hoeldtke et al 1998]. However, 
octreotide also appears to improve OH not related to food intake [Hoeldtke et al 1991; Alam 
et al 1995; Bordet et al 1995]. Usually octreotide is prescribed for severe post-prandial 
hypotension, with the patients injecting themselves just before meals. The main side-effects 
relate to abdominal pain and diarrhoea. 
 
e) Glypressin: Glypressin (triglycyllyseine-vasopressin)  is a synthetic vasopressin analogue 
acting as a V1 agonist without action on V2 receptors.  The resultant vasoconstriction of 
venous capacitance and arteriolar resistance vessels has been shown to improve OH in AF 
[Kochar et al 1985; Rittig et al 1991]. This pressor effect has been shown to be related to 
increased total peripheral resistance (TPR) rather than cardiac output [Rittig et al 1991]. 
Interestingly there may be a link between reduced endogenous vasopressin levels and the 
degree of OH in AF [Zeber et al 1983]. 
 
f) L-Threo-DOPS: L-Threo-DOPS (L-DOPS; L-threo 3,4-dihydroxyphenylserine; 
Doxidropa) is a synthetic noradrenaline precursor which is active both orally and intranasally 
[Suzuki et al 1982; Ando et al 1995]. L-DOPS has been clearly shown to reduce OH and its 
symptoms in MSA, PAF and haemodialysis patients [Tohgi et al 1993;Yoshizawa et al 1999; 
Mathias 2001]. Whilst not changing BP in healthy controls, L-DOPS leads to a peak increase 
in serum noradrenaline 3-5 hours [Suzuki et al 1982; Parfitt 1999]. Interestingly, L-DOPS 
also appears to have a central action, increasing muscle sympathetic activity (as measured by 
tibial nerve microneurography) in both healthy subjects and MSA patients [Nordenfelt & 
Mellander 1972; Tohgi et al 1993]. The MSA patients showed a rise in muscle sympathetic 
activity 30 minutes to 3 hours post L-DOPS ingestion, after which time the OH returned 
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despite peak levels of serum NA occurring at this time [Tohgi et al 1993]. These results 
suggest that the central actions of L-DOPS may be more important to its pressor effect than its 
peripheral production of NA. An additional factor in OH control may be the increase in 
Angiotensin II levels and rennin activity observed 2 weeks into L-DOPS treatment in MSA 
patients [Tohgi et al 1993]. Overall, L-DOPS appears to be well tolerated and in Parkinsonian 
subjects has additional benefits of reducing episodes of freezing. L-DOPS is usually taken 
orally, with the dose of 300mg twice daily being recommended as optimum [Tohgi et al 1993; 
Mathias 2001}. 
 
g) Dihydroergotamine: Dihydroergotamine is a semi synthetic ergot alkaloid which has 
occasionally been used to treat OH via its vasoconstrictive actions [Nordenfelt & Mellander 
1972; Parfitt 1999]. The major draw back to Dihdroergotamine is its poor bioavailability; 
whilst it can be delivered by parenteral routes, this tends to be more appropriate for its other 
main indication, that of acute migraine treatment, than several times daily chronic use as for 
OH [Bobik et al 1981]. Supine hypertension is exacerbated and nausea, vomiting and 
vasospasm are recognised side-effects [Parfitt 1999].  
 
 
 
iii) drugs working via other mechanisms 
 
a) Erythropoietin: Erythropoietin (EPO) increases haematopoiesis in response to 
hypoxia and has been shown to improve OH in autonomic failure [Hoeldtke & 
Streeten 1993; Biaggioni et al 1994; Winkler et al 2002]. Autonomic failure can be 
associated with erythropoietin deficiency anaemia, presumably because renal 
sympathetic activity stimulates erythropoietin secretion [Beynon 1977; Biaggioni et 
al 1994; Winkler et al 1999; Winkler et al 2001; Winkler et al 2002]. Although EPO 
increases haematocrit in these patients, there was not an associated increase in plasma 
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volume [Hoeldtke & Streeten 1993; Winkler et al 2002]. The major mechanism 
appears to be related to an increase in total peripheral resistance, likely to be in turn 
due to increased oxygen tension reducing NO-mediated vasodilatation [Rao & 
Stamler 2002]. The available data suggests that anaemic patients with AF and OH 
could benefit from EPO. However, EPO is not without risks, notably of 
cardiovascular morbidity and mortality, is expensive, and a formal randomised trial of 
its effectiveness in OH is still awaited [Besarab et al 1998; Rao & Stamler 2002]. 
 
b) Pyridostigmine: The reversible cholinesterase inhibitor pyridostigmine has recently 
been proposed as an alternative treatment for orthostatic hypotension. Pyridostigmine 
has long been used for myasthenia gravis as it delays breakdown of acetylcholine 
(Ach) at the skeletal neuromuscular junction. It produces a similar effect at 
sympathetic ganglia, thus enhancing existing sympathetic drive. It thus has been 
proposed as a “smart” drug that acts mainly when required (when the subject is 
upright leading to increased sympathetic activity) [Singer et al 2006]. Thus the 
theoretical attraction is that increased vasoconstrictive effects would not occur when 
the subject is supine (as existing sympathetic activity is less), reducing the risk of 
supine hypertension. In practice the effect on orthostatic hypotension in MSA and 
PAF is modest at 60mg and concerns remain about side-effects with 29% of subjects 
who initiated maintenance pyridostigmine bromide discontinuing therapy [Gales BJ 
2007]. 
 
 
 
iv) Future drugs to aid postural hypotension 
 
a) NOS inhibitors: Nitric Oxide (NO) is a powerful vasodilator produced from L-Arginine 
by the enzyme Nitric Oxide Synthase (NOS). In healthy humans NO is involved in the basal 
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regulation of vascular tone [Palmer et al 1987]. NO-mediated vasodilatation has been shown 
to be exaggerated in humans after sympathectomy [Charkoudian et al 2002]. NOS inhibition 
by agents such as L-NMMA may also cause increase in blood pressure in healthy young 
subjects. Some studies have shown that infusions of L-Arginine lower BP in normal and 
hypertensive subjects, and in patients with AF L-Arginine has a profound hypotensive effect 
[Ebel et al 1993; Kimber et al 2001]. It is possible that this marked hypotension is caused by 
an increase in NO production caused by the L-Arginine, but there are some questions 
regarding this. 
 
 
 
b) Endothelin agonists/antagonists: Endothelin (ET) is one of the most potent 
vasoconstrictors known. The normal increase in serum ET on assuming upright posture may 
be impaired in OH [Kaufmann 1991]. Its vasoconstrictor actions are primarily mediated via 
ETA receptors. ETB receptors modulate this action increasing ET breakdown and also 
leading directly to vasodilatation by an NO related mechanism. Inhibition of ETB receptors 
by the ET-B receptor antagonist BQ788 leads to vasoconstriction but without increase in 
blood pressure in healthy subjects by enhancing the action of ET [Strachan et al 1999]..  
 
An additional way to enhance the vasoconstrictor effect of ET is to reduce its breakdown by 
inhibition of Neutral Endoeptidase (NE). NE is a membrane bound enzyme involved in the 
breakdown of ET. It is also important in metabolism of Angiotensin II, ADH and bradykinin. 
However, studies in healthy patients show that not only is the predominant action of NE 
inhibitors to cause vasoconstriction without increase in blood pressure, but that only the 
inhibition of ET (with ETA inhibitor) is sufficient to prevent this vasoconstriction. ACE 
inhibition does NOT prevent the vasoconstriction implying that ET action is the predominant 
mechanism. The Neutral Peptidase inhibitor Candoxatril does indeed cause vasoconstriction 
in normal subjects [Ferro et al 1998].  
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Neither of the above agents has yet been evaluated for use in treating OH, but provides an 
interesting future area of research. 
 
 
 
CONCLUSIONS: OH is a common and debilitating problem. Exclusion of treatable causes 
such as medication, hypovolaemia (including rare pathologies such as Addison’s disease and 
common ones such as dehydration) should be initially performed. Most other cases will 
respond to non-pharmacological methods. If OH persists despite these, then the possibility of 
AF should be considered and, if suspected, evaluated with formal autonomic function tests. 
The next stage of treatment will normally take the form of fludrocortisone 100µg once daily, 
increasing if needed to 200µg once daily, with vigilance for hypokalaemia being required. 
Excessive fluid retention is the other major problem which may be encountered, and for this 
reason fludrocortisone is not recommended for dialysis patients with OH, and leg oedema 
may be considered an unacceptable side-effect in some other patients. If fludrocortisone alone 
is insufficient ephedrine is usually added at a dose of 15mg-45mg three times daily. Contra-
indications include tendency to tachyarrhythmias. Midodrine can be added in if required at a 
dose of 2.5mg-12.5mg three times daily. Both midodrine and ephedrine should be avoided in 
the hours before bedtime due to the risk of exacerbating supine hypertension. 
 
If early morning hypotension is a major problem, especially when associated with nocturia, 
DDAVP (typical doses 200µg orally or 20µg intranasally) may be tried at night. Serum 
sodium should be checked for evidence of hyponatraemia. Post-prandial hypotension, if not 
improved by the reduction of carbohydrate component of the meal, may respond to octreotide 
subcutaneous injections, typically 50-100µg up to three times daily just before a meal. 
Finally, in AF OH is sometimes exacerbated by anaemia. If these patients exhibit resistant 
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OH, then erythropoietin can be tried by subcutaneous injection (such as 50units/kg body 
weight 3 times weekly). The various other medications described in this review and elsewhere 
in the literature are probably best only considered in cases resistant to the medications 
described above. 
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1.2:  Multiple System Atrophy (MSA)  
         
 
 
 
Introduction 
 
  
MSA is a sporadic, progressive adult-onset disorder characterized by autonomic dysfunction, 
Parkinsonism and ataxia in any combination [Gilman et al 1998 & 1999]. The condition we 
now know as MSA has undergone several changes in nomenclature over the years. It is even 
possible that James Parkinson’s first case in his classic 1817 paper ‘An Essay on the Shaking 
Palsy’ was in fact a case of MSA [Quinn 1994], although on reading the original paper, 
reprinted recently, this distinction is less clear [Parkinson 1817]. The first report of sporadic 
olivopontocerebellar atrophy was in 1900 [Dejerine and Thomas 1900], with additional 
pathological involvement of the basal ganglia confirmed in 1918 by Stauffenberg 
[Stauffenberg 1918]. At the beginning of the 1960s two separate subtypes of MSA were 
described with striatonigral degeneration [van der Eecken et al 1960; Adams et al 1961] and 
orthostatic hypotension predominant MSA [Shy & Drager 1960]. The term MSA itself was 
introduced by Graham & Oppenheimer [Graham & Oppenheimer 1969], although it was 
twenty years later before the hallmark glial cytoplasmic inclusion bodies were described, 
giving neuropathological justification for the description of MSA as a group [Papp et al 
1989]. Nine years later sub-cellular description of these inclusion bodies as being 
consistently α-synuclein positive was the next major step forward [Wakabayashi et al 1998 
and Spillanti et al 1998]. Classification of MSA has been modified to incorporate these new 
findings from Quinn’s first proposal for a unifying classification in 1989 [Quinn 1989] to the 
Consensus guidelines of Gilman et al [Gilman et al 1998 and 1999]. Originally 3 sub-groups 
of MSA were described: MSA-C (cerebellar type), MSA-P (Parkinsonian-type) or Shy 
Drager Syndrome (where autonomic dysfunction is the major feature). The new Gilman 
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criteria have encouraged a generalized diagnosis of ‘MSA’ in which initial presentations 
may be broadly divided into two, namely MSA-P for striatonigral degeneration with 
predominant Parkinsonian features (SND) and MSA-C for olivopontocerebellar atrophy with 
predominant cerebellar atrophy (MSA-C), with the older Shy-Drager syndrome with 
prominent autonomic features being discouraged. Both SND and MSA-C have similar life 
expectancies [Ben-Shlomo et al 1997] with SND being more common in the West (49% of 
cases) [Geser et al 2005], although up to two-thirds had additional cerebellar dysfunction 
[Gilman et al 2005]. Increasingly it appears that both the final clinical and neuropathological 
endpoint is similar no matter what the presentation [Ozawa 2004] and as such MSA can be 
treated as a unified group. It is possible that MSA still represents a heterogeneous group of 
aetiologies, but there is not clear evidence that clinical features of investigations can reliably 
split the diagnosis further at present. For this reason the studies described in this thesis, all 
using clearly established cases of MSA established not only with the Gilman criteria but also 
in most cases with additional investigations such as Clonidine or sphincter EMG testing, 
have addressed MSA subjects as a group rather than attempting to further subdivide them 
along arbitrary lines. Sub-set analysis of my studies with MSA separated into MSA-C, 
MSA-P or Shy Drager failed to show any significant differences in results during my studies, 
further supporting this view. Studies, mainly based in the USA, have attempted to clarify the 
epidemiology of MSA. An example is a 14-year survey [Bower et al 1997], which followed 
people over the age of 50 in Minnesota. No convincing evidence of a potential 
environmental toxin has been yet suggested, although the possibility of increased risk 
amongst farmers exposed to pesticides, as with PD, remains, with a weakly protective effect 
apparently provided by a history of smoking as with PD [Vanacore 2005]. 
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Clinical Features of MSA 
 
The incidence of MSA has been estimated at 3 new cases per 100,000 per year [Bower et al 
1997] placing it as an uncommon but not rare condition on a par with Huntington’s disease 
and Motor Neuron disease. Point prevalence is similar at 1.9-4.9 per 100,000 [Chrysostome et 
al 2004]. Males may be slightly more affected than females (1.3:1) [Wenning et al 1997]. 
Although still referred to as a sporadic disease, the possibility of rare cases with family 
history has recently been raised [Soma et al 2006]. Unfortunately there is a relatively poor 
prognosis following diagnosis, with a mean survival of 6-9 years with onset usually in the 5th-
6th decade of life [Ben-Shlomo et al; Watanabe et al 2002]. Cases can present as young as the 
late 30’s however, and there is substantial variation of disease progression with survival of 
more than 15 years after diagnosis being possible.  The main features include autonomic 
failure, Parkinsonism, cerebellar ataxia, and pyramidal signs in any combination. In a 
prospective study of 87 MSA subjects in the first year of their diagnosis in the USA, there 
were 56 male and 31 female subjects with a mean age of 63+/-8.6 years (mean+/-standard 
deviation) [Gilman et al 2005]. In this group, Parkinsonian and autonomic symptoms were the 
commonest presentations. About a third had experienced postural syncope with more 
experiencing presyncope events in the upright position. Erectile dysfunction was almost 
universal in the male subjects and this is invariably one of the earliest symptoms in male 
subjects.  Examination confirmed Parkinsonian features in the majority of these patients, with 
bradykinesia, postural instability of the Parkinsonian type and rigidity affecting most subjects. 
Two-thirds showed postural tremor, one third had a resting tremor with symptoms being 
persistently asymmetrical in up to a third. Unsteadiness and falls with ataxia of gait, speech 
and limbs related to cerebellar dysfunction were present in most patients. Dysphagia was 
common with urinary incontinence and incomplete bladder emptying with constipation 
reported in a large majority. Sleep disorders occurred in approximately two-thirds of patients, 
with vivid dreams in about half, often occurring years before other symptoms. Interestingly in 
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view of emerging cognitive research in MSA, almost one-third of subjects complained of 
memory impairment. Sweating impairment may also be present but is variable and will 
usually not be a symptom volunteered by the patient unless directly asked for. 
 
Although pathological and clinical studies show that MSA is ultimately a fairly homogenous  
condition whatever the initial symptoms, two major initial presentations are still described. In 
MSA-C the initial symptoms reflect the prominent cerebellar involvement with dysfunction 
leading to ataxia of gait, kinetic limb movements, speech (scanning dysarthria) and eye 
movements. Pure cerebellar disorders of course may present in a similar manner, but in MSA 
the additional features, including autonomic and Parkinsonian features will eventually declare 
themselves. Between 29-33% of patients with apparently isolated cerebellar ataxia will 
ultimately go to develop MSA [Gilman et al 2000; Abele et al 2002] 
 
An apparent limb kinetic tremor can develop in MSA-P presentations of MSA, although this 
actually reflects a jerky postural tremor. Resting tremor, characteristic of PD, occurs less 
commonly in MSA, although akinesia and rigidity is often present. Despite this and the 
frequent presence of OH, early falls would be more characteristic of progressive 
supranuclear palsy (PSP).  Orofacial or craniocervical dystonia when present can be severe, 
and other related disorders such as head drop (antecollis) would be atypical for idiopathic PD 
[Wenning et al 2003]. Dystonia of the vocal cords may also occur, leading not only to a 
high-pitched strained voice but to a danger of aspiration pneumonias. Finally, although the 
Parkinsonian features may initially be responsive to levodopa in nearly a third of cases, up to 
half of those so treated develop dyskinesias [Boesch 2002].  
 
 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      48                                            
Clinical diagnostic criteria 
 
 
Quinn first proposed clinical diagnostic criteria to subdivide cases into both possible and 
probable MSA, and then into striatonigral-degeneration type (SND) or olivopontocerebellar-
atrophy type (OPCA) MSA based on the dominant motor symptom- Parkinsonism or 
cerebellar ataxia respectively [Quinn 1989]. A definite diagnosis of MSA could only be 
made with neuropathological confirmation. Unfortunately, despite providing a good 
specificity, the Quinn criteria have since been shown to offer relatively poor sensitivity 
based on clinicopathological studies [Litvan et al 1998]. Therefore internationally accepted 
consensus criteria have been developed for the clinical diagnosis of MSA [Gilman et al 1998 
& 1999]. The Consensus criteria are used worldwide for clinical studies involving MSA, and 
have been used throughout this thesis in establishing MSA subjects for the studies. As with 
the Quinn criteria, MSA is categorized into possible, probable or definite MSA 
(pathologically confirmed by the presence of a high density of glial cytoplasmic inclusions 
in association with a combination of degenerative changes in the nigrostriatal and 
olivopontocerebellar pathways.). The further subdivision into MSA-C or P is no longer key 
to the diagnosis, reflecting the ultimate clinical and neuropathological similarities.  
 
In practice these criteria may be applied to the diagnosis of MSA as follows [adapted from 
Gilman et al 1999]: 
 
Exclusion Criteria:   a) HISTORY: If onset is under 30 years of age, a family history of 
similar condition, another significant systemic condition which could explain the features, or 
hallucinations unrelated to medication. 
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                                      b) EXAMINATION: DSM IV criteria for dementia, prominent 
slowing of vertical saccades or vertical supranuclear gaze palsy or evidence of focal cortical 
dysfunction such as aphasia, alien limb syndrome, and parietal dysfunction. 
                                      c) INVESTIGATIONS: Metabolic, molecular genetic and imaging 
evidence of an alternative cause of features 
 
      B)      Clinical domains, features, and criteria used in the diagnosis of MSA:   
Possible MSA requires 1 criterion plus 2  features from separate other 
domains. When the criterion is Parkinsonism, a poor levodopa response 
qualifies as one feature (hence only one additional feature is required). 
Probable MSA requires criterion for autonomic failure or urinary 
dysfunction plus poorly levodopa-responsive Parkinsonism or cerebellar 
dysfunction. 
 
I) Autonomic and urinary dysfunction Domain 
Features: Orthostatic hypotension (by 20 mm Hg systolic or 10 
mm Hg diastolic), urinary incontinence or incomplete bladder 
emptying. 
Criteria: Orthostatic fall in blood pressure (by 30 mm Hg systolic or 15 mm Hg 
diastolic) or urinary incontinence (persistent, involuntary partial or total bladder 
emptying, accompanied by erectile dysfunction in men) or both 
 
II) Parkinsonism Domain 
Features: Bradykinesia (slowness of voluntary movement with 
progressive reduction in speed and amplitude during repetitive 
actions) or Rigidity or Postural instability (not caused by primary 
visual, vestibular, cerebellar, or proprioceptive dysfunction) or 
Tremor (postural, resting or both) 
Criteria: Bradykinesia AND at least one other Parkinsonian Feature 
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III) Cerebellar Dysfunction Domain 
             Features: Gait ataxia (wide based stance with steps of irregular 
length and direction) OR Ataxic dysarthria OR Limb ataxia OR  
Sustained gaze-evoked nystagmus 
                   Criteria: Gait ataxia AND at least one other cerebellar dysfunction 
feature 
 
IV) Corticospinal tract dysfunction Domain 
Features: Extensor plantar responses with hyper-reflexia 
Criteria: NIL 
  
 
Additional “Red Flags” suggestive of MSA [adapted from Wenning et al 2004] 
Atypical spontaneous or levodopa induced dystonia or dyskinesia mainly affecting 
orofacial muscles, occasionally resembling risus sardonicus of cephalic tetanus. 
Axial dystonia (Pisa syndrome (subacute axial dystonia with a severe tonic lateral 
flexion of the trunk, head, and neck) or early severe camptocormia) 
Disproportionate antecollis  (Chin on chest, neck can only be passively and forcibly 
extended to its normal position with difficulty; despite severe chronic neck flexion, 
flexion elsewhere is minor). 
Abnormal respiration (including inspiratory stridor and classically involuntary deep 
inspiratory sighs and gasps which are seen frequently in MSA.  Sleep apnoea (arrest of 
breathing for >10 s), and snoring increased from premorbid level. 
Intermittent loss of muscle atonia and appearance of elaborate motor activity (striking 
out with arms in sleep often with talking or shouting) associated with dreaming 
Cold hands or feet (Coldness and colour change (to purple or blue) of extremities not 
caused by drugs Although may be exacerbated by ergot derived agents), blanching on 
pressure and poor circulatory return) 
Emotional incontinence (i.e. inappropriate crying without sadness or laughing without 
mirth) 
 
Table 1:1  Red flags to aid the diagnosis of MSA [Adapted from Wenning et al 2004] 
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Investigations 
 
As outlined above, the diagnosis of MSA using the Consensus guidelines is based on clinical 
history and neurological examination. These guidelines do suggest that additional 
investigations can be used to further support the diagnosis, although they play no part in 
classifying into possible or probable MSA mainly because the results of investigations into 
MSA are not well known at the early stage of presentation when a diagnosis needs to be 
made. Autonomic function tests play an important role not only in supporting the diagnosis 
but also monitoring the progression of such features as orthostatic hypotension, which is a 
treatable symptom. In a similar way sleep studies and video fluoroscopic swallow testing 
help monitor the progress of respiratory and swallowing impairments, which may be at least 
modifiable factors.  
 
  
Cardiovascular Autonomic Function Testing 
 
Orthostatic hypotension (OH) is one of the most striking cardiovascular abnormalities that 
can develop in MSA but may be clinically silent, and is not an uncommon finding in healthy 
subjects over 50 years of age. OH is usually assessed with tilt table testing is part of standard 
autonomic function testing. In our autonomic function laboratory subjects are investigated 
after a stable haemodynamic baseline had been obtained after 20 minutes supine. The subject 
is then secured to the tilt table test and tilted head-up to 60o for 10 minutes (or less time if 
not tolerated) before being returned to supine. BP and HR monitoring is measured both with 
Intermittent brachial BP values every 3 minutes using an automated Dinamap (Critikon) 
sphygmomanometer on the left arm and continuous measurement of beat-to-beat BP is 
simultaneously obtained non-invasively throughout with the Portapres II device on the 
middle finger of the right hand. OH, defined as a drop in systolic blood pressure of 20 
mm Hg or more (or 10 mm Hg or more in diastolic blood pressure), compared with baseline 
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is assessed for on upright tilt, although supine to seated to standing posture may also be used 
in addition to the tilt table testing [Gilman et al 1999], although mild OH is not an 
uncommon finding amongst otherwise healthy subjects in a similar age range. In addition to 
OH, MSA subjects may also have a reduction in the expected increase in HR on upright 
posture.  
The Valsalva manoeuvre allows assessment of the baroreflex pathways. The seated subject 
blows with an open glottis into a disposable syringe connected to the mercury column of a 
sphygmomanometer, attempting to maintain a forced expiratory pressure of 40 mmHg for 10 
seconds. This normally causes a rise in intrathoracic pressure, leading to reduction in venous 
return and BP with increase in HR whilst the pressure is maintained. In healthy subjects this 
action induces an increase in sympathetic activity, resulting in a brief BP overshoot 
compared to baseline when the pressure is released. Normally this is rapidly compensated by 
a reduction in HR caused by activation of the baroreflex response to the BP overshoot. In 
sympathetic cardiovascular failure the initial sympathetic activation is impaired, thus when 
the pressure is released the BP remains low and only slowly returns to baseline. If there is 
parasympathetic impairment the HR does not markedly increase during the Valsalva 
manoeuvre itself. The Valsalva manoeuvre occurs over such a short time frame that beat-to 
beat assessment with devices such as the Portapres are essential in its analysis. Various 
derived ratios may be obtained from this test. One of the commonest derived is the Valsalva 
ratio which is the maximum rise in HR during the manoeuvre (phase II) divided by the 
minimum HR in the first 30 seconds after the pressure is released (phase IV). This ratio is 
usually 1 or less in autonomic failure. There are problems with this test however, with not all 
subjects able to perform it adequately, especially with the motor complications often found 
in MSA. In addition the test simultaneously measures facets of both parasympathetic and 
sympathetic activity. It therefore has a limited role in analysis of AF. A clearer test of 
parasympathetic cardiovascular function is probably the measure of HR variability on deep 
breathing. Age adjusted values for healthy subjects are available for comparison [Mathias 
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and Bannister 1999] However questions had been raised about the ability of abnormal 
cardiovascular autonomic function tests to differentiate conditions such as MSA and PD 
[Riley and Chelimsky 2003].  
Pressor tests provide testing of the sympathetic nervous system and elicit a transient increase 
in systolic and diastolic blood pressure (SBP and DBP) and increased heart rate (HR) 
[Mathias 1999; Mathias 2004]. There are 3 standard pressor stimuli: Isometric Exercise (IE) 
evoked by sustained handgrip; Mental Arithmetic (MA) evoked by the subject performing 
serial subtractions; Cold Pressor (CP) evoked with application of an icepack to the hand. All 
three stimuli lead to pressor effects by activation of the sympathetic nervous system, but the 
pathways involved differ. CP evokes a pain response involving of Aδ and C afferent fibres 
and subsequent activation of brainstem structures leading to increased sympathetic outflow 
[Hilz et al 2002; Petrovic et al 2004]. With MA, by contrast, there is initial activation of 
central areas such as the right insula and right anterior cingulate, resulting in increased 
sympathetic outflow [Critchley et al 2000]. IE has important peripheral and central input to 
the medullary vasomotor centres, although there have been contrasting views as to the 
relative importance of these inputs in the generation of the IE pressor effect it is currently 
felt that both play a significant role [Alam and Smirk 1937; Victor et al 1989; Winchester et 
al 2000; Critchley et al 2000]. 
 
 
Urogenital Dysfunction-Bladder ultrasound and Urodynamics 
 
Urogenital dysfunction is common in MSA. Erectile dysfunction is one of the earliest 
symptoms in Male MSA subjects, being almost universal [Kirchhof et al 2003]. Neurogenic 
bladder dysfunction may actually be commoner in early stages of MSA than OH [Sakakibara 
et al 1999]. Both incontinence and retention can be early problems. Whilst the incontinence 
can severely affect quality of life, and may predispose to reduced fluid intake in an attempt 
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to control symptoms, retention can result in urinary tract infection with occasionally serious 
sequelae. Detrusser failure appears to be a major mechanism  [Ito et al 2006]. Whatever the 
underlying cause, uro-dynamic and static (such as bladder ultrasound) studies allow 
assessment of important variables such as post-void residual volume. At much over 100mls 
the risk of recurrent urinary tract infections is high and measures to reduce the volume such 
as clean intermittent self-catheterization (CISC) may be beneficial to reduce this risk. Unlike 
in PD, MSA subjects tend to show stress incontinence from an early stage, with urodynamic 
studies showing a particular pattern of progression. Detrusser hyper-reflexia, with abnormal 
urethral sphincter function (causing frequency and urge incontinence) occurs early in MSA. 
With advancing disease the bladder may become atonic, leading to increased post-void 
residual volumes [Kirby et al 1986]. 
 
  
Sphincter Electromyogram (EMG) 
 
Due to the frequent early involvement of Onuf’s nucleus in MSA, denervation of the 
external anal and urethral sphincters occurs. As with the denervation that occurs in motor 
neurone disease, the resultant spontaneous muscle activity and polyphasia that results may 
be detected with needle EMG. Although the technique can be challenging both for the 
operator and patient, some 80% of MSA cases show these findings [Palace et al 1997]. The 
prevalence of abnormalities in early stages of MSA is unknown. Although fairly sensitive, 
sphincter EMG has problems of specificity, especially in multiparous women (vaginal 
deliveries) where obstetric complications may similarly cause denervation changes in the 
sphincters [Colosimo et al 2000]. Similar changes have also been found in PD and PSP 
[Valldeoriola et al 1995; Giladi et al 2000]. Despite these limitations, sphincter EMG in 
experienced hands seems to a useful tool in helping to establish a likely diagnosis in early 
cases when other confounding factors have been excluded  [Vodusek 2001]. 
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Other Investigations 
 
Polysomnography: REM-sleep behaviour disorder may precede other clinical features of 
MSA, sometimes by many years [Plazzi et al 1997]. This is likely to related to both marked 
striatal monoaminergic deficit and subcortical and brainstem disease in MSA with damage to 
the sleep atonia cells of the pons. In addition respiratory signs may be unmasked during 
polysomnography. Nocturnal or diurnal inspiratory stridor and classically involuntary deep 
inspiratory sighs and gasps are seen frequently in MSA.  Sleep apnoea (arrest of breathing 
for >10 s), and snoring increased from premorbid level, or newly arisen, are important, not 
merely from a diagnostic perspective but also have therapeutic relevance with CPAP 
treatment sometimes indicated. 
 
Video fluoroscopy: Dysphagia is a serious complication of MSA, and is closely related to 
overall prognosis [Muller et al 2001]. Both video fluoroscopy and manometry may be used to 
investigate dysphagia. As with idiopathic Parkinson’s disease, the oral phase of swallowing 
was most commonly involved, with a delay in bolus transport from the oral cavity to the 
pharynx being the commonest dysfunction, found in over two-thirds of MSA. In nearly half of 
cases bolus holding in the oral cavity was also disturbed, with slowing of the upward 
relocation of the larynx was also found in over a third [Higo et al 2003]. The bolus transport 
phase was affected to a greater extent when cerebellar symptoms were prominent, presumably 
relating to poor tongue coordination impairing control of the food bolus [Ryuzaburo et al 
2005]. These authors also raise a very important point, namely that aspiration can still occur 
in MSA even if it is not detected on standard video fluoroscopy. This may reflect the fact that 
video fluoroscopy is performed under optimum conditions, not always reflecting the 
conditions of everyday swallowing. Testing the cough reflex may increase the sensitivity of 
aspiration risk assessment [Addington et al 1999]. 
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Pupillograhy: Pupil abnormalities may be found in MSA, although not universally. Iris 
atrophy and anisocoria were reported in both of the original cases of Shy and Drager’s 
patients [Shy and Drager 1960]. Since then the finding of anisocoria has been replicated, 
although some patients with MSA may have in fact had had unilateral Horner syndrome. Up 
to 70 % of MSA cases appear to have normal pupils, despite extensive autonomic dysfunction 
elsewhere  [Thomas et al 1970]. 
 
 
Blood Tests: Blood testing usually has a limited role in MSA management. Catecholamine 
levels and growth hormone levels following clonidine administration have been used to help 
in the diagnosis of MSA. Supine plasma noradrenaline levels are within the normal range, 
reflecting the preserved postganglionic sympathetic efferent activity, with Noradrenaline 
(NA) spill over from nerve terminals into the blood [Mathias 1999]. On upright tilt however, 
increases in NA are reduced relative to normal, reflecting the lack of sympathetic activation 
because of central sympathetic outflow obstruction in MSA [Mathias 1999]. Intravenous 
infusion of the selective α2-adrenoceptor agonist clonidine has been used in the investigation 
of Parkinsonian syndromes, as clonidine-induced release of growth hormone (GH) is impaired 
in MSA but spared in pure autonomic failure (PAF) and PD where the lesion site is 
postganglionic [Thomaides et al 1992]. Similarly, both circadian release, and release 
secondary to postural challenge, of the hormone ADH from the posterior pituitary is impaired 
in MSA [Benarroch et al 2006], presumably because of hypothalamic involvement. Other 
roles of blood sampling include the occasional need to exclude celiac disease or SCA 
(spinocerebellar atrophy) genetic mutation in certain atypical presentations. Many MSA 
subjects are prescribed fludrocortisone to treat postural hypotension. As a mineralocorticoid, 
the possibility of hypokalaemia needs to be borne in mind and periodic potassium 
measurements may be indicated. 
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Cerebrospinal fluid (CSF) Analysis: Increased CSF levels of neurofilament light chain and 
tau and decreased levels of 3-methoxy-4 hydroxyphenylethyleneglycol have been found to 
relatively specific in differentiating the cerebellar subtype of multiple-system atrophy from 
idiopathic late-onset cerebellar ataxia. CSF potentially could provide a useful marker, as it is 
contiguous with the extracellular fluid of brain structures. Neurofilament light chain (NFL) 
protein appeared to have the greatest specificity. NFL proteins appear to have an important 
role in the axonal microenvironment, being involved in cytoskeletal plasticity. [Lycke et al 
1998]. CSF examination however is not standard practice in the work-up of MSA, not least 
because it requires an invasive procedure (lumbar puncture) and NFL protein estimations are 
not widely available. 
 
Imaging 
 
 
 
MRI 
 
 
MRI scanning of the brain has been investigated as a tool both to strengthen the diagnosis of 
MSA and to monitor its progression. This later aspect is an important baseline to establish 
now that trials of neuroprotective agents in MSA have begun [Geser et al 2005]. It has been 
known for some time that MRI may potentially show characteristic abnormalities in the 
striatum, brainstem, and cerebellum in patients with MSA. This has been used to aid 
differentiation of early MSA-P from PD in some research studies. Striatal abnormalities 
include putaminal abnormalities such as atrophy, T2 hypointensity and ‘‘slit-like’ marginal 
hyperintensity (Fig. 1.1). Only half of MSA-P subjects have putaminal slit changes on T2 
within 3 years after symptom onset, increasing to 86% after 6 years [Horimoto et al., 2002]. 
Of putaminal changes, the atrophy appears to be most specific for MSA, whilst hyper-or 
hypointensities may also be seen in idiopathic PD [Bhattacharya et al.2002; Seppi 2005]. 
Exact sensitivities are difficult to calculate as MRI strength (in Teslas), slice thickness and 
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use of conventional or fast spin echo images will affect the image quality. The slit-like 
hyperintensity sign is likely to reflect gliosis [Schwarz et al 1996]. Brainstem changes include 
atrophy (especially of the pons and lower brainstem, middle cerebellar peduncles, and 
cerebellum). These areas may also demonstrate T2 weighted hyperintensity changes including 
the classical “hot cross bun” sign when the pontocerebellar degeneration takes a cruciform 
appearance (fig 1.1) [Bürk et al 2001; Bhattacharya et al., 2002; Seppi et al 2005]. This sign is 
felt to be due to degeneration of pontocerebellar fibres leading to hyperintensities in the pons 
and middle cerebellar peduncles, but is not unique to MSA [Muqit et al., 2001]. Cerebellar 
involvement primarily involves atrophy, which is often but not always associated with 
cerebellar dysfunction. 
 
 
 
 
 
 
Figure 1:1: Slit-like putaminal hypointensity (left image-arrowed) [Seppi et al 2005] and 
hot cross bun sign (right image-arrowed) with extensive pontine, middle cerebellar 
peduncle and cerebellar atrophy [Bürk et al 2001] 
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Advanced MRI related Techniques 
 
 
 
Whilst conventional MRI focuses primarily on structural findings, Proton magnetic resonance 
spectroscopy (1H-MRS) studies brain metabolism. 1H-MRS detects several metabolite signs, 
including N-acetylaspartate (NAA), choline (Cho) and creatine /phosphocreatine (Cr). NAA 
reflects the integrity of neurons, Cho the integrity of membranes and glial activity, with Cr 
being a marker for general metabolism. Reduced NAA/Cr ratios in the lentiform nucleus and 
the pons have been reported in MSA [Davie et al 1995; Watanabe et al. 2004]. There is 
evidence to suggest that the increased resolution provided by increased Telsa strength MRIs 
may further enhance the usefulness of 1H-MRS in diagnosing MSA at an early stage.  
 
 
Diffusion-weighted imaging (DWI) is often included in standard MRI sequences in clinical 
use and utilizes the diffusion of water, classically used to diagnose acute ischaemia. It utilizes 
the fact that, whilst intact nerve tracts and other cellular architecture closely restrict the ability 
of water to diffuse, damage to these structures increases the ability of water molecules to 
diffuse in random directions. Quantification of diffusion is performed by applying differing 
field gradients, from which the apparent diffusion coefficient (ADC) is derived. The trace of 
diffusion tensor is then calculated from the sum of ADCs measured in three orthogonal 
directions allowing assessment of brain structures damaged by either acute or ongoing insults. 
DWI may be more accurate than IBZM SPECT in the differential diagnosis of MSA-P versus 
PD [Seppi et al. 2004]. Magnetization transfer imaging (MTI) sequences provide further 
details which are based on the application of irradiation selectively saturating the energy level 
of bound protons, inducing an exchange of magnetization between bound and free protons, 
thus reducing the signal intensity of bound protons. Magnetization transfer ratios (MTRs) are 
then calculated, correlating with the degree of myelinisation and with axonal density [Seppi et 
al 2005].  
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Atrophy may be assessed accurately by use of MRI-based volumetry. By focusing on the 
volume reduction in specific areas such as the striatum and brainstem it has been possible to 
fairly accurately distinguish MSA from PD and PSP although there was some overlap of cases 
[Schulz et al. 1999]. Comparison of brain FDG PET and MR volumetry has suggested near 
equal ability at diagnosing MSA, with no further gain in accuracy if the techniques were 
combined [Ghaemi et al. 2002)]. The use of voxel-based morphometry has highlighted more 
distant atrophy in MSA in the cortex, presumably reflecting striatal projections [Ghaemi et 
al.2002].  
 
MRI may also be used to measure the progression of MSA. At present this is primarily a 
research tool but gaining clinical relevance in the era of trials of neuroprotective agents in 
MSA. Measurement of MSA progression by MRI and is also helpful in evaluating the 
sequence of changes as MSA progresses. Such studies have suggested that putaminal 
DWI parameters may be correlated with motor severity in patients with MSA, thus providing 
a marker for disease progression [Schocke et al., 2002, 2004].  
 
MRI thus provides various techniques which may be used to potentially increase the diagnosis 
of early MSA, and to follow the progression of changes as the disease advances, both to 
provide a means to estimate disease progression, and to better understand the underlying 
pathological changes. Most of these sequences are used only for research projects and the 
diagnosis of MSA is still a clinical or neuropathological one based on consensus criteria 
[Gilman 1998;1999]. Of all the MRI techniques, that of DWI seems to show most promise for 
a wider clinical application in the future. DWI images are widely available on most MRI 
scanners, only take minutes to acquire, and show promise in the early detection of MSA. It is 
possible, if the early studies are confirmed with larger cohorts, that in the future MRI changes 
may be added into the formal MSA diagnosis criteria, as has been seen with the changes in 
multiple sclerosis diagnosis criteria in 2001 [McDonald et al 2001]. 
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                                              Functional imaging 
 
Whilst MRI mainly focuses on structural changes, such as volume loss and effects on 
diffusion, functional imaging provides a means to examine the dynamic ability of the brain 
to function in terms of metabolism (usually based on glucose) or receptor binding. As the 
striatal receptors have been well studied in Parkinson patients, it is the dopaminergic system, 
which is often targeted in functional imaging of MSA, especially where there is an initial 
Parkinsonian presentation. Presynaptic nigrostriatal neurons can be imaged by assessment of  
dopa-decarboxylase activity and dopamine transporters. Postsynaptic dopaminergic neurone 
function is assessed by use of dopamine D2-receptor ligands. For example, PET studies 
ligands such as  18F fluorodeoxyglucose [Perani et al 1995] have been able to distinguish the 
striatal of MSA-P and PD patients, with the differentiation aided by combination with 
dopamine D2-receptor functional imaging (receptor density being lower in MSA than in PD 
[Ghaemi et al 2002] 
  
The dopamine transporter system has been studied with single-photon-emission CT using 
123I-2β-carboxymethoxy-3β-4-iodophenyl-tropane (β CIT). This system is affected in MSA, 
PD, and PSP and so is only useful in the reliable differentiation of these conditions from 
healthy controls [Kim et al 2002]. Extracranial sites have also proved useful in functional 
imaging studies of MSA, with single-photon-emission CT and PET ligands allowing study 
of cardiac sympathetic innervation. Iodobenzamide and metaiodobenzylguanidine single-
photon-emission CT and fluorodeoxyglucose PET may be helpful in detecting early MSA. 
Scintography with 123I-metaiodobenzylguanidine has shown loss of binding in patients with 
even early PD reflecting postganglionic sympathetic denervation, whilst MSA shows 
preserved binding, presumably reflecting the central, preganglionic lesion sites. This 
technique has been shown in provisional studies to have a high sensitivity (90%) and 
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specificity (95%) in distinguishing PD and MSA [Braune 2001]. As might be expected PAF, 
with its postganglionic sympathetic involvement, has evidence of cardiac sympathetic 
denervation as evidenced by 18F-dopa PET, compared to MSA where sympathetic 
innervation was again preserved [Goldstein et al 1997]. 
 
 
                                                     Pathology 
 
The initial presentation of MSA can be reflected in the site of lesion burden. In MSA-P, the 
striatonigral system is the main site of pathology,  reflecting the clinical phenotype, but 
degeneration normally includes the olivopontocerebellar system [Kume et al1993;Wenning 
et al 1996]. The putamen is shrunken with grey-green discolouration (figure 1.2) mainly 
effecting caudal and dorsolateral regions [Kume et al 1993]. The substantia nigra pars 
compacta also show degeneration, although cells of the pars reticulata are reported as normal 
[Wenning et al 2004]. Striatal cell loss or impaired function of D1 and D2 receptors in the 
striatum explains the lack of L-Dopa responsiveness in many cases of MSA. 
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Fig 1:2 Putaminal (PU) and Globus palidus (GP) atrophy with grey-green discolouration 
of putamin. TH= thalamus [Wenning et al 2004].  
  
With a MSA-C presentation, the reverse is true with the burden of lesion sites involving the 
olivopontocerebellar system, such as atrophy of the basis pontis and middle cerebellar 
peduncles, but the striatum and substantia nigra are also involved. Cell loss in the inferior 
olives, pontine nuclei and cerebellum explain the cerebellar ataxia, including nystagmus. 
Despite these apparent differences in subtype of MSA, there is no difference between the 
frequency of neuronal cytoplasmic inclusions (NCI) in the putamen, pontine nuclei, and 
inferior olivary nucleus between MSA-P and MSA-C clinical subtypes, and one recent large 
post-mortem study failed to find any cases of pure SND (MSA P) or OPCA (MSA-C) from 
pathological studies [Ozawa et al 2004]. GCIs are consistently found in MSA despite the 
presentation [Papp et al 1989].  
Autonomic involvement is evident as the disease advances no matter what the presentation. 
The dorsal motor nucleus of the vagus nerve, catecholaminergic neurons of ventrolateral 
medulla and locus coeruleus all show marked involvement [Sung et al 1979; Wenning et al 
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1997; Benarroch et al 1998]. Whilst spinal cord degeneration of sympathetic preganglionic 
neurons in the intermediolateral column has been postulated to result in OH, the degree of 
atrophy is not clearly correlated with degree of OH [Daniel 1999]. Erectile and bladder 
dysfunction appear to relate both to spinal involvement ( parasympathetic preganglionic 
nuclei), and supraspinal involvement of the pontomedullary reticular formation [Papp et al 
1994] . The spinal involvement localises to S2-4, including Onuf's nucleus [Konno et al 
1986]. This preganglionic cell loss in the spinal cord (intermediolateral cell columns), leads 
to detrusor hyperreflexia by virtue of loss of inhibitory input of the pontine micturition 
centre, whilst Detrusser atony leads to retention. 
Additional sites of gross pathological damage in MSA include the cerebral hemisphere, of 
interest given recent reports of cognitive impairment in MSA, and anterior-horn cells in the 
spinal cord [Konno et al 1986; Sima et al 1993]. Severe cell loss in the nucleus ambiguus, or 
resultant atrophy of posterior cricoarytenoid muscles help explain the laryngeal stridor which 
can be a serious complication in late MSA, and rarely the presenting feature [Hayashi et al 
1997; Glass et al 2006.]. Loss of neurones in the ventrolateral region of the nucleus ambiguus 
includes loss of preganglionic autonomic outflow to the heart, and its dysfunction appears to 
contribute to the cardiovagal impairment in MSA [Hopkins et al 1996]. 
 
 
 
Subcellular Neuropathological damage in MSA 
Wherever the gross pathological changes of MSA are found, the characteristic subcellular 
finding is that of the glial cytoplasmic inclusions (GCI), first found in 1989 [Papp et al 1989]. 
The fact that these inclusions are predominantly glial rather than neuronal in location sets 
MSA apart from other neurodegenerative conditions where the characteristic lesions are 
focused within the neurones themselves. GCIs are argyrophilic and half-moon, oval, or 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      65                                            
conical in shape. GCIs distribution largely reflects the gross neuropathological locations such 
as basal ganglia, supplementary and primary motor cortex, reticular formation, and 
pontocerebellar system [Papp et al 1994]. Whilst the inclusions contain ubiquitin and tau, α-
synuclein appears to be the major component of both GCIs and neuronal cytoplasmic 
inclusions (NCIs) in MSA [Cairns et al 1997;Wakabayashi et al 1998]. Although the exact 
function of α-synuclein is unknown, it is known to be a presynaptic protein which may be 
important in vesicle induced signalling. Whilst other disease processes such as Parkinson’s 
disease, Alzheimer’s disease, Lewy body disease, Amyotrophic Lateral Sclerosis and even 
PAF are all known to show inclusions with α-synuclein (Synucleinopathies), the inclusions in 
these other disease processes tend to involve neurones not glial and involve deposition of α-
synuclein filaments which are insoluble in buffered saline, unlike in MSA [Jellinger 2003]. 
What is unclear is whether the α-synuclein contributes to the pathogenesis of MSA, or is a by-
product of the underlying aetiology. The burden of GCI does reflect the severity of MSA in 
both olivopontocerebellar and striatonigral systems [Inoue et al 1997]. GCIs appear to occur 
before established neuronal damage in MSA, with myelin loss seemingly taking place earlier 
than axonal damage, at least in the pons [Wakabayashi et al 2005]. Similarly, early MSA 
cases have shown functional dysfunction in the brainstem (hypometabolism), and this may 
reflect the early autonomic failure sometimes seen in early MSA despite limited pathological 
evidence of neuronal damage [Wenning et al 1994; Taniwaki et al 2002]. 
 
Uncommon familial cases of PD have been associated with point mutations in the α-synuclein 
gene [Spillantini et al 1997]. Although cases of α-synuclein gene triplication have been 
reported to be associated with GCI like pathology, Lewy bodies are also present and the 
phenotype is that of Parkinson’s disease [Gwinn-Hardy et al 2000]. However, no similar 
mutations have yet been identified in MSA, and oligodendrocytes (glial cells) may not even 
express α-synuclein mRNA at all [Ozawa et al 2001]. The possibility of glial cells taking up 
α-synuclein from damaged neurones using aberrantly expressed Rab5 endocytosis regulatory 
proteins found on MSA oligodendrocytes and then being unable to digest the protein leading 
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to inclusions is certainly possible [Nakamura et al 2000]. Evidence that may support  this 
includes the fact that that α-synuclein is found in CSF from healthy subjects, suggesting 
release from neurones [Borghi et al 2000]. Whether or not the aggregations are related to 
ectopic accumulation of α synuclein or due to low level expression with subsequent faulty 
processing (including hyperphosphorylation) within the oligodendrocytes, the GCIs not only 
provide a key pathological feature of MSA but are likely to hold some of the secrets of the 
underlying aetiology. Work in this field is continuing rapidly and hopefully will soon yield 
important new information.   
 
Management 
 
Unfortunately to date there is no effective treatment for the underlying neurodegenerative 
process in MSA, although studies of neuroprotective therapies are now being undertaken 
[Wenning et al 2005]. In the mean time there is still much that can be done in terms of 
supportive management for MSA patients and their carers. Non-pharmacological 
management, including input from speech, language and continence advisors together 
occupational/physiotherapists, is extremely important as the disease progresses, and 
sometimes provides a more relaxed forum for specific concerns to be raised than in the busy 
doctor’s clinic. OH is not only a common problem in MSA, but can usually be controlled with 
adequate treatment. The non-pharmacological and pharmacological management of OH has 
already been discussed in some detail earlier in this thesis (1.1:  The Autonomic Nervous 
System in Health and Disease) and so will not be dealt with here. Cerebellar dysfunction is 
extremely difficult to treat pharmacologically at present. As with other neurodegenerative 
conditions, if tremor or myoclonus are marked, clonazepam or antiepileptics such as valproate 
or even isoniazid or baclofen are sometimes beneficial. 
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For the Parkinsonian features, although less effective than in PD, L-dopa replacement may 
still be beneficial especially in the early stages. Motor improvement in up to 79% of MSA 
cases with L-Dopa replacement has been reported in cases defined by the Consensus criteria [ 
Testa et al 2001]. The benefits of L-Dopa replacement may last for up to 4 years [Wenning et 
al 2005]. Dyskinesias, especially those affecting the orofacial area and characteristically 
unilateral, are unfortunately often induced by L-Dopa replacement even when there is no 
apparent motor benefit [Boesch et al 2002]. Dystonias, either arriving primarily from the 
underlying disease or from drug side-effects,  may respond to injection of Botulinum toxin 
injections into the relevant muscles, although the injections may need to be repeated after a 
few months.  Furthermore L-Dopa can unmask or worsen OH in MSA. From the limited 
studies so far performed, dopamine agonists appear to be ineffective in most cases. 
Amantidine, a non-selective NMDA antagonist, is also usually ineffective with a few notable 
exceptions. Anticholinergics, such as trihexyphenidyl, whilst not usually effective for 
Parkinsonian features, may be useful for dystonia, rigidity and sialorrhea [Wenning et al. 
2005]. Alternative options for sialorrhea include injecting the major salivary glands with 
botulinum toxin, which has shown considerable promise as a therapy [Mancini et al 2003]. 
 
 
 
Urological dysfunction is often managed by non-pharmacological approaches, such as 
adequate fluid intake and clean intermittent self-catheterization (CISC) when post-void 
residual bladder volumes are elevated. Indeed, adequate fluid intake and laxatives also help 
prevent constipation, which is not only common in MSA but can itself cause urinary 
retention. CISC is not always possible however when either Parkinsonian or cerebellar 
dysfunction significantly impair insertion. In these circumstances a carer may perform 
catheterization, or a permanent indwelling catheter may be chosen. In such cases a suprapubic 
catheter is a better long-term option in terms of reduction in complications. Pharmacological 
treatment is based on peripherally acting anticholinergic agents such as oxybutynin that 
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improve detrusor hyperreflexia and sphincter–detrusor dyssynergy. Unfortunately by virtue of 
their action these agents may actually induce urinary retention and drying of the saliva. Newer 
agents such as Trospium chloride, a nonselective quaternary ammonium compound, are more 
selective for the bladder as opposed to the salivary glands [Wenning et al 2005]. 
Desmopressin may provide relief from nocturnal polyuria, and also indirectly improve 
postural tolerance during the day [Mathias and Young 2003]. Erectile dysfunction may be 
overlooked but can represent one of the most distressing symptoms. Use of phosphodiesterase 
inhibitors such as sildenafil citrate may help in some cases but its vasodilating action on blood 
vessels may exacerbate OH [Hussain et al 2001]. Yohimbine or intracavernosal injection of 
papaverine or even penile implants may also be beneficial in selected cases [Beck et al 1994]. 
 
Dysphagia is always a concern in MSA because of the risk of aspiration pneumonia. Frequent 
assessments with the aid of speech and language therapy are an important component of 
management. At first mild dietary modifications such as thickened fluids and double –
swallow techniques may be sufficient. Ultimately however nasogastric feeding or feeding via 
gastrostomy tubes may be required. Similarly respiratory function is an important factor to 
consider on every visit; sleep apnoea may benefit from continuous positive airway pressure 
therapy whilst stridorous patients may require tracheotomies, although this is rarely indicated 
[Iranzo et al 2000]. Ultimately MSA unfortunately remains a fatal illness: end-of life 
decisions should ideally be carefully considered on an individual basis, and psychological 
support provided if needed for the patient and their carers. There is hope of additional 
therapies in the near future. Studies into the possible neuroprotective roles of minocycline and 
riluzole are nearing completion with stem cell and neural trophic factor intervention 
possibilities further afield. 
 
  
 
  
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      69                                            
References: 
 
 
 
 
Abele M, Burk K, Schols L et al., The aetiology of sporadic adult-onset ataxia Brain 
2002;125:961–968. 
 
Adams R, van Bogaert L, van der Eecken H  Nigro-striate and cerebello-nigro-striate 
degeneration: clinical uniqueness and pathological variability of presenile degeneration of 
the extrapyramidal rigidity type Psychiatr Neurol (Basel) 1961;142:219–259 
 
Addington WR, Stephens RE, Gilliland KA Assessing the laryngeal cough reflex and the 
risk of developing pneumonia after stroke: an interhospital comparison. Stroke 
1999;30:1203–1207 
 
Alam M and Smirk FH Observation in man upon a blood pressure raising reflex arising from 
the voluntary muscles. Journal of Physiology. 1937; 89:372-383 
 
Beck RO, Betts CD, Fowler CJ. Genitourinary dysfunction in multiple system atrophy: 
clinical features and treatment in 62 cases. J Urol 1994;151:1336 –1341 
 
Benarroch EE, Smithson IL, Low PA, Parisi JE  Depletion of catecholaminergic neurons of 
the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure Ann 
Neurol 1998;43:156–163 
 
Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Paris JE Differential involvement of 
hypothalamic vasopressin neurons in  multiple system atrophy. Brain 2006;129:2688-2696 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      70                                            
Ben-Shlomo Y, Wenning G, Tison F, Quinn N  Survival of patients with pathologically 
proven multiple system atrophy: a meta-analysis Neurology 1997;48:384–393 
 
Bhattacharya K, Saadia D, Eisenkraft B, Yahr M, Olanow W, Drayer B et al. (2002) Brain 
magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic 
algorithm. Arch Neurol 59: 835–842 
 
Boesch SM, Wenning GK, Ransmayr G, Poewe W  Dystonia in multiple system atrophy J 
Neurol Neurosurg Psychiatry 2002;72: 300–303 
 
Borghi R, Marchese R, Negro A et al Full length α-synuclein is present in cerebrospinal fluid 
from Parkinson’s disase and normal subjects. Neurosci Lett 2000;287:65-67 
 
Bower J, Maraganore D, McDonnell S, Rocca W Incidence of progressive supranuclear 
palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990 Neurology 
1997;49:1284–1288 
 
Braune S The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of 
parkinsonian syndromes, Clin Auton Res 11 (2001), pp. 351–355 
 
Bürk K, Skalej M, Dichgans, J  Pontine MRI Hyperintensities (“the Cross Sign”) are not 
Pathognomonic for Multiple System Atrophy (MSA) Movement Disorders 2001;16 
No.3:535–536 
 
Cairns NJ, Atkinson PF, Hanger DP, Anderton BH, Daniel SE, Lantos PL  Tau protein in the 
glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal 
tau in Alzheimer's disease, Neurosci Lett 1997;230:49–52    
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      71                                            
Chrysostome V, Tison F, Yekhlef F, Sourgen C, Baldi I, Dartigues JF  Epidemiology of 
multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France. 
Neuroepidemiology 2004;23:201–208 
 
Colosimo C, Inghilleri M, Chaudhuri KR, Parkinson's disease misdiagnosed as multiple 
system atrophy by sphincter electromyography J Neurol 2000;247 559–561 
 
Critchley HD, Corfield DR, Chandler MP, Mathias CJ, Dolan RJ. Cerebral correlates of 
autonomic cardiovascular arousal: a functional neuroimaging investigation in humans.  
Journal of Physiology 2000; 523.1:259-70 
 
Daniel S  The neuropathology and neurochemistry of multiple system atrophy. In: C Mathias 
and R Bannister, Editors, Autonomic failure: a textbook of clinical disorders of the 
autonomic nervous system, Oxford University Press, Oxford 1999; 321–328 
 
Davie CA,Wenning GK, Barker GJ, Tofts PS, Kendall BE, Quinn N et al. (1995) 
Differentiation of multiple system atrophy from idiopathic Parkinson’s disease using proton 
magnetic resonance spectroscopy. Ann Neurol 37: 204–210 
 
Dejerine J and Thomas A  L'atrophie olivo-ponto-cerebelleuse. Nouvelle iconographie de la 
Salpetriere: clinique des malacies du systeme nerveux 1900;13:330–370. 
 
Geser F, Seppi K, Stampfer-Kountchev M et al The European Multiple System Atrophy 
Study Group (EMSA-SG) Journal of Neural Transmission 2005;112:1677-1686 
 
Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD (2002) Differentiating multiple system 
atrophy from Parkinson’s disease: contribution of striatal and midbrain MRI volumetry and 
multi-tracer PET imaging. J Neurol Neurosurg Psychiatry 73:517–523 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      72                                            
 
Giladi N, Simon ES, Korczyn AS et al., Anal sphincter EMG does not distinguish between 
multiple system atrophy and Parkinson's disease Muscle Nerve 2000;23:731–734 
 
Gilman S, Low P, Quinn N et al., Consensus statement on the diagnosis of multiple system 
atrophy Clin Auton Res 1998;8:359–362 
 
Gilman S, Low P, Quinn N et al., Consensus statement on the diagnosis of multiple system 
atrophy J Neurol Sci 1999;163:94–98 
 
Gilman S, Little R, Johanns J et al., Evolution of sporadic olivopontocerebellar atrophy into 
multiple system atrophy Neurology 2000;55:527–532. 
 
Gilman S, May SJ, Shults CW, Tanner CM, Kukull W, Lee VMY, Masliah E, Low P, 
Sandroni P, Trojanowski JQ, Ozelius L, Foroud T  The North American Multiple System 
Atrophy Study Group J Neural Transm (2005);112:1687–1694 
 
Glass GA, Josephs KA, Ahlskog JE Respiratory Insufficiency as the Primary Presenting 
Symptom of Multiple-System Atrophy Archives of Neurology 2006;63:978-981 
 
Goldstein DS, Holmes C, Cannon RO III, Eisenhofer G, Kopin IJ Sympathetic 
cardioneuropathy in dysautonomias, N Engl J Med 336 (1997), pp. 696–702.. 
 
Graham J and Oppenheimer DR Orthostatic-hypotension and nicotine sensitivity in a case of 
multiplesystem atrophy J Neurol Neurosurg Psychiatry 1969;32:28–34 
 
Gwinn-Hardy K, Mehta ND, Farrer M, Maraganore D, Muenter M, Yen SH, Hardy J, 
Dickson DW Distinctive Neuropathology revealed by alpha-synuclein antibodies in 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      73                                            
hereditary parkinsonism and dementia linked to chromosome 4p Acta Neuropathol (Berl) 
2000;99:663-672 
 
Hayashi M, Isozaki E, Oda M, Tanabe H, Kimura J  Loss of large myelinated nerve fibres of 
the recurrent laryngeal nerve in patients with multiple system atrophy and vocal cord palsy. J 
Neurol Neurosurg Psychiatry 1997; 62:234–238 
 
Higo R, Tayama N, Watanabe T, Nitou T, Ugawa Y (2003) Videofluoroscopic and 
manometric evaluation of swallowing function in patients with multiple system atrophy. Ann 
Otol Rhinol Laryngol 112:630–636 
 
Hilz MJ, Axelrod FB, Braeske K, Stemper B. Cold pressor test demonstrates residual 
sympathetic cardiovascular activation in familial dysautonomia. Journal of the Neurological 
Sciences 2002; 196:81-89 
 
Hopkins DA, Bieger D, de Vente J, Steinbusch HWM Vagal efferent projections: viscerotopy, 
neurochemistry and effects of vagotomy. Progressive Brain Resaerch 1996;107:79-96 
 
Horimoto Y, Aiba I, Yasuda T, Ohkawa Y, Katayama T, Yokokawa Yet al. (2002) 
Longitudinal MRI study of multiple system atrophy – when do the findings appear, and what 
is the course? J Neurol 249: 847–854 
 
Hussain IF, Brady CM, Swinn MJ, Mathias CJ, Fowler CJ  Treatment of erectile dysfunction 
with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system 
atrophy with observations on orthostatic hypotension, J Neurol Neurosurg Psychiatry 
2001;71:371–374 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      74                                            
Inoue M, Yagishita S, Ryo M, Hasegawa K, Amano N, Matsushita M The distribution and 
dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system 
atrophy: a correlation between density of GCIs and the degree of involvement of striatonigral 
and olivopontocerebellar systems. Acta Neuropathol 1997;93:585-591 
 
Iranzo A, Santamaria J, Tolosa E. Continuous positive air pressure eliminates nocturnal 
stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. 
Lancet. 2000;356(9238):1329-30. 
 
Ito T, Sakakibara R,Yasuda K, Yamamoto T, Uchiyama T, Liu Z, Yamanishi T, Awa Y, 
Kaori K, Hattori T Incomplete Emptying and Urinary Retention in Multiple-System Atrophy: 
When Does It Occur and How Do We Manage It? Movement Disorders 2006; 21,No. 6:816–
823 
 
Jellinger KA Neuropathological Spectrum of Synucleinopathies Movement Disorders 
2003;18,Suppl. 6: S2–S12 
 
Kim YJ, Ichise M, Ballinger JR Combination of dopamine transporter and D2 receptor 
SPECT in the diagnostic evaluation of PD, MSA, and PSP, Mov Disord 17 (2002), pp. 303–
312 
 
Kirby R, Fowler CJ, Gosling J, Bannister R Urethro-vesical dysfunction in progressive 
autonomic failure with multiple system atrophy, J Neurol Neurosurg Psychiatry 
1986;49:554–562 
 
Kirchhof K, Apostolidis AN, Mathias CJ, Fowler CJ Erectile and urinary dysfunction may be 
the presenting features in patients with multiple system atrophy: a retrospective study 
International Journal of Impotence Research 2003;15 No4:293-298 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      75                                            
 
Konno H, Yamamoto T, Iwasaki Y, Iizuka H  Shy-Drager syndrome and amyotrophic lateral 
sclerosis: cytoarchitectonic and morphometric studies of sacral autonomic neurons, J Neurol 
Sci  1986;73:193–204 
 
Kume A, Takahashi A, Hashizume Y Neuronal cell loss of the striatonigral system in multiple 
system atrophy J Neurol Sci 1993;117:33–40 
 
Litvan I, Booth V, Wenning GK et al., Retrospective application of a set of clinical diagnostic 
criteria for the diagnosis of multiple system atrophy J Neural Transm 1998;105:217–227 
 
Lycke JN, Karlsson JE, Andersen O, Rosengren LE. Neurofilament protein in cerebrospinal 
fluid: a potential marker of activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 
1998;64:402–404 
 
McDonald WI, Compston A, Edan G, Goodkin DE, Hartung HP, Lublin FD, et al. 
Recommended Diagnostic Criteria for Multiple Sclerosis: Guildelines from the International 
Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-127. 
 
Mancini F, Zangaglia R, Cristina S, et al. Double-blind, placebocontrolled study to evaluate 
the ef.cacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. 
Mov Disord 2003;18:685– 688 
 
Mathias CJ and Bannister R  Autonomic Failure - A Textbook of Clinical Disorders of the 
Autonomic Nervous System Fourth Edition  1999 4th edition Oxford University Press p195 
 
Mathias CJ, Young TM  Plugging the leak-the benefits of the vasopressin-2 agonist 
desmopressin in autonomic failure. Clinical Autonomic Research 2003; 13(2):85-7 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      76                                            
 
Mathias CJ.  Disorders of the autonomic nervous system.  In: Neurology in Clinical Practice.  
4th edition.  Eds. WG Bradley, RB Daroff, GM Fenichel, CD Marsden. Butterworth-
Heinemann, Boston, USA 2004, 2131-2165 
 
Muller J, Wenning GK, Verny M, McKee A, Chaudhuri KR, Jellinger K, Poewe W, Litvan I 
(2001) Progression of dysarthria and dysphagia in postmortem-con.rmed parkinsonian 
disorders. Arch Neurol 58:259–264 
 
Muqit MM, Mort D, Miskiel KA, Shakir RA (2001) ‘‘Hot cross bun’’ sign in a patient with 
parkinsonism secondary to presumed vasculitis. J Neurol Neurosurg Psychiatry 71: 
565–566 
 
Nakamura S, Kawamoto Y, Nakano S, Akiguchi I Expression of the endocytosis regulatory 
proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple 
system atrophy Clin Neuropathol 2000;19:51-56 
 
Ozawa T, Okuizumi K, Ikeuchi T, Wakabayashi K, Takahashi H, Tsuji S  Analysis of the 
expression level of α-synuclein mRNA using postmortem brain samples from pathologically 
confirmed cases of multiple system atrophy. Acta Neropathol 2001;102:188-190 
 
Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, Healy DG, Wood NW, 
Lees AJ, Holton JL, Revesz T  The spectrum of Pathological involvement of the striatonigral 
and olivopontocerebellar systems in multiple system atrophy: clinicalpathological correlations 
Brain 2004;127:2657-2671 
 
Palace J, Chandiramani VA, Fowler CJ Value of sphincter electromyography in the diagnosis 
of multiple system atrophy, Muscle Nerve 1997;20:1396–1403 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      77                                            
 
Papp JE, Kahn M, Lantos PL  Glial cytoplasmic inclusions in the CNS of patients with 
multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-
Drager syndrome) J Neurol Sci 1989;94:79–100 
 
Papp M and Lantos PL  The distribution of oligodendroglial inclusions in multiple system 
atrophy and its relevance to clinical symptomatology, Brain 1994; 117:235–243 
 
Parkinson J An Essay on the Shaking Palsy-James Parkinson originally a monograph 
published by Sherwood, Neely and Jones (london 1817)-reprinted in J Neuropsychiatry Clin 
Neuroscience 2002;14:2 
 
Perani D, Bressi S, Testa D et al., Clinical/metabolic correlations in multiple system atrophy. 
A fludeoxyglucose F 18 positron emission tomographic study, Arch Neurol 52 (1995), pp. 
179–185 
 
Petrovic P, Petersson KM, Hansson P, Ingvar M. Brainstem involvement in the initial 
response to pain.  NeuroImage 2004; 22:995-1005 
 
Plazzi G, Corsini R, Provini F  REM sleep behavior disorders in multiple system atrophy  
Neurology 1997;48:1094–1097 
 
Quinn N: Multiple system atrophy in Movement Disorders 3: Ed by Marsden CD. Fahn S. 
Oxford: Butterworth-Heinemann 1994, 263—281 
 
Quinn N, Multiple system atrophy: the nature of the beast J Neurol Neurosurg Psychiatry 
1989;52:78–89 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      78                                            
Riley DE and Chelimsky TC, Autonomic nervous system testing may not distinguish 
multiple system atrophy from Parkinson's disease, J Neurol Neurosurg Psychiatry 74 (2003), 
pp. 56–60 
 
Ryuzaburo H, Takaharu N, Niro T Swallowing function in patients with multiple-system 
atrophy with a clinical predominance of cerebellar symptoms (MSA-C) Eur Arch 
Otorhinolaryngol (2005) 262:646–650 
 
Sakakibara R, Hattori T, Uchiyama T, Kita K, Asahina M, Suzuki A, Yamanishi T. Urinary 
dysfunction and orthostatic hypotension in multiple system atrophy: which is the more 
common and earlier manifestation? J Neurol Neurosurg Psychiatry 1999;67:1–5 
 
Schocke MF, Seppi K, Esterhammer R, Kremser C, JaschkeW, PoeweWet al. (2002) 
Diffusion weighted MRI differentiates the Parkinson variant of multiple system atrophy from 
PD. Neurology 58: 575–580 
 
Schocke MF, Seppi K, Esterhammer R, Kremser C, Mair KJ, Czermak BV et al. (2004) Trace 
of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and 
Parkinson’s disease. Neuroimage 21: 1443–1451 
 
Schulz JB, Skalej M, Wedekind D, Luft AR, Abele M, Voigt K et al. (1999) Magnetic 
resonance imaging-based volumetry differentiates idiopathic Parkinson’s syndrome 
from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 45: 
65–74 
 
Schwarz J, Weis S, Kraft E Signal changes on MRI and increases in reactive microgliosis, 
astrogliosis, and iron in the putamen of two patients with multiple system atrophy, J Neurol 
Neurosurg Psychiatry 1996; 60:98–101. 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      79                                            
 
Seppi K, Schocke MF, Donnemiller E, Esterhammer R, Kremser C, Scherfler C et al. (2004c) 
Comparison of diffusion-weighted imaging and [(123)I]IBZM-SPECT for the differentiation 
of patients with the Parkinson variant of multiple system atrophy from those with Parkinson’s 
disease. Mov Disord 19: 1438–1445 
 
 
Seppi K, Schocke MFH, Wenning GK, Poewe W  How to diagnose MSA early: the role of 
magnetic resonance imaging J Neural Transm (2005) 112:1625–1634 
 
Shy G and Drager GA A neurological syndrome associated with orthostatic hypotension: ac 
linicopathological study Arch Neurol 1960;2:511–527 
 
Sima A, Caplan M, D'Amato CJ, Pevzner M and Furlong, JW Fulminant multiple system 
atrophy in a young adult presenting as motor neuron disease Neurology 1993;43:2031–2035 
 
Soma H, Yabe I, Takei A, Fujiki N, Yanagihara T, Sasaki H Heredity in multiple system 
atrophy Jouranl of the Neurological Sciences 2006; 240:107-110 
 
Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M  Alpha-
synuclein in Lewy bodies Nature 1997;388:839–840 
 
Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M Filamentous 
alpha-synuclein inclusions link multiple system trophy with Parkinson's disease and 
dementia with Lewy bodies Neurosci Lett 1998;251:205–208. 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      80                                            
Stauffenberg, Zur Kenntnis des extrapyramidalen motorischen Systems und Mitteilung eines 
Falles von sog. Atrophie olivo-pontocerbelleuse Zeitschr Ges Neurol Psychiatrie 1918;39:1–
55 
 
Sung J, Mastri A, Segal E  Pathology of Shy-Drager syndrome J Neuropathol Exp Neurol 
1979;38:353–368 
 
Taniwaki T, Nakagawa M, Yamada T, Yoshida T, Ohyagi Y, Sasaki M, Kuwabara Y, 
Tobimatsu S, Kira J. Cerebral metabolic changes in early multiple system atrophy: a PET 
study. J Neurol Sci 2002;200:79–84 
 
Testa D, Monza D, Ferrarini M, Soliveri P, Girotti F, Filippini G. Comparison of natural 
histories of progressive supranuclear palsy and multiple system atrophy. Neurol Sci  
2001;22:247–251 
 
Thomaides TN, Chaudhuri KR, Maule S, Watson L, Marsden CD, Mathias CJ   Growth 
hormone response to clonidine in central and peripheral primary autonomic failure.  The 
Lancet  1992; 340: 263-266 
 
Thomas JE, Schirger A. Idiopathic orthostatic hypotension. A study of its natural history in 
57 neurologically affected patients. Arch Neurol 1970;22:289–93 
 
Valldeoriola F, Valls-Sole J, Tolosa ES, Marti MJ Striated anal sphincter denervation in 
patients with progressive supranuclear palsy Mov Disord 1995;10:550–555 
 
van der Eecken H, Adams RD,  van Bogaert L  Striopallidal-nigral degeneration: a hitherto 
undescribed lesion in paralysis agitans J Neuropathol Exp Neurol 1960;19:159–161. 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      81                                            
Vanacore Epidemiological evidence on multiple system atrophy  N  J Neural Transm 
2005;112:1605–1612 
 
Victor RG, Pryor SL, Secher NH, Mitchell JH. Effects of partial neuromuscular blockade on 
sympathetic nerve responses to static exercise in humans. Circulation Research. 1989; 
65(2):468-476 
 
Vodusek B Sphincter EMG and differential diagnosis of multiple system atrophy Mov 
Disord 2001;16:600–607 
 
Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H Alpha-synuclein immunoreactivity in 
glial cytoplasmic inclusions in multiple system atrophy Neurosci Lett 1998;249:180–182.  
 
Wakabayashi K, Mori F, Nishie M et al An autopsy case of early (“minimal 
change”)olivopontocerebellar atrophy (multiple system atrophy-cerebellar) Acta Neuropathol 
2005;110:185-190 
 
Watanabe H, Saito Y, Terao S , Ando T, Kachi T, Mukai E  Progression and prognosis in 
multiple system atrophy: an analysis of 230 Japanese patients Brain 2002;125:1070–1083 
 
Watanabe H, Fukatsu H, Katsuno M, Sugiura M, Hamada K, Okada Y et al. (2004) Multiple 
regional 1H-MR spectroscopy in multiple system atrophy: NAA=Cr reduction in pontine 
base as a valuable diagnostic marker. J Neurol Neurosurg Psychiatry 75: 103–109 
 
Wenning GK, Quinn N, Magalhaes M, Mathias CJ, Daniel SE. “Minimal change” multiple 
system atrophy. Mov Disord 1994;9:161–166   
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      82                                            
Wenning GK, Tison F, Elliott L, Quinn NP, Daniel SE Olivopontocerebellar pathology in 
multiple system atrophy Mov Disord 1996;11:157–162 
 
Wenning GK, Tison F, Ben-Shlomo Y, Daniel SE, Quinn NP Multiple system atrophy: a 
review of 203 pathologically proven cases. Movement Disorders 1997;12:133-47 
 
Wenning GK, Geser F, Poewe W  The ‘risus sardonicus’ of multiple system atrophy Mov 
Disord 2003;18:1211 
 
Wenning GK, Colosimo C, Geser F, Poewe W  Multiple System Atrophy The Lancet 
Neurology 2004;3:93-103 
 
Wenning GK, Geser F, Poewe W   Therapeutic Strategies in Multiple System Atrophy 
Movement Disorders 2005;20, Suppl 12:S67–S76 
 
Winchester PK, Williamson JW, Mitchell JH Cardiovascular responses to static exercise in 
patients with Brown-Séquard syndrome. Journal of Physiology 2000; 527.1:193-202 
 
 
 
 
 
 
 
 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      83                                            
 
1.3:  Pure Autonomic Failure (PAF)  
         
 
 
Introduction: 
 
 
Pure Autonomic Failure (PAF) was first described some 80 years ago and initially named 
Bradbury-Eggleston syndrome [Bradbury and Eggleston 1927].It is only since the more 
rigorous classification and diagnostic criteria for MSA that we can be now sure about the 
diagnosis of PAF as earlier cases may have been confused with early MSA. It is clear that 
PAF is a rare disease. Despite being able to live up to decades after the diagnosis is made, we 
have less than 40 clearly diagnosed cases on our recent casebook of PAF subjects at The 
National Hospital for Neurology and Neurosurgery, the National tertiary referral centre for 
autonomic dysfunction. It is possible that the true prevalence is higher as patients may put up 
with their symptoms for many years before diagnosis. Indeed, in our experience it is 
sometimes ironically the supine hypertension which can finally bring the OH to the attention 
of a neurologist, as this is sometimes treated with antihypertensives without a standing BP 
being taken, and the resulting exacerbation of OH leading to a referral or admission. 
 
 
Clinical Features of PAF: Like MSA, OH is the major symptom in many cases at presentation 
although symptoms related to sudomotor dysfunction such as hypohidrosis are also common.  
OH is often more severe than in MSA, although the orthostatic tolerance which subjects can 
develop is astonishing- I have been able to hold a rational conversation with one subject 
whilst their standing SBP had dropped to 45 mmHg (symptoms were just starting to develop 
at this time point)! Unlike MSA Parkinsonian or cerebellar symptoms are absent. 
Hypohidrosis has been shown to be a common symptom in PAF at presentation and to occur 
significantly earlier in the disease course than in MSA [Mabuchi et al 2005]. Sweating 
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abnormalities are usually more pronounced than in MSA with prominent anhidrosis common 
although this will usually only be a major problem for subjects in hot climates where 
excessive body temperatures can develop. Exercise would theoretically also be dangerous for 
this reason but in reality most subjects avoid vigorous exercise because this further 
exacerbates OH. Exceptions can occur-one of our younger subjects has climbed Ben Nevis 
since his diagnosis, although he required very frequent stops to sit or lie down. As with MSA 
erectile dysfunction is very common in male subjects, although urological disorders are less 
commonly seen than in MSA, with only 3 out of 8 PAF subjects reporting urinary urgency, 
urinary frequency, or incontinence in the first five years of symptoms [Mabuchi et al 2005].  
With longer duration of symptoms the difference in respiratory symptoms becomes striking. 
Up to 80% of MSA subjects will have developed respiratory complications in the first decade 
of symptoms whilst no PAF subjects did so in 30 years of follow-up [Mabuchi et al 2005].  
 
In the first few years care has to be taken in making a diagnosis of PAF as occasional cases of 
apparently ‘pure’ autonomic failure will declare as MSA after even 3 or 4 years. For this 
reason all the PAF cases used in this study had had their symptoms for at least 5 years (& in 
most cases over 10 years), as well as having their diagnosis confirmed using current criteria, 
and further backed up with additional testing such as plasma noradrenaline levels. 
 
 
 
Clinical diagnostic criteria: 
 
 
Pure autonomic failure is an idiopathic sporadic disorder characterized by OH usually with 
evidence of more widespread autonomic failure. No other neurological features are present. 
Reduced supine plasma norepinephrine levels are characteristic of PAF. [Anonymous 1998]. 
Older terms such as idiopathic orthostatic hypotension have been superseded by PAF as it has 
increasingly been realised that initial presentation with apparently ‘pure’ autonomic failure 
may merely be the presenting features of other conditions such as MSA or Parkinson’s 
disease with autonomic failure.  In view of this it is generally recognised that a minimum 
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period of 5 years is needed from symptom onset without additional features developing for 
the diagnosis of PAF to be made with confidence [Freeman 2004; Mabuchi et al 2005]. 
 
 
 
Investigations 
 
  
Autonomic Function Testing: 
 
 
Orthostatic hypotension (OH) is one of the most striking cardiovascular abnormalities that can 
develop in PAF, and although it is usually not clinically silent, patients often instinctively 
adapt their day to day activities and posture so that its effects may not be immediately obvious 
even with striking falls in BP on upright posture. As with MSA OH is usually assessed with 
tilt table testing is part of standard autonomic function testing as described in the discussion 
on MSA (1.1 Multiple system atrophy (MSA)). In our autonomic function laboratory subjects 
are investigated after a stable haemodynamic baseline had been obtained after 20 minutes 
supine. The subject is then secured to the tilt table test and tilted head-up to 60o for 10 minutes 
(or a shorter time if not tolerated) before being returned to supine. BP and HR monitoring is 
measured both with intermittent brachial BP values every 3 minutes using an automated 
Dinamap (Critikon) sphygmomanometer on the left arm. Continuous measurement of beat-to-
beat BP is simultaneously obtained non-invasively throughout with the Portapres II device on 
the middle finger of the right hand. OH, defined as a drop in systolic blood pressure of 20 
mm Hg or more (or 10 mm Hg or more in diastolic blood pressure), compared with baseline is 
assessed for on upright tilt. Supine to seated to standing posture may also be used in addition 
to the tilt table testing [Gilman et al 1999], although mild OH is not an uncommon finding 
amongst otherwise healthy subjects in a similar age range. As with MSA, PAF  subjects 
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usually show marked OH. In addition the expected HR rise on upright tilt is even more 
attenuated than in MSA. As with MSA the Valsalva manoeuvre, heart rate variability on deep 
breathing and pressor responses are also assessed and typically are markedly abnormal, these 
tests having been described in more detail in the previous chapter. Accurate comparisons of 
response to these standard autonomic function tests had not previously been reported, and are 
examined in this thesis (3.2:  Validating Standardized Pressor Responses in MSA and PAF).  
 
 
Urodynamics:  
 
Although bladder involvement in PAF is a relatively late feature (mean time to onset has been 
quoted at 9 years after presenting complaint), eventually it is present in most PAF subjects 
[Mabuchi et al 2005]. In a study of 6 symptomatic PAF subjects, urodynamics revealed mixed 
results [Sakakibara et al 2000]. Post-micturition residuals were present in two subjects, small 
bladder capacities in two, detrusor hyperreflexia in four, and denervation supersensitivity of 
the bladder in two.  
 
 
Polysomnography:  
 
REM sleep behavioural disorder (RBD) appears to be an almost universal feature of 
synucleinopathies such as MSA, PD and diffuse Lewy Body Disease (DLBD) [Boeve et al 
2004]. It is present in up to 90% of MSA subjects, often occurring years before more 
disabling features develop [Plazzi et al 1997].  In the late 1990s a study followed 10 patients 
on initial presentation of primary autonomic failure [Plazzi et al 1998]. These subjects had 
videopolysomnography  performed and were followed up for approximately 5 years, after 
which time the diagnosis of MSA had been made in 4 with the remaining 6 being labelled 
PAF. Interestingly all 6 PAF subjects had had normal polysomnography whilst all 4 MSA 
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subjects showed signs of RBD with the histories suggesting onset years before. A later study 
of Videopolysomnography in 3 PAF subjects however revealed typical features of RBD with 
intermittent absence of muscle atonia during REM sleep in all patients. These episodes were 
accompanied by simple and complex motor behaviours like twitching and beating [Weyer et 
al 2006]. The discrepancy between the results of these two studies may reflect the likely 
greater duration of PAF in Weyer et al’s group. Thus it appears PAF may exhibit RBD 
(possibly only later in the disease process) in keeping with the other synucleinopathies. 
Unlike MSA, severe sleep apnoea is not a noted feature, although mild apnoea was found in 
one PAF subject [Weyer et al 2006]. 
 
 
 
Pupillograhy:  
 
Pupil abnormalities may be found in PAF [Shy and Drager 1960;  Bremner and Smith 2006]. 
In the largest recorded study 67% of 33 PAF subjects had some form of pupillary 
abnormality. Almost 50% had bilateral Horner’s syndrome (the bilateral ptosis being quite 
striking in some cases). Pupillotonia or reduced light/accommodation reflexes (reflecting 
predominant parasympathetic dysfunction) is less common [Bremner and Smith 2006]. The 
bilateral Horner’s syndrome or pupillotonia were very specific in differentiating PAF from 
MSA although they did both occur in patients with autonomic failure caused by diabetes or 
amyloidosis. Interestingly in most patients the deficits had been detected by neither the patient 
nor their physician 
 
 
 
 
Blood Tests:  
 
Blood testing usually has a limited role in PAF management. Supine plasma noradrenaline 
levels are markedly reduced, reflecting the dysfunctional postganglionic sympathetic efferent 
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activity, with Noradrenaline (NA) spillover from nerve terminals into the blood reduced as a 
result [Mathias 2004]. On upright tilt, increases in NA are similarly reduced [Mathias 2004]. 
Recent suggestion of circulating antibodies binding to neuronal ganglionic acetylcholine 
receptors detected by a radioimmunoprecipitation assay requires further study to determine if 
PAF or autonomic neuropathy is the associated phenotype [Schroeder et al 2005]. 
 
 
 
Cerebrospinal fluid (CSF) Analysis:  
 
CSF analysis has not usually been performed in PAF as it is not part of standard assessment, 
both because of the invasive nature of the procedure and the lack of any clear utility at 
present. One recent study looked specifically for antibodies reacting with structures of rat 
pons/medulla in patients with PAF as well as in MSA and controls [Imrich et al 2006]. No 
significant association was found. 
 
 
 
Imaging 
 
MRI:  
 
Unlike in MSA, conventional MRI of PAF subjects fails to show significant abnormalities 
specific to the condition. Advanced MRI related techniques however have been used to show 
subtle distinctive features. Voxel-based morphometry in particular has suggested loss of grey 
matter density in cortical regions which have previously been shown to be involved in the 
generation and representation of bodily states of autonomic arousal [Critchley et al 2003]. 
During fear-conditioning, in PAF patients, the absence of peripheral arousal in response to a 
learnt threat-stimulus was associated with reduced activity in the amygdalar and insular 
regions which were activated in controls [Critchley et al., 2002]. These findings thus suggest 
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that the cingulate, insular, pontine, and amygdalar regions are involved in autonomic control, 
the afferent feedback loop of which is impaired in PAF. Voxel-based morphometry of 15 PAF 
subjects showed no global atrophy compared with controls, but a localised loss of grey matter 
density in the left anterior cingulate and right anterior insula/frontal operculum [Critchley et 
al 2003]. Only the degree of atrophy in the left cingulate gyrus clearly correlated with disease 
severity in the PAF subjects, possibly reflecting the relatively small size of this voxel-based 
morphometry study. In a PET study, increased right anterior cingulate activity was observed 
in PAF relative to control subjects during effortful tasks associated with increased 
sympathetic drive [Critchley & Mathias et al 2001]. Consolidating the results of these studies 
suggests that the left anterior cingulate may be involved in decreasing heart rate and blood 
pressures, and an earlier study had shown this area to be activated in healthy controls during 
volitional reduction in electrodermal activity [Critchley & Melmed, et al., 2001]. In such a 
system involvement of the left cingulate would exacerbate many of the symptoms in PAF, 
effectively leading to gradual disuse atrophy.  
 
Critchley et al suggest that overall the observed localised grey matter atrophy seen in PAF 
reflected experience-dependent change resultant from loss of afferent input to brain regions 
involved in representation of autonomic states. Certainly increased stimulation has been 
suggested to result in increased grey matter density in taxi drivers in the posterior 
hippocampus that is implicated by functional neuroimaging in spatial navigation [Maguire et 
al., 2000]. Certainly this suggestion is of importance as PAF is considered essentially a 
peripheral and post-ganglionic disease in terms of major pathophysiology. The normal global 
grey/white/csf volumes as measured by this same study would add weight to the assumption 
that there is not widespread central dysfunction in PAF 
. 
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Functional imaging:  
 
As might be expected, PAF with its postganglionic sympathetic involvement has evidence of 
cardiac sympathetic denervation as evidenced by 18F-dopa PET, compared to MSA where 
sympathetic innervation is preserved [Goldstein et al 1997]. Functional brain imaging has 
been less clear cut, with a minority of cases studied suggesting possible striatonigral 
dysfunction [Brooks et al 1990; Compta et al 2006] in a few subjects. 
 
Positron Emission Tomography (PET) scanning utilizing intravenous injection of 6-18F-
fluorodopamine allows visualization of cardiac sympathetic innervation [Goldstein et al 
1990]. In previous studies both PAF and PD with autonomic failure showed markedly 
reduced left ventricular myocardial concentrations of 6-18F-fluorodopamine–derived 
radioactivity [Goldstein et al 1997 & 2000]. Extracardiac post-ganglionic sympathetic 
denervation was suggested to involve decreased 6-18F-fluorodopamine–derived radioactivity 
in the thyroid gland and renal cortex in PD, with PAF subsequently being found to show a 
similar picture in the renal cortex but surprisingly showing preservation of sympathetic 
innervation to the thyroid [Li et al 2002; Tipre and Goldstein 2005]. Somewhat surprisingly 
given the marked sympathetic innervation of the nasopharyngeal region, neither PD nor PAF 
patients showed a reduction in sympathetic innervation on PET scanning. PAF has evidence 
of cardiac sympathetic denervation as evidenced by 18F-dopa PET, compared to MSA where 
sympathetic innervation was preserved [Goldstein et al 1997]. 
 
 
Pathology: 
 
 
In the most complete autopsy of a PAF subject, performed 8 hours post-mortem, 
systemic autopsy findings were unremarkable except for mild cardiac hypertrophy, papillary 
muscle necrosis, moderate systemic atherosclerosis, moderate pulmonary emphysema and 
acute and chronic cystitis [Hague et al 1997]. Coronal sections of the brain revealed no gross 
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lesions. Inclusion bodies staining positive for α-synuclein have been identified in autonomic 
nerves in the epicardial fat, and capsular nerves of the adrenal and parasympathetic nerves in 
the bladder wall [Kaufmann et al 2001]. Inclusions were not encountered in the cerebral 
cortex or dorsal motor vagal nucleus. Postganglionic nerves were clearly involved with 
peripherally based lesion burden as expected for a postganglionic condition, with α-synuclein 
staining inclusions in the superior cervical ganglia sympathetic nerves (see Fig 1.3). However, 
in a single case report some Lewy bodies (not GCIs or NCIs) were seen in the  substantia 
nigra pars compacta, locus ceruleus, sacral spinal cord (spinal tissue was difficult to assess 
due to severe ischaemic necrosis). One other autopsy case suggested moderate neuronal loss 
in the substantia nigra, locus ceruleus and intermediolateral cell columns of the spinal cord; 
however this case had previously been embalmed casting doubt on the relevance of a 
perceived moderate loss of neurons in these anatomical areas [Roessmann et al 1971].  
Whether this was a chance finding reflecting age (63) of the patient or coincidental early 
disease process such as PD or Alzheimer’s remains speculative. This same autopsy case had 
earlier been published. Although the only three earlier published cases of PAF autopsy had 
failed to note such central findings, technical factors may have reduced the yield in these 
cases [Bradbury and Eggleston 1927; Roessmann et al 1971; Ingelghem et al 1994]. 
Functional imaging has not significantly clarified the degree of striatal involvement, if at all, 
in PAF, with one study of fluorodopa F 18 positron emission tomography showing 
abnormalities of the nigrostriatal dopaminergic system in only 1 of 7 subjects, with a single 
case report suggesting straital involvement of the caudate and putamen with single-photon 
emission computed tomography with iodine 123 ioflupane [Brooks et al 1990; Compta et al 
2006]. There remains the possibility that PAF is a “forme fruste” of PD in which the 
postganglionic autonomic lesions form the main clinical picture without progression 
[Oppenheimer 1980]. Whilst some doubt thus remains about the degree of central 
involvement in PAF, both pathological and physiological studies strongly support the 
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peripheral, postganglionic dysfunction of PAF [Bradbury and Eggleston 1927; Roessmann et 
al 1971; Ingelghem et al 1994; Mathias 2004]. 
  
 
 
 
 
 
 
 
 
Fig 1:3 High power (X300) light microscope vie of H & E stained adrenal gland post 
ganglionic nerve (top picture) and sympathetic ganglion (lower picture) from PAF 
autopsy showing Lewy Bodies (arrowed). [Hague et al 1997] 
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Management:  
 
Some of the management options discussed for MSA will be applicable to PAF, especially 
those concerning OH. The management of OH is considered in more detail in this thesis (1.1 
The Autonomic Nervous System in Health and Disease). Given the possibility of survival for 
many decades post-diagnosis, concerns about the cumulative effects of supine hypertension in 
PAF are probably more relevant to PAF subjects in whom cardiac hypertrophy has been 
demonstrated [Vagaonescu 2000]. As such, a delicate balance of control of orthostatic 
hypotension should be employed, using measures such as head-up tilt at night and late-night 
meals where needed to minimize supine hypertension. It is important to realize that PAF, 
when well managed, is entirely compatible with a good quality of life.  In one study activities 
of daily living were not significantly affected even many years after onset with survival up to 
90 years of age reported [Mabuchi et al 2005].  
 
Recently an exciting new approach to treatment has been suggested with immunotherapy. A 
case report of an apparent case of PAF with antibodies binding to neuronal ganglionic 
acetylcholine receptors [Schroeder et al 2005] demonstrated improvement of orthostatic 
hypotension following courses of plasma exchange. Whilst volume expansion from plasma 
exchange alone might be expected to improve orthostatic hypotension, the improvement in 
both the pressor responses and tests of parasympathetic function are not so easy to explain. 
An earlier case report of a subject who superficially resembled PAF with circulating 
antibodies to the ganglionic nicotinic AchR has been reported [Goldstein et al 2002] 
In contrast to PAF however, the subject had normal left ventricular myocardial concentrations 
of 6-[18F] fluorodopamine-derived radioactivity and a marked increase in plasma NA on 
standing, suggesting that postganglionic sympathetic innervation was intact. Thus a label of 
autoimmune autonomic neuropathy maybe more appropriate than PAF. Whether or not some 
PAF subjects may have an autoimmune aetiology or not remains to be seen. For the present 
this approach raises possible hope of even better management of PAF in the future.  
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1.4: Aims of Thesis 
 
 
PAF primarily involves the post-ganglionic autonomic nervous system, whilst in MSA the 
pre-ganglionic structures are impaired. My central hypothesis is that this underlying 
neuropathological difference between MSA and PAF will lead to differing cardiovascular 
responses. By utililizing the non-invasive methods available in the autonomic laboratory the 
aim was to examine the differing cardiovascular responses in MSA and PAF to varying 
stimuli. In some cases (cold pressor, isometric exercise, inspiratory gasp) the stimuli were 
well established but the responses in MSA and PAF have not been. Other stimuli (such as 
water ingestion and inhaled CO2) were more novel. It was hoped that such investigations 
would help further elucidate the underlying pathophysiology of these diseases. In the case of 
the water ingestion studies described in this thesis, a symptomatic benefit in orthostatic 
hypotension was demonstrated for the first time. By establishing differing responses in well-
established cases of MSA and PAF it is hoped that future studies might usefully employ these 
methods to subjects first presenting with autonomic failure. At the initial presentation 
distinction between MSA and PAF is not always clear: better differentiation would be 
important for prognostication, management, and increasingly for better definition in selection 
of study populations for therapeutic trials.  
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                                                2:  Apparatus 
 
 
 
1) Autonomic Laboratories:  
 
 
All studies were performed in our dedicated autonomic laboratories at The National Hospital 
for Neurology & Neurosurgery Queen Square, London or at Imperial College at St.Mary’s 
Hospital, London. These laboratories allowed the application of adequate experimental 
conditions including  minimisation of ambient noise and controlled environmental conditions. 
 
Temperature control was validated by a series of recordings based in the laboratories over a 4-
month period in mid-year (April, May, June, July). Temperatures were taken from a wall-
mounted mercury column thermometer based in the laboratory at mid-morning for each 
working day (Monday-Friday inclusive) on a randomly chosen week in each month.  
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Month Temperature 
April 24 oC 
April 25 oC 
April 24 oC 
April 24 oC 
April 23 oC 
May 25 oC 
May 22 oC 
May 23 oC 
May 23 oC  
May 24 oC 
June 25 oC 
June 23 oC 
June 26 oC 
June 24 oC 
June 23 oC 
July 24 oC 
July 25 oC 
July 23 oC 
July 25 oC 
July 24 oC 
  MEAN TEMPERATURE: 24+/- 1 oC 
 
Table 2:1  Autonomic Laboratory Temperature recordings over 3 months 
 
The mean temperature of these recordings was 24+/-10C, the same value commonly quoted in 
published work by other authors for temperature references ranges in their autonomic 
laboratories. It is possible that temperatures in the laboratory would have been higher than 
this at the peak of summer, or lower in the midst of winter. Substantial variation would 
however seem unlikely given the consistency shown in Table 2.1 for each of the months 
tested. Furthermore, slightly higher temperatures in summer, and slightly lower temperatures 
in winter would probably have merely increased the standard deviation of the overall mean 
temperature rather than change the mean value itself. 
 
 
 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      102                                            
2) Multi-Purpose Tilt Table (Akron):  
 
 
For studies which included tilting in the protocol, an electronically operated, hydraulic tilt 
table was used. This was approximately 190cm in length and 70cm in width. The maximum 
recommended load was 180Kg, when distributed evenly. The table was fitted with lockable 
casters and stabilisers for safety in use. Additional security in upright positions provided by a 
footrest and body belts (2X narrow Belts, 1X Wide Belt), secured by means of Velcro strips 
threaded through the side chrome rails of the table. These straps were placed around the legs, 
waist and chest whilst the subject was still in the horizontal position. The body belts were 
placed to avoid excessive pressure on the subject, which might otherwise have compromised 
relaxed breathing. By the side of the tilt table, manually operated controls allowed raising or 
lowering of the table. In addition, these controls permitted tilting upright and back to 
horizontal. The degree of table tilt from the horizontal was gauged by means of a degree scale 
under the table, which was fixed, and a pointer permitted to move freely with the influence of 
gravity. Time to raise the bed from horizontal to 600 was 3 seconds, with similar time interval 
required to return the table to the horizontal from this inclination. Prior to each study a 
protective tissue cloth was placed on the table and changed at the end of each study. Between 
subjects the body straps were cleaned with disinfectant. Regular maintenance was carried out 
during the period of the studies. 
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Figure 2:1: Akron Multi Purpose Tilt Table  ref: 
http://www.akronproducts.co.uk/mutli%20tilt/index.htm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      104                                            
 
3) Dinamap automated oscillometric blood pressure recorder (Critikon) 
 
 
 
A Dinamap automated oscillometric blood pressure recorder (including  1846SX model) was 
used throughout the studies of this thesis to obtain non-invasive BP & HR from over the 
brachial artery [Gorback et al 1991; Goonasekera & Dillon 1995]. The 1846SX (figure 2.2) 
has been shown by validation study to have a consistency of measurement compatible with 
research level requirements with accuracy of diastolic and MAP in particular comparable with 
intra-arterial measurements [Whincup et al 1992].  
 
 
 
 
 
Figure 2:2: Dinamap on study subject 
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4) Portapres Model-II: 
 
 
The Portapres (Model-II) is a non-invasive medical device used to monitor continuous finger 
arterial pressure waveform and to calculate estimates of SBP, DBP and HR. Subsequent 
Modelflow analysis can then be utilised to calculate additional cardiovascular indices such as 
CO, SV, TPR and EF. The Portapres (figure 2.3) is a lightweight device which fits around the 
wrist and is secured to the forearm with non-constricting Velcro straps. A hydrostatic height 
correction unit allows free movement of the arm in relation to heart level, and allows for 
measurements during tilting from the horizontal. Despite the fact Portapres can be used to 
record for up to 24 hours, and that no damage to fingers has resulted from the finger-cuff, 
patient discomfort from local congestion can arise with prolonged recordings. For this reason 
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on recordings in excess of  2 hours “finger-switching” is recommended. This method allows 
automatic switching between adjacent fingers fitted with appropriately sized cuffs after a set 
period, and thus allowing congestion in one finger to resolve whilst recording from the other 
finger. In practice finger switching was not required for the studies described in this thesis as 
the recording intervals were less than 2 hours. Thus the potential error of comparing arterial 
waveforms in different fingers was avoided. The Portapres calibrates itself at regular intervals 
during each recording (not less frequently than every 5 minutes) to prevent pressure drift.  . 
The data from each study are stored on an in-built memory card, capable of storing more than 
24 hours of finger arterial waveform data. The data were subsequently transferred to a PC 
(Dell Inspiron Laptop) via a serial link for beat-to-beat analysis with the Beatscope software. 
 
 
 
 
 
 
 
Figure 2:3 Portapres used for non-invasive beat-to-beat recording of cardiovascular 
indices. Two Velcro finger cuffs (bottom left) are shown connected to the fronted unit. 
Additional leads shown allow height correction to be performed prior to readings.  
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      107                                            
 
Figure 2:4 Portapres on left arm. Portapres height correction lead shown at heart level. 
 
 
 
Power supply either from mains (using AC adaptor with a grounded 240 Volt 50/60Hz AC 
receptacle or batteries (Portapres non-rechargeable 13Ah Lithium batteries or Portapres 
rechargeable NiCd 2.4 Ah batteries). There is a low finger cuff  LED current (<30mA), 
voltage (<1.8V) and power dissipation (<50mW) thus reducing risk of undue skin heating or 
electrical hazard. Any electrical short circuit in either finger cuff or main instrument, or an 
interruption in cable signal results in a cut off of cuff pressure within 1 second.  
 
Fronted Unit 
The fronted unit (see figure p21 Portapres2) contains the electronics for the infrared 
plethysmograph in the finger cuff and a switching valve to enable switching of finger cuffs if 
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required. In addition an air pressure control valve and pressure transducer is stored within the 
unit. The air pump unit is stored separately in Portapres waist belt (which also houses the 
battery if required, and the computer board of the Portapres, together with flash card for data 
storage). The pump unit, height correction unit, control unit and finger cuffs all attach to the 
fronted unit.  
 
Finger cuff 
Air pressure in the finger cuff is regulated to 380mmHg (0.5atm) by use of an electrically 
regulated air compressor in combination with a pressure transducer. In the event of internal 
computer malfunction, or cuff pressure of > 250mmHg sustained for 2.5 seconds, the cuff 
pressure is automatically released by means of a watch dog timer. During the initial start-up a 
pressure in excess of 295mmHg will result in cuff deflation. If fully occluded finger arteries 
are detected during the initial start-up the Portapres issues a warning display and shuts off the 
cuff pressure. Near full occlusion of finger arteries can increase the variability of readings. 
Such situations are highlighted on the Portapres display panel and in the data files by means 
of “?” or “!” signs in front of the displayed values.  
 
The finger cuff consists of an air bladder and several layers of plastic, rubber material and 
Velcro. The cuff includes the electronic components such as Light Emitting Diode (LED) and 
photodiode of an infrared plethysmograph. The cuff is connected to the fronted unit by means 
of a cuff cable connector and air hose connector. The cuffs come in three sizes: small (white), 
medium (beige) and large (blue). These allow correct size fitting of cuffs to fingers so that the 
sides of the cuff bladder come into contact but do not overlap. The white cuff fits fingers with 
circumferences of 45-55mm; beige fits fingers with circumferences of 55-65mm; blue fits 
fingers with circumferences of 65-75mm). Once the correct size is chosen, the cuff is wrapped 
around the middle phalanx of a finger, ideally on the non-dominant hand to allow for 
activities using the dominant hand if required during a study. The orientation of the cuff is 
important with the LED and photodiode being placed symmetrically on the palmar surface of 
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the finger to allow maximal opposition with the two digital arteries in each finger.  The cuff 
cable and air hose are then threaded between two adjacent fingers to the volar side of the hand 
to reach the fronted unit. The cuff cable and air hose may then be inserted into their respective 
sockets on the fronted unit. These steps are then repeated for a second adjacent finger if finger 
switching is required for the study. The finger cuff pressure means that the patient senses a 
slight pulsation in the cuffed finger synchronous to the heart beat.  
 
Height Correction Unit  
The Height correction unit  (figure 2.4) is a liquid filled tube with a pressure transducer at one 
end. The transducer end is kept secured to the finger cuff (by means of Velcro attached to the 
Velcro of the cuff). The other end (reference end) contains a compliant plastic bag in the 
circular container which is kept at heart level. The height correction unit is attached to the 
Fronted unit by means of a height correction unit connector. Height correction is performed 
prior to each study by holding the both ends of the height correction unit at heart level and 
pressing the “Height” button on the Portapres control unit until height nulling has been 
confirmed on the display unit (see below). After confirming height nulling with the Start/Stop 
key the transducer end is attached to the finger cuff whilst the reference end of the height 
correction unit is taped at heart level.  
 
Control Unit 
The Control Unit has a 2 X 16 character Liquid Crystal Display (LCD) and a 6 key keypad 
(Figure 2.3 & 2.4). The control unit is connected to the Front Unit by means of a control unit 
cable connector. In addition a serial interface socket (“RS-232 to PC”) can be used to 
download data from the Portapres flash card to the PC for analysis with Beatscope software.  
 
 
 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      110                                            
 
 
Key  Main Function 
Start/Stop -Start a measurement 
-Stop a measurement 
-Confirm a query 
Finger -Set up finger switching mode 
-Arrow up key 
Physio -Switch on/off physiological calibrations  
Event -To mark events (exact event and time written down separately in log book) 
-Arrow left key 
Height -To perform initial height nulling allowing different hand and heart levels 
-Arrow down key 
Output -Perform analog output calibration.  
-Arrow right key 
 
 
Table 2:2 Portapres Control Unit Keys 
 
 
 
 
Control Unit Display: 
When switched on but prior to a recording the display will show “Ready Mode”. The display 
shows time in hh:mm whenever event marker is pressed. During height nulling the display 
will signal when nulling has been successfully completed and subsequent confirmation by 
means of the Start/Stop key will return the display to ready mode. During recordings SBP and 
DBP are displayed (mmHg) as well as HR (bpm) as beat-to-beat values. Error signals appear 
on the display panel if the pump system fails to generate enough pressure, or if pressures are 
not stable enough. In addition, any problem with the Portapres circuitry or connections will 
also be displayed as an error.  
 
Maintenance and calibration 
The Portapres unit was regularly cleaned using a soft, slightly moistened cloth, avoiding the 
direct use of liquid to the unit. Calibration is carried out on a yearly basis by connecting a 
calibrated manometer to the air outlet of the fronted unit. Zero level is then checked and the 
arrow keys on the control unit used to increase the pressure in 50mmHg stages to 300mmHg. 
For each pressure level the accepted precision should be within 1% of the manometer reading 
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(for values outside these reference ranges TNO-TPD . These steps are performed for each of 
the two air outlets in the fronted unit. 
 
 
 
5) Beatscope Software & Modelflow Measurement Principles 
 
 
The analysis of the Portapres raw data is performed by Beatscope software supplied with the 
Portapres device. The Portapres measurements can be transferred to a PC for beat to beat 
analysis with BeatScope 1.1A Software to obtain brachial pressure waveforms and 
cardiac parameters using the ModelFlow cardiac output method. The Modelflow system unit 
is covered in some detail here as it is an important aspect of the beat-to-beat recordings 
employed in this thesis. The principle of haemodynamic measurement with the Portapres 2 is 
based on the volume-clamp method, first described by Jan Penaz [Penaz 1973] and the 
Physiocal system of  [Wesseling 1995].The volume clamp method involves maintaining 
(clamping) the finger artery diameter, despite changing  arterial BP, by means of a finger cuff 
with inflatable air bladder. Potential changes in arterial diameter are detected by the infrared 
photo-plethysmograph in the finger cuff which leads to appropriate changes in the finger cuff 
pressure by means of a fast pressure servo controller. Thus during systole the increase in BP 
results in increased light absorption from the LED and therefore a decrease in the signal 
detected by the plethysmograph. The Physiocal system is used to define and maintain the 
diameter at which the artery is clamped.  
 
 
Volume-Clamp Method 
 
 
Compliant arteries show greater changes with any given change in intra-arterial pressure than 
non-compliant ones. Arterial compliance is related to transmural pressure, which describes 
the difference between pressure inside the artery and that of the surrounding tissue. The 
pressure of the surrounding tissue is effectively regulated by the finger cuff. If this pressure is 
too high the arteries will almost be collapsed and diameter changes will be small for given 
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changes in intra-arterial pressure. Conversely, if the finger cuff pressures are too low the 
arteries will be distended and effectively of low compliance, with changes in intra-arterial 
pressure again having limited effects on arterial diameter. The optimum finger cuff pressure 
will maintain zero transmural pressure difference as arterial diameter changes in response to 
given changes in intra-arterial pressure will be maximal. Furthermore, a transmural pressure 
of zero means that the finger cuff pressure will provide an estimate of intra-arterial BP. At 
zero transmural pressure the artery is said to be ‘unloaded’.   
 
To maintain near-zero transmural pressure therefore, the finger cuff pressure must change, to 
oppose the changing intra-arterial pressure during each cardiac cycle. As outlined above, this 
is achieved by means of a negative feedback loop with the infrared photo-plethysmograph 
providing afferent signalling for the efferent servo controller to rapidly change finger cuff 
pressure. The finger artery is thus clamped a certain set point diameter.  
The servo controller defines this set point and then detects changes from this diameter by 
means of the infrared photo-plethysmograph signal and responds by controlling a fast 
pneumatic proportional valve in the fronted unit. The proportional valve then modulates the 
air pressure generated by the air compressor, thus resulting in changes in finger cuff pressure 
to maintain finger artery diameter at the set point. 
 
 
Physiocal System 
 
. 
When the Portapres cuff is deflated, the unloaded finger artery diameter corresponds with the 
pressure level at which amplitudes in the plethysmogram will be greatest. However, using the 
amplitudes alone is a relatively inaccurate way of determining blood pressure. The Physiocal 
algorithm [Wesseling 1995] utilises both the amplitude of pulsations and the shape of the 
plethysmogram when the finger cuff pressure is constant. The algorithm employs brief 
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periods at which the finger cuff pressure is fixed at several different pressure levels. These 
periods (“physiocals”) are repeated at regular intervals during any recording. These data from 
two or more pressure levels can then be analysed to track the unloaded diameter of the finger 
artery (see Figure p17 Finger cuff manual). The example shown below illustrates this in 
practice. 
 
1) When a fixed finger cuff pressure is deployed which is below the intra-arterial 
diastolic pressure, the arterial diameter will be relatively large so that the 
plethysmographic signal is low.  
2) When the fixed cuff pressure is  above the intra-arterial DBP, but below the MAP or 
SBP, then the plethysmographic signal will still be low, but will vary in diastole as 
the cuff pressure will be above DBP.  
3) When the fixed cuff pressure is above MAP but below SBP the artery will remain 
collapsed for much of the cardiac cycle. The plethysmographic signal will still be 
high, only varying in systole.  
 
The end-diastole period is analysed for each of the fixed cuff pressures. If the top of the 
plethysmographic signal at this time is a clear peak (“too sharp”) then that fixed cuff pressure 
will be below MAP. If, however, the end-diastole pattern on the plethysmographic signal is a 
plateau (“too flat”), then the cuff pressure is too high. These characteristic shapes of the end-
diastolic period on the plethysmograph will also depend on the vessel tone. For this reason the 
interpretation of “too sharp”, or “too flat” is verified at different cuff pressures as described 
above. The Physiocal algorithm also ensures that the chosen unloaded artery diameter is not 
too close to the fully collapsed diameter of the finger artery and compares the calculated 
unloaded diameter with previous values obtained earlier in the recording. If a consistent value 
for the unloaded finger artery diameter is not obtained at the end of the above readings further 
fixed cuff pressures are employed automatically until a satisfactory diameter is obtained.  
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A similar situation is encountered at the start of each new recording; without previous 
diameter values for comparison the Physiocal algorithm deploys multiple steps of increasing 
fixed cuff pressures to obtain an initial value of finger artery diameter. After starting a new 
recording the frequency of Physiocals is initially set at every 10th arterial pulsation. Only 
when a stable set point has been achieved (usually after 4 minutes of recording) will the 
frequency gradually be decreased down to a final frequency of one Physiocal for every 70 
arterial pulsations. If at any point during the recording the variation in the set point diameter 
becomes too large (as might occur with extreme movement artefact), the Physiocal frequency 
will automatically increase again to maintain accuracy until stability returns.  
 
 
During recordings the finger tip distal to the finger cuff usually appears slightly cyanosed, and 
the subject will often experience mild parasthesia (but not pain) in the area. The reason for 
this is that the arteries distal to the cuff are being held at zero transluminal pressure, and as 
such have about 60% of their original distended diameter. The blood that enters the finger tip 
during systole can only leave during diastole when the pressure in the fingertip vessels is 
greater than the cuff. This congestion leads to fractionally delayed venous return and thus 
greater deoxygenation of the venous blood. The net result is the slight colour change observed 
in the fingertips, whilst the congestion itself results in slight parasthesia. The Physiocal 
algorithm ensures that the finger artery is kept open during the recording and so arterial 
supply to the fingertip is not compromised. Thus, although finger cuff switching is 
recommended to avoid discomfort if continuous recordings exceed 2 hours, there have been 
no incidents of damage to the fingertip in over 20 years of use of finger cuffs for the 
Portapres/Finapres machines.  
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Figure 2:5  Finger plethysmogram at five cuff pressures [Taken from Portapres II user-
manual TNO-TPD Biomedical Instrumentation] 
 
      
 
In each systole the increase in aortic pressure causes inflow of blood into the arterial system. 
This inflow is, however, opposed by both aortic and peripheral systemic properties including 
arterial counter pressure and impedance.  Modelflow simulates this according to the three-
element Windkessel model of arterial input impedance [Burkhoff et al 1988; de Vaal et al 
2005]. The three main components of this model are aortic characteristic impedance, 
(opposition of the aorta to pulsatile inflow), Windkessel compliance (representing the elastic 
storage capacity of the entire arterial system in response to increasing aortic pressure), and 
peripheral resistance. The aortic Windkessel compliance decreases substantially in a non-
linear manner when aortic pressure increases. By contrast the aortic impedance increases 
moderately with increasing aortic pressure. Taking these non-linear relationships into account 
is important to allow appropriate corrections to the basic model for changing aortic pressure. 
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This has been done with post-mortem studies with results adjusted for age, sex, height and 
weight [Langewouters et al 1984]. 
 
 
 
 
VALIDATION STUDIES 
 
 
The Portapres is considered sufficiently accurate to track changes in BP and correlates well 
with group data compared to the Dinamap 1846SX as part of a validation study for this thesis 
[Imholz  et al 1998 & Figure 2.6]. Although estimation of SV using the Portapres with 
subsequent Modelflow analysis is considered accurate, even under orthostatic stress [Harms et 
al 1999], recent concern has been raised concerning the accuracy of CO [Remmen et al 2002; 
Azabji Kenfack et al 2004; Pitt et al 2004]. Earlier validation studies have suggested that 
Modelflow does provide reliable values for cardiac indices such as SV, which have been 
validated in a variety of settings [Harms et al 1999, Jellema, Imholz et al.1999 Langewouters 
et al.1998]. However, the reliability of the absolute values of CO have been questioned 
[Jellema et al 1999, Azabji Kenfack et al 2004; Pitt et al 2004], with a view that relative 
change of CO values in groups rather than individuals could still provide reliable data.  
 
There has been some debate about the accuracy of the use of constants established from post-
mortem aortic elastic characteristics in Modelflow analysis.  These vessels differ from those 
of finger arteries and may therefore reduce the accuracy of the calculated value for CO. 
Comparison of CO values calculated by either Modelflow or by values obtained 
simultaneously by CO2 rebreathing suggested some limitations of the Modelflow absolute 
estimates, although the CO2 rebreathing method is not a gold-standard technique for CO 
estimate and only provides very intermittent values [Houtman et al 1999]  Studies comparing 
intra arterial BP values with those obtained with the Portapres have been performed to 
investigate this further [Rongen et al 1995; Azabji Kenfack et al 2004]. The first of these 
studies actually found that the Finapres (the earlier version of the Portapres) absolute values 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      117                                            
of MAP and DBP closely followed intrabrachial arterial values, although SBP was slightly 
underestimated by the Finapres [Rongen et al 1995]. Comparison of the Portapres with 
intraradial arterial BP measurements was made in a later study in which both were then 
subjected to Modelflow analysis to obtain CO estimates [Azabji Kenfack et al 2004]. In this 
study DBP, SBP and calculated CO were lower when obtained from the Portapres. However, 
several factors may have contributed to this discrepancy. There were fewer subjects in this 
second study (7 versus 15 from the Rongen et al study), and the subjects were much younger 
(mean age 24 years) compared with a mean age of 75.9 years in Rongen et al’s group (much 
closer to the age of subjects used in my thesis). Furthermore the Modelflow used in the 
Beatscope software to estimate values for CO etc is based on intra-aortic pressures, not intra-
radial. There are some differences between readings taken from these sites, and therefore it is 
conceivable that the intra-brachial techniques of Rongen et al may have been more accurate  
[Wesseling et al 1993]. Direct comparison with thermodilution again questioned the accuracy 
of Portapres/ Modelflow-derived CO for individual and absolute values. However, possible 
reasons for this discrepancy, not least of which is the inherent inaccuracy of thermodilution 
(+/- 15%) have been pointed out [Guyton et al 1973; Pitt et al 2004]. 
 
The Modelflow method actually determines stroke volume with CO subsequently calculated. 
The Portapres responds equally to increases and decreases in stroke volume, irrespective of 
the heart rate change [Pitt et al 2004]. Although there is therefore some debate about the 
accuracy of individual absolute values of cardiac indices such as CO obtained from 
Modelflow analysis of Portapres signals, there is consensus that the tracking of serial results 
of BP/HR/CO/SV/TPR from Portapres and subsequent Modelflow analysis, as performed 
throughout this thesis, is valid [Azabji Kenfack et al 2004; Pitt et al 2004]. Furthermore 
alternative non-invasive techniques to obtain beat-to-beat estimates of cardiac indices are 
fraught with difficulties. Impedance cardiography is limited by artefacts due to thoracic 
movements which also are likely to differ markedly between the study subjects of my thesis 
given the frequent respiratory system involvement in MSA [Kubicek]. Doppler 
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echocardiography requires the probe to remain fixed at a given position above the 
investigated artery which would be challenging during the postural change utilised in many of 
the studies in this thesis. As changes in values of groups of subjects were involved in all the 
major studies of this thesis it would therefore have been unethical to use invasive intra-arterial 
recordings in place of the Portapres recordings for the studies in this thesis. 
 
We therefore feel justified in using the considerably less invasive Portapres/Modelflow 
methods in investigating the changes of cardiac indices in the studies of this thesis whilst 
acknowledging the greater importance to be given to trends of readings above the absolute 
derived values themselves.   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2:6 Correlation of seated SBP in 14 subjects with AF (7 MSA and 7 PAF) 
Obtained with automated brachial BP pressure cuff (Dinamap 1846SX) and Portapres 
on contralateral arm as part of this thesis.  
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3.1:  Introduction to Studies 
 
 
 
The following studies were performed to enhance the differentiation of MSA and PAF based 
on the cardiovascular responses to various stimuli. A key concept to the studies is that of a 
comparison between a pre-ganglionic (MSA) and post-ganglionic (PAF) lesion model of 
autonomic dysfunction. Although there is some evidence that in PAF there maybe some 
additional pre-ganglionic disease burden, the post-ganglionic component is felt to 
predominate. This thesis will help to validate this assumption as the studies are based on 
predicted responses from theoretically pure models of pre- or post-ganglionic lesions.  
 
The first study is essentially a large validation of existing practice by assessing the responses 
of MSA and PAF to our unit’s standard cardiovascular autonomic function tests. This had not 
been previously been performed on such a large scale. Pressor tests are widely used 
autonomic function tests, yet the cutaneous vasomotor responses in pre- and post ganglionic 
models of autonomic failure had not previously been clearly determined. The use of laser 
Doppler technology has allowed this comparison to be performed in MSA and PAF subjects 
in this thesis.  
 
The intravenous clonidine test is widely used to help distinguish MSA subjects. In these 
subjects the preganglionic lesion site includes hypothalamic involvement resulting in a 
suppression of the normal increase in plasma growth hormone (GH) response with the 
selective α2-adrenoceptor agonist clonidine. The cardiovascular response to clonidine in MSA 
and PAF had not been well established however. The clonidine study in this thesis is the 
largest published series to focus on this aspect. Assuming the supine position immediately 
after upright posture may lead to a transient supine hypertension in MSA more than PAF 
subjects. Support for this observation was obtained from the studies on BP overshoot on tilt-
reversal. Secretion of the posterior pituitary hormone ADH in response to upright tilt also 
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appears to be impaired in MSA but not PAF. As ADH is a pressor compound the possibility 
that it could be involved in the tilt-reversal supine hypertension in PAF was explored in these 
studies.  
 
In addition to comparisons of cardiovascular responses in MSA and PAF to established 
autonomic function tests, newer pressor substances such as oral water and CO2 inhalation 
were explored in MSA and PAF subjects, with possible diagnostic and therapeutic 
implications being explored. Although the water pressor effect had already been observed in 
autonomic failure, detailed haemodynamic responses to oral water with comparisons between 
MSA and PAF and symptom response had not previously been examined. Both systemic and 
regional cutaneous responses to CO2 inhalation were studied in MSA and PAF subjects and 
the findings discussed in terms of possible novel means to aid differentiation of these 
conditions non-invasively.  
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3.2:  Validating Standardised Pressor Responses in MSA and PAF 
 
 
 
 
Abstract 
 
 
 
Background & Aim: Haemodynamic responses to isometric exercise (IE: handgrip), mental 
arithmetic (MA) and cold pressor (CP) stimuli are frequently used in the assessment of 
autonomic failure. Multiple system atrophy (MSA) and pure autonomic failure (PAF) provide 
contrasting models of primary chronic autonomic failure. In MSA the lesion is central and 
pre-ganglionic, whilst in PAF the lesion site is peripheral and postganglionic. The value of 
pressor testing to aid differentiation of MSA and PAF has not been firmly established. We 
therefore evaluated the haemodynamic responses to standardised IE, MA, and CP stimuli in 
large groups of MSA and PAF subjects who had been tested in our autonomic laboratory. 
Methods: We studied a total of 69 subjects (47 MSA and 22 PAF). Baseline supine systolic 
blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR) were obtained with 
an automated sphygmomanometer (Dinamap). The subject then underwent standardised 
pressor stimuli with rest periods in between. These stimuli consisted of: IE (submaximal hand 
grip for 180 seconds); MA (serial subtraction calculations); CP test (contralateral hand placed 
between two ice packs for 90 seconds). The post-stimulus Dinamap recording was made at 
the end of each pressor test. Paired and un-paired t-tests were used to compare baseline and 
post-stimulus haemodynamics both within and between groups. 
Results: There was no significant difference in baseline haemodynamics between the groups. 
Haemodynamic responses were attenuated in both groups to all pressor stimuli. In MSA HR 
increased following each pressor stimulus, whilst BP increased with IE and CP but not MA, 
which led to a fall in SBP and DBP. In PAF HR increased with CP and MA, but not with IE. 
There was no significant BP change with pressor stimuli. Comparing groups showed a greater 
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increase in HR following IE and CP in MSA than PAF and a greater increase in SBP in MSA 
following CP. SBP and DBP decreased to a greater extent in MSA following MA. 
Conclusions:  Our results suggest differences in pressor responsiveness in MSA and PAF. 
HR and BP increases tended to be preserved to a greater extent in MSA than in PAF. These 
differences may reflect the contrasting pathophysiology of these groups, and may aid their 
clinical differentiation. 
 
Introduction 
 
 
Standardised autonomic function testing includes the use of pressor testing to assess the 
autonomic control of the cardiovascular system [Mathias 2002]. Despite this the responses to 
pressor testing in pre- and post-ganglionic models of chronic autonomic failure have not been 
well delineated. This study therefore set out to assess the haemodynamics of pressor testing in 
multiple system atrophy (MSA) and pure autonomic failure (PAF) which provide models of 
pre- and post-ganglionic autonomic failure respectively [Mathias 2004].  
 
In healthy subjects pressor tests elicit a transient increase in systolic and diastolic blood 
pressure (SBP and DBP) and increased heart rate (HR) [Mathias 2002]. There are 3 standard 
pressor stimuli: Isometric Exercise (IE) evoked by sustained handgrip; Mental Arithmetic 
(MA) evoked by the subject performing serial subtractions; Cold Pressor (CP) evoked with 
application of an icepack to the hand. All three stimuli lead to pressor effects by activation of 
the sympathetic nervous system, but the pathways involved differ. CP evokes a pain response 
involving of Aδ and C afferent fibres and subsequent activation of brainstem structures 
leading to increased sympathetic outflow [Hilz et al 2002; Petrovic et al 2004]. With MA, by 
contrast, there is initial activation of central areas such as the right insula and right anterior 
cingulate, resulting in increased sympathetic outflow [Critchley et al 2000]. IE has important 
peripheral and central input to the medullar vasomotor centres, although there have been 
contrasting views as to the relative importance of these inputs in the generation of the IE 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      126                                            
pressor effect it is currently felt that both play a significant role [Alam and Smirk 1937; 
Victor et al 1989; Winchester et al 2000; Critchley et al 2000].  
 
Because of the differing afferent pathways involved in the 3 pressor responses, the 
haemodynamic responses may vary in autonomic failure associated with specific lesion sites. 
Thus in subjects with complete high cervical spinal cord injury, MA will not elicit a pressor 
response whilst CP below the level of the lesion can produce an abnormal, enhanced pressor 
response termed autonomic dysreflexia [Mathias 2002; Mizushima et al 2003]. MSA and 
PAF provide contrasting models of chronic primary autonomic failure, with the lesion site 
being preganglionic and central in MSA but postganglionic in PAF [Daniels 2002; Matthews 
2002]. We anticipated that the haemodynamic responses to standard pressor stimuli may vary 
between MSA and PAF because of the differing lesion sites. We therefore set out to assess the 
haemodynamic responses to IE, MA and CP in MSA and PAF subjects tested in our 
autonomic laboratories. 
 
Subjects  
 
 
We studied a total of 69 subjects with chronic autonomic failure who had been tested in our 
autonomic laboratories over the previous decade as part of their clinical assessment. In total 
47 MSA (18 females and 29 males, mean age 58.7 ±10.0 years) and 22 PAF (11 females and 
11 males, 63.3±8.6 years) were studied. MSA and PAF subjects had diagnosis made using 
existing criteria [Gilman et al 1998, Mathias 2004]. All MSA and PAF subjects had 
documented sympathetic and parasympathetic dysfunction with severe orthostatic 
hypotension. The mean disease duration for MSA was 4.6 +/-2.0 years; for PAF 12.9 +/- 62.7 
years. There was no significant difference in baseline supine SBP or DBP between MSA and 
PAF (150.1 +/-26.1 / 84.5+/-15.5 versus 159.8 +/-29.3 / 89.0+/-16.6). HR was slightly higher 
in MSA than in PAF, but this did not reach significance (72.8 +/-10.1 vs.  69.3 +/- 12.3). Of 
the 22 PAF, 16 were on fludrocortisone, 4 were on ephedrine and 5 on midodrine. Of the 47 
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MSA, 21 were on fludrocortisone, 12 on ephedrine, 5 on midodrine and 12 on dopaminergic 
medication for Parkinsonism. Vasoactive medication was withdrawn from the night prior to 
the study. Local ethics approval from The National Hospital for Neurology and Neurosurgery 
London was obtained to use the results of these pressor tests.  
 
 
 
Methods 
 
 
All studies were performed in a dedicated, temperature controlled (24+/-10C), autonomic 
laboratory. Each subject had brachial SBP, DBP and HR recorded with a Dinamap (Critikon) 
automated sphygmomanometer before and immediately after each pressor test. Once a stable 
baseline was obtained, the subject first underwent pressor testing as follows: 
 
1) IE test: The subject gripped a partially inflated sphygmomanometer cuff at maximum 
intensity for 2 seconds and then ceased gripping. The target grip intensity was calculated as 
follows: 
                                           Maximum grip – initial cuff pressure 
     Target Grip intensity =                           3 
 
The subject then sustained handgrip to above target grip intensity for 3 minutes. A Dinamap 
reading was taken at end of this period and compared with baseline. 
 
2) MA test:  The subject underwent 1 minute of performing serial subtractions starting with 7 
from 100 being requested to perform the calculations as fast as possible. Answers were 
verbalised and more complex subtractions requested if judged that serial 7’s were not 
sufficiently challenging for the individual subject. 
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3) CP test: Ice cold packs 0-40C were placed on dorsum of the hand for 90 seconds.  
 
 
After each stimulus, SBF was allowed to return to stable baseline levels before commencing 
the next stimulus.  
 
Statistics Dinamap recordings of SBP, DBP and HR were compared within each group before 
and after each pressor test (using paired t-test). Between group comparisons were made by 
calculating the change in BP or HR following each pressor stimulus, and then comparing the 
mean change for each group using non-paired t-test. Statistical significance was taken as 
p<0.05. 
 
 
 
Results 
 
There was no significant difference in baseline haemodynamics between the groups. 
Haemodynamic responses were attenuated in both MSA and PAF to all pressor stimuli as 
compared with values obtained for age-matched healthy controls [Mathias 2002].  
 
MSA showed a significant increase in SBP and DBP following CP (∆SBP  +11.2 +/- 13.3;  
∆DBP +3.6 +/- 5.8 mmHg), but only showed a smaller rise following IE (∆SBP  +2.6 +/- 
10.3;  ∆DBP +2.1 +/- 8.0 mmHg). Following MA there was a small reduction in SBP and 
DBP (∆SBP  -2.1 +/- 10.3;  ∆DBP -1.6 +/- 6.6 mmHg). In MSA HR increased following each 
pressor stimulus (Figure 3.2: ∆HR following IE: +5.9 +/-5.7 bpm; following MA +4.9 +/-5.4 
bpm; following CP +4.8+/-6.4 bpm). 
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Change in BP and HR in 47 MSA following Pressor tests
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Change in BP and HR in 22 PAF following Pressor tests
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Figure 3.2.1:∆SBP, ∆DBP and ∆HR following pressor tests in MSA and PAF (error bar 
= SE).*=p<0.05; **=p<0.01; **=p<0.001 comparing results before and after test (paired 
t-test) 
 
 
 
 
PAF showed no significant changes in SBP or DBP following any pressor test. There was a 
small increase in HR in PAF following MA and CP (Figure 3.2.1; ∆HR following MA +2.8 
+/-3.3 bpm; following CP +1.5+/-3.3 bpm) but there was no significant change in HR 
following IE. The reduction in SBP and DBP seen in MSA was significantly greater than with 
PAF (Figure 3.2.2).  HR increase following IE and CP was significantly greater in MSA than 
PAF (Figure 3.2.2) and there was a significantly greater increase in SBP following CP in 
MSA compared with PAF.  
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Change in BP and HR in 47 MSA and 22 PAF
following Isometric Exercise
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Change in BP and HR in 47 MSA and 22 PAF
following Mental Arithmetic
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Change in BP and HR in 47 MSA and 22 PAF
following Cutaneous Cold
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Figure 3.2.2: ∆SBP, ∆DBP and ∆HR following pressor tests; MSA and PAF (error bar = 
SE). *=p<0.05; **=p<0.01; **=p<0.001 comparing MSA with PAF (t-test) 
 
 
 
 
Discussion  
 
We have found differences in the response to pressor stimuli between MSA and PAF despite 
similar baseline haemodynamics. Both groups showed attenuation of pressor response 
following standard IE, MA and CP testing, as would be expected given the sympathetic 
impairment in MSA and PAF. However, responses varied with different pressor stimuli. SBP 
was increased to a greater extent in MSA following CP, whilst IE and CP produced a greater 
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increase in HR in MSA than in PAF. Intriguingly, following MA SBP and DBP actually 
decreased in MSA, this reduction being greater than seen with PAF.  
 
Previous reports on the haemodynamic effects of pressor testing in autonomic failure have 
been limited by small numbers or by the use of MSA but not PAF subjects. Two such studies 
in MSA reported attenuation of pressor response to CP [De Marinis et al 2000; Kimber et al 
2000], IE and MA [Kimber et al 2000] without specific comment as to any differences 
between pressor responses. The one previous study to compare the pressor responses in MSA 
and PAF showed no clear differences in pressor responsiveness, but did not report on pressor 
response to MA [Shannon et al 2000]. Thus the differential effects of standard pressor testing 
in MSA and PAF had not been well established previously. 
 
In PAF there is profound post-ganglionic fibre and parasympathetic impairment. As these are 
believed to be integral to the pressor responses to IE, MA and CP, it would be expected that 
there would be a similar attenuation of BP and HR response in PAF to all 3 stimuli, as indeed 
we found. However, the pressor responses in MSA, where the post-ganglionic nerves are still 
functional, varied according to the stimulus. CP produced a significant increase of SBP in 
MSA, which was significantly greater than seen in PAF. How can this partial preservation of 
pressor response to CP in MSA be explained? In controls CP elicits nociceptive afferent 
signals from Aδ and C nerve fibres in the periphery, which are then transmitted via the 
spinothalamic tract to cortical and limbic structures [Lovallo 1975].The brainstem and 
hypothalamus seem to be especially important in integrating the pressor response to the initial 
noiceptive stimulus [Petrovic et al 2004]. It has been suggested that the periaqueductal grey 
(PAG), locus coeruleus and C1 cells of the rostral ventrolateral reticular nucleus are important 
components of this integration between early nociception and pressor response [Faneslow 
1982; Reis et al 1989 Aston-Jones et al 1999; Becerra et al 2001; Daniel 2002] with 
subsequent increase in sympathetic outflow via the intermediolateral cell column (IML). 
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However, the locus coeruleus, C1 cells and IML are known to be pathologically involved in 
MSA [Wenning et al 1997; Benarroch 2002].  
 
Given the central pathological involvement in MSA of structures felt important in generating 
the CP response it seems somewhat surprising that there is still such preservation of the SBP 
pressor response to CP. Alternative pathways may also be important in generating the CP 
response and these may be preserved to a greater extent allowing some preservation of pressor 
response.  There has been some suggestion of spinal cord level reflexes being able to generate 
a pressor response to CP. High level complete spinal cord lesion patients, like MSA, have 
intact post-ganglionic nerves but here the central integration of nociceptive stimuli and 
autonomic response is dissociated from the peripheral afferent stimulus. It is known that in 
stable, complete cervical cord lesion patients, CP below the level of the lesion results in a 
heightened pressor response [Mizushima et al 2003]. However, unlike in MSA the 
ventromediolateral column is intact in SCI and dissociated from supraspinal control. This 
results in autonomic dysreflexia not only to CP stimulus, but even minor stimuli such as 
bladder tapping, a situation not seen in MSA. Also, because of the complete dissociation of 
afferent signal and central vasomotor control centre, there is no change in HR following CP in 
these patients. HR increases elicited following CP may be more important in generating a 
pressor response than vasoconstriction [Yamamoto et al 1992]. Some preservation of vagal 
withdrawal may still occur in MSA resulting in the observed increase in HR in MSA and 
resultant pressor response. 
  
Following IE MSA showed only slight increase in SBP and DBP. MSA showed an increase in 
HR, which was significantly greater to that seen in PAF. In PAF there was no significant 
change in BP or HR following IE. The situation with IE is however more complex than with 
CP. In normal subjects central command pathways, resulting in voluntary contraction of 
muscle, cause activation of the sympathetic outflow [Victor et al 1989; Winchester et al 2000; 
Critchley et al 2000]. In addition, peripheral input from the muscles and local vessels results 
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in both a pressor effect [Alan and Smirk 1937; Mitchell et al 1977; Victor et al 1989] despite 
vasodilatation of the skeletal muscle vascular bed [Corcondilas et al 1964; Joyner et al 1999]. 
The mechanism involved in this vasodilatation has been much debated in the past century, but 
it appears most likely to be a non-neural effect involving local NO release [Joyner and 
Halliwell 2000]. NO release from the endothelium of muscle bed vessels may be produced 
both by circulating adrenaline, also indirectly by local metabolites in contracting muscles 
which result in vasodilatation which in turn increases endothelial NO by a flow-dependant 
means [Gilligan 1994; Joyner and Proctor 1999; Reed et al 2000]. Skeletal muscle 
vasodilatation appears to be preserved in autonomic failure as well as in subjects following 
stellate ganglion blockade or α-adrenoceptor blockade [Dietz et al 1997; Reed et al 2000]. 
Thus in MSA or PAF where efferent vasoconstriction is known to be impaired, the 
preservation of exercise-induced vasodilatation will tend to further attenuate BP rise. Finally, 
MSA subjects may not be able to generate as great as an intensity of IE as PAF or normal 
subjects because of features such as parkinsonism or cerebellar dysfunction which are often 
also present in MSA. Thus the haemodynamic responses to IE seen in MSA and PAF seem 
likely to reflect various aspects of the underlying condition. 
 
The afferent origins to MA are clearly central in origin. In addition to the pressor response 
induced by MA, vasodilatation in certain regional beds is known to occur in healthy controls 
[Blair 1959, Lindqvist et al 1996]. Initially it was felt that sympathetic activation resulted in 
vasodilatation via cholinergic vasodilator nerves, as seen in animals and in human non-acral 
skin [Roddie et al 1957], especially as the vasodilatation  was attenuated in sympathectomised 
arms or with prior atropine [Blair 1959]. However, it is currently felt that the major 
mechanism of muscle bed vasodilatation in response to mental stress in humans is via 
adrenaline, which acts partly through release of local nitric oxide [Dietz et al 1994; Eisenach 
et al 2002]. It is known that, in normal subjects, whilst sympathetic activation by CP will 
result in raised noradrenaline and adrenaline, it is adrenaline which is predominantly released 
with MA [LeBlanc et al 1979]. In addition a greater increase in HR was seen following MA 
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than seen with CP. The increase in HR was correlated with increase in adrenaline whilst 
increase in BP was correlated with increase in noradrenaline. If the NA action is blocked with 
phentolamine infusion in normal controls, a vasodilatation in the forearm is seen to CP or IE 
similar to that normally seen with MA. A similar vasodilatory response to IE is seen in 
normal controls after axillary blockade [Lindqvist et al 1996].   In MSA we observed a 
decrease in SBP and DBP after MA. Unlike in PAF, in MSA NA and adrenaline are still 
produced to similar levels as in normal controls. The relative increase in A and NA following 
MA is not known in MSA, but MSA are known to have impaired increase in NA in response 
to head-up tilt [Mathias 2002]. A relatively greater impairment of NA compared to a release 
following MA may therefore help explain the slight depressor effect that we noted in MSA.  
 
 
We have clarified the responses to standardised pressor testing in MSA and PAF. Differences 
have thus been highlighted between these groups which may relate to the contrasting lesion 
sites in these conditions. These differences have clinical significance. As standardised pressor 
tests are routinely used in the autonomic investigations of subjects with autonomic failure, 
these differences may aid the separation of MSA and PAF. A further aspect occurs in relation 
to orthostatic hypotension, a condition common to both MSA and PAF. Whilst the pressor 
responses in PAF were uniformly attenuated, an increase in SBP was retained in MSA 
following CP. It may therefore be that, in the event of presyncope in MSA a painful stimulus 
may elevate SBP enough to retain consciousness whilst the subject is trying to lie down. 
However, mental concentration may worsen SBP and DBP in MSA, a factor which may 
warrant consideration in subjects engaged in stressful situations, such as public speaking, 
whilst upright. 
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3.3:  Cardiovascular Responses to Clonidine in MSA and PAF 
 
 
 
 
ABSTRACT 
 
Objective: To assess the effects of clonidine on blood pressure (BP) and heart rate (HR) in 
multiple system atrophy (MSA), where the lesion site is preganglionic, and in pure autonomic 
failure (PAF) where it is postganglionic.  
Background: In normal subjects intravenous infusion of the selective α2-adrenoceptor 
agonist clonidine reduces BP and plasma noradrenaline (NA) levels via central α2-
adrenoceptor [α2] action, as well as inducing growth hormone (GH) release. Clonidine-
induced GH release is impaired in MSA, but spared in PAF. However, the haemodynamic 
effects of clonidine have not been extensively studied in these disorders. 
Methods: We examined intravenous clonidine test results (performed in our autonomic 
laboratories using the London Autonomic Units protocol [Thomaides et al 1992]) in 58 
patients, 39 with probable MSA and 19 with PAF. Systolic (S) and diastolic (D) BP and HR 
and plasma noradrenaline (NA) levels were measured supine at baseline and for up to 60 min 
post-clonidine.  
Results: Clonidine resulted in a significant BP fall in MSA, which occurred earlier (within 15 
minutes of clonidine), and to a greater extent, than seen in PAF. Both MSA and PAF showed 
HR reduction after clonidine, although this was significantly greater in MSA than PAF. NA 
levels decreased significantly after clonidine in both groups. Although basal NA levels were 
lower in PAF than MSA, there was no difference in NA reduction relative to baseline between 
groups. MSA showed significant negative correlation between basal NA levels and BP 
response to clonidine. 
Conclusions:  Clonidine infusion reduces BP and HR in both MSA and PAF, but to a greater 
extent in MSA. The greater vasodepressor action of clonidine in MSA suggests that there is 
partial preservation of brainstem sympathetic outflow pathways in MSA, and may reflect its 
action at sites in the brainstem and spinal cord that were in part functionally preserved in 
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MSA. Despite similar degrees of NA reduction after clonidine, the vasodepressor effect of 
clonidine was attenuated in PAF compared with MSA. This attenuation in PAF may reflect 
greater peripheral α2-adrenoceptor denervation supersensitivity due to the postganglionic 
lesion site. These BP differences may thus reflect the underlying lesion site in MSA and PAF, 
and the haemodynamic data following clonidine infusion may help differentiate these 
conditions.  
 
 
Introduction 
 
Intravenous infusion of the selective α2-adrenoceptor agonist clonidine has been used in the 
investigation of parkinsonian syndromes, as clonidine-induced release of growth hormone 
(GH) is impaired in multiple system atrophy (MSA) where the lesion site is preganglionic, but 
spared in pure autonomic failure (PAF) where the lesion site is postganglionic [Thomaides et 
al 1992; Zoukos et al 1993]. Clonidine also has significant cardiovascular effects, and reduces 
blood pressure (BP) in normal and hypertensive subjects [Warren et al 1989, Kooner et al 
1991, Zoukos et al. 1992; Kimber et al 2001] by central sympatholytic action. The 
haemodynamic response to clonidine may vary therefore in MSA and PAF because of their 
contrasting lesion sites. However, the haemodynamic effects of clonidine in autonomic failure 
are not well understood, and previous studies have only reported results from small numbers 
of patients.  
 
Previous assessments of clonidine effects in small numbers of MSA have shown a reduction 
in SBP and DBP similar to that seen in healthy controls [da Costa et al 1984; Thomaides et al 
1992]. The haemodynamic effects of clonidine in PAF have not been clearly established. 
Previous results in PAF vary, from no effect on BP [da Costa et al 1984], a pressor action 
[Robertson et al 1986] and a slight vasodepressor action [Thomaides et al 1992].  Clonidine 
formulation also differed in these studies with oral [Robertson et al 1986] and intravenous 
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forms [da Costa et al 1984; Thomaides et al 1992] being used. There is therefore uncertainty 
in the existing literature as to the haemodynamic response of PAF to clonidine, and this may 
be related in part to the relatively small numbers of subjects studied in previous studies. We 
set out to assess the haemodynamic responses to intravenous clonidine (which is now the 
established means of clonidine-GH testing) in a large group of patients with MSA and PAF. 
 
Subjects and Methods 
 
We retrospectively examined data from the clonidine-GH test [Kimber et al 1997] performed 
in our Units over the last decade. A total of 58 subjects with chronic autonomic failure were 
studied in whom the diagnosis had been made using established criteria [Gilman et al 1998, 
Mathias 2004] (39 MSA, 19 PAF). PAF subjects were carefully selected for certainty of 
diagnosis, having isolated autonomic symptoms for a minimum of 10 years and being age-
matched with MSA. In addition only subjects able to omit medication prior to the study were 
included. The mean age of MSA (23 males and 16 females) was 59 +/- 11.8 and PAF (11 
males and 8 females) 63.9 +/- 8.8 years with no significant difference between the two 
groups. Mean disease duration in MSA was 4.6 +/- 2 years. A total of 14 PAF and 20 MSA 
subjects were on vasoactive medication prior to the study. Of these subjects 15 MSA and 14 
PAF were on fludrocortisone, 4 MSA and 3 PAF were on ephedrine, 4 MSA and 5 PAF were 
on midodrine, and 5 MSA were on L-Dopa medication. All subjects had documented 
sympathetic and parasympathetic dysfunction with severe orthostatic hypotension. Vasoactive 
medication was omitted from the evening before the study. After an overnight fast the subject 
was rested supine in a dedicated autonomic laboratory for 30 minutes. With the subject 
supine, brachial BP and HR readings were measured intermittently using the automatic 
sphygmomanometer (Dinamap, Critikon, UK). Venous access was obtained with cannulation 
of an antecubital fossa vein to allow infusion of clonidine. Clonidine was infused 
intravenously over a 10 minute period with a total dose of 2µg/Kg body weight in 20ml of 
normal saline. Further BP and heart rate (HR) recordings were taken 15, 30, 45 and 60 
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minutes post-clonidine and compared with baseline. The plasma levels of noradrenaline (NA) 
at baseline and 60 min post-clonidine were analysed. Electrochemical detection for NA 
concentration was subsequently performed using high-performance liquid chromatography 
[Smedes et al 1982; May et al 1988; Mathias et al 1990]. 
 
 
Statistics 
 
Mann-Whitney U test was used to analyse the difference in parametric parameters between 
the MSA and PAF patients. The difference before and after clonidine infusion in each group 
was assessed with Wilcoxon’s signed rank test. Correlation between BP response to clonidine 
and plasma NA concentration was assessed with Spearman’s Correlation Coefficient.  
 
 
Results 
 
There were no significant differences in supine SBP and DBP pre-clonidine between MSA 
and PAF. SBP and DBP were significantly reduced after clonidine infusion compared with 
baseline in both MSA and PAF (Table 3.3.1). However, the vasodepressor response to 
clonidine occurred sooner in MSA than PAF, with significantly greater reduction in BP seen 
in MSA at 15, 30 and 45 minutes post-clonidine. The reduction in SBP and DBP were 
significantly greater in MSA than in PAF at 15, 30 and 45 minutes post-clonidine (Figure 
3.3.1).  
 
Baseline HR was significantly higher in MSA than PAF (p<0.05). Both groups showed a 
significant reduction in HR after clonidine infusion (Table 3.3.1).The reduction in HR was 
significantly greater in MSA than in PAF at 15 and 30 minutes post-clonidine (Figure 3.3.1).  
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Figure 3.3.1: Changes in systolic BP (upper panel), diastolic BP (middle panel) and heart 
rate (lower panel) in PAF versus MSA following Clonidine at minute 0.  Comparison 
with Mann-Whitney U test baseline level. *p<0.05, **p<0.005, †p<0.0001, ‡p<0.00005.  
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Table 3.3.1: BP and HR pre- and post clonidine in 39 MSA and 19 PAF. p value = 
comparison with the baseline in each group 
  
   
 
 
 
The baseline level of plasma NA was significantly lower in PAF (116.4 +/- 52pg/ml) than 
MSA (276 +/- 111.7 pg/ml (p<0.00000005) (Figure 2). Levels of NA significantly decreased 
in both MSA (-67%) and PAF (-70%) 60 min after clonidine infusion (Figure 3.3.2). In MSA 
but not PAF there was a significant negative correlation between ∆SBP 30 minutes post-
clonidine and basal NA levels (Figure 3.3.3). 
 
 
 
 
 
 
 
 
   Baseline 15 min 30 min 45 min 60 min 
       
SBP (mmHg)     
 MSA 146+/-31 119+/-29 116+/-26 115+/-25 115+/-26 
  p value  p<0.0000005 p<0.0000001 p<0.0000001 p<0.0000001 
 PAF 166+/-21 154+/-25 150+/-21 145+/-28 136+/-26 
  p value    p<0.01 p<0.0005 
       
DBP (mmHg)     
 MSA 83+/-15 71+/-13 70+/-13 70+/-13.6 67+/-28 
  p value  p<0.000001 p<0.000001 p<0.0000005 p<0.0000001 
 PAF 86+/-13 86+/-15 84+/-15 82+/-14 77+/-13 
  p value     p<0.0005 
       
HR (beats/min)     
 MSA 72+/-10 67+/-9 65+/-9 65+/-9 64+/-9 
  p value  p<0.00001 p<0.0000005 p<0.0000005 p<0.0000001 
 PAF 66+/-8 63+/-9 62+/-9 62+/-8 62+/-8 
  p value  p<0.005 p<0.0005 P<0.005 p<0.005 
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Figure 3.3.2: The plasma levels of noradrenaline concentration before and 60 minutes 
after clonidine infusion. The difference between means of NA concentration before and 
after clonidine infusion in each group was assessed with Wilcoxon’s signed rank test.  
 
 
 
 
 
 
Figure 3.3.3: Correlation between baseline resting supine Noradrenaline (NA) levels and 
∆SBP at 30 minutes post-clonidine in MSA (upper trace) and PAF (lower trace) p<0.05 
denotes significant correlation in MSA between NA levels and ∆SBP 
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Discussion 
 
Our study has shown clear differences in BP responsiveness between MSA and PAF after 
intravenous administration of the selective α2-adrenoceptor agonist clonidine. We found that 
clonidine reduces SBP and DBP in both MSA and PAF following clonidine. The BP fall 
occurred sooner in MSA than PAF. BP reduction was significantly greater in MSA than PAF, 
being similar in magnitude to the reduction previously seen in healthy controls [Warren et al 
1989; Kooner et al 1991; Thomaides et al 1992; Zoukos et al. 1992; Kimber 2003]. There 
was a significant reduction in HR following clonidine in both groups, being greater in MSA 
than PAF. NA levels were significantly reduced in both groups to a similar extent.  
 
An earlier report of the pressor effects of clonidine in autonomic failure [Robertson et al 
1986] utilised a variable dose (0.1-0.8mg) of oral clonidine in a heterogeneous group of 12 
subjects, including 4 patients with MSA and 8 patients with idiopathic orthostatic hypotension 
(probable PAF). In another study, with data pooled from 2 PAF and 4 MSA, a low dose (1.5 
µg/kg) of intravenous clonidine resulted in no significant change in BP [da Costa et al 1984]. 
A small reduction in BP was shown with 2µg/kg intravenous clonidine in 10 PAF [Thomaides 
et al 1992]. As the haemodynamics of clonidine are dependent on the concentration of 
clonidine in the blood [Davies et al 1977, Kroin et al 1996], with greater pressor effects seen 
at higher doses, it may be difficult to compare results between intravenous fixed dose 
clonidine and variable-dose oral clonidine. In our study we used the now accepted protocol 
for clonidine-GH testing based on subject body weight (2µg/kg) [Thomaides et al 1992], and 
we used substantially larger numbers in each group than previous studies had done. 
 
Clonidine has been reported to reduce HR in normal subjects [Warren et al 1989, Kooner et al 
1991, Thomaides et al 1992; Nurnberger et al 2003]. In our study a HR reduction was seen in 
both groups, being significantly greater in MSA than PAF.  Previous reports of the HR effects 
of clonidine in MSA have shown a non-significant reduction following clonidine.  Of note 
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these studies involved smaller numbers of MSA than in our present study [da Costa et al 
1984; Thomaides et al 1992; Zoukos 1992]. In PAF the HR response following clonidine has 
not been firmly established, with a few subjects showing a marked reduction in response to 
oral clonidine [Robertson et al1986], but other studies suggesting no change in heart rate 
[Zoukos et al 1992; Thomaides 1992]. No previous direct comparisons of HR change in MSA 
and PAF have been reported. The HR effect of clonidine in PAF or MSA therefore had not 
previously been established, partly as a result of the small numbers previously studied  
 
Postulated preganglionic cerebral sites of clonidine action have included the nucleus tractus 
solitarii and anterior hypothalamus [Isaac 1981]. The central effects of hypotension and 
bradycardia appear to be mainly mediated by α2 adrenoceptor agonist action in pressor area 
of ventrolateral medulla, resulting in increased inhibition of sympathetic outflow [Punnen et 
al 1987; Wang et al 2003]. This central sympatholytic action would explain the reduction in 
BP and HR seen in normal subjects. Clonidine is also known to have agonist actions at 
imidazoline-1 receptors, and activation of these receptors is known to produce a hypotensive 
effect [Prichard and Graham 1997]. Imidazoline-1 receptors, like α2 adrenoceptors, are well 
localised in the rostral ventrolateral medulla in man and other species [Bricca et al 1989]. It 
has been postulated that the agonist action of clonidine on imidazoline-1 receptors may play a 
role in the hypotensive and bradycardic effects of clonidine. However, moxonidine, a 
selective imidazoline-1 agonist at the rostral ventrolateral medulla cardiovascular regulatory 
centres, results in reduced BP and NA levels but does not cause bradycardia in humans 
[Haxui et al 1994; Prichard and Graham 1997]. Although intact vagi seem to be important in 
the bradycardia induced by clonidine, an additional reduction in heart rate may result from a 
direct action on the heart [Tsai and Lin 1987; Mukaddam-Daher et al 1997]. This later point 
remains an intriguing possibility to help explain the clonidine-induced reduction in HR we 
observed in both MSA and PAF, given the extensive parasympathetic impairment seen in 
these subjects.  
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Patients with high cervical, complete, spinal cord injury do not show a decrease in BP 
following oral or intravenous clonidine [Reid et al 1977; Kooner et al 1991]. Thus intact 
central sympathetic outflow appears important for clonidine to result in a vasodepressor effect. 
With intravenous clonidine 2µg/Kg body weight, high cervical cord lesion patients show an 
initial pressor response to clonidine. This fact, taken together with the low basal NA levels 
seen in high cervical cord injury patients has lead to the suggestion that the pressor effect of 
clonidine in these subjects may be related to chronic sympathetic denervation supersensitivity.  
The pressor effect is likely to be mediated by vasoconstriction resulting from activation of 
postsynaptic peripheral α2 adrenoceptors rather than α1 adrenoceptors [Kiowskiw et al 1983]. 
Presynaptic α2 adrenoceptors are present on the postganglionic nerves and when activated 
tend to inhibit neurotransmission. However, clonidine produces a pressor rather than 
vasodepressor action in high cervical cord injury, and so post-synaptic activation appears to 
be the major effect. α2 adrenoceptors are present in large numbers in the intermediolateral cell 
column of the spinal cord, and have been suggested to play a role in the haemodynamic 
effects of clonidine [Sinha et al 1973; Reid et al 1977; Unnerstall et al 1984].  In high cervical 
cord lesion patients clonidine reduced the pressor response to bladder stimulation, thus 
providing evidence to suggest that additional preganglionic spinal sites are involved in the 
sympatholytic action of clonidine [Mathias et al 1979]. 
 
The prominent BP, HR and NA level reduction in MSA following clonidine infusion suggests 
a degree of functional preservation of brainstem pathways such as the nucleus tractus 
solitarius and its associated baroreflex pathways, despite being areas known to be involved 
pathologically in MSA. The preservation of vasodepressor effects of clonidine suggests that 
there is at least partial preservation of baseline vasomotor sympathetic outflow in MSA. 
Clonidine reduces plasma NA levels in normal subjects [Reid et al 1977, Warren et al 1989, 
Zoukos et al. 1992] and in MSA and PAF [Zoukos et al 1992; Thomaides 1992]. Our study 
showed similar relative reductions in NA levels to those previously seen in normal subjects 
and in MSA and PAF. We found a similar relative reduction in NA levels in MSA (67%) and 
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PAF (70%) following clonidine. This suggests that the central α2 adrenoceptor sympatholytic 
effects of clonidine may occur to a similar extent in MSA and PAF. Post-synaptic α2 
adrenoceptors are also present on the smooth muscle of peripheral vasculature, and their 
activation results in vasoconstriction. In pithed rabbits clonidine results in a pressor effect 
mediated predominantly by this post-synaptic α2 adrenoceptor activation at low doses, and by 
post-synaptic α1 adrenoceptor activation only at higher doses [Pompermayer et al 1999]. The 
relative importance of post-synaptic α2 adrenoceptor agonist action of clonidine in a single 
patient with autonomic failure has been suggested previously with the pressor effect of oral 
clonidine being markedly attenuated by pre-treatment with yohimbine (α2 adrenoceptor 
antagonist), but not by pre-treatment with prazocin (α1 adrenoceptor antagonist) [Onrot  et al 
1987]. Chronic denervation of post-ganglionic sympathetic nerves, as seen in PAF, induces 
supersensitivity of peripheral α-adrenoceptors to a greater extent than in MSA where the 
lesion is preganglionic [Polinsky, (2002)]. We found lower basal NA levels in PAF, which are 
known to be associated with peripheral adrenoceptor sensitivity [Senard et al (1991), Polinsky, 
(2002)]. Animal studies have also suggested that non-acute sympathetic denervation abolishes 
the vasodepressor effect of clonidine, which produces a pressor action [Petty et al 1976]. The 
attenuation of blood pressure fall following clonidine in PAF may therefore result from 
additional peripheral agonist action on supersensitive α2 adrenoceptors counteracting the 
central vasodepressor action.   
 
There may be a negative correlation between NA concentrations and pressor response to 
clonidine. In a previous study [Robertson et al 1986], where responsiveness to oral clonidine 
(0.1-0.8mg) was assessed in a heterogeneous group of 12 subjects with differing forms of AF, 
there was  a significant negative correlation in the group as a whole between BP and basal NA 
levels. In our study, if pre- and postganglionic autonomic failure patients are considered 
together, there is also a significant negative correlation between basal NA levels and pressor 
response to clonidine.  However, the correlation is only seen in MSA when MSA and PAF 
cases are considered separately (Figure 3.3.3). The disparity between these findings reflects 
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the problems inherent in considering two fundamentally different groups as a homogenous 
entity.  We found a negative correlation between SBP after clonidine and baseline NA levels 
in MSA. PAF showed no such correlation. At first sight these results may suggest that MSA 
and not PAF demonstrate pressor supersensitivity in response to low NA levels. Alternatively, 
in PAF, where postganglionic impairment is extensive, supersensitivity may have been 
present to a similar degree in all subjects regardless of absolute NA levels. With MSA, if 
some subjects demonstrated a degree of supersensitivity whilst others did not, then a 
correlation such as we found may be explained.  
 
There are additional clinical implications to our observations. This study demonstrated a 
differing BP response to clonidine, with a vasodepressor effect occurring earlier and to a 
greater extent, in MSA than in PAF. This occurs despite a similar relative reduction in NA 
levels in both groups following clonidine. The attenuation of BP drop in PAF compared with 
MSA may reflect a denervation supersensitivity to clonidine in PAF, resulting in 
vasoconstriction via peripheral α2 adrenoceptors.  A major role for the intravenous clonidine 
test in clinical practice is to add in the differentiation and diagnosis of central and peripheral 
autonomic conditions with GH responses providing important information. Our results have 
confirmed that BP responses to clonidine also differ significantly between MSA and PAF, and 
that comparing these difference responses following an intravenous, standard dose of 
clonidine may be a further aid in separating these conditions. 
 
 
We gratefully acknowledge the support of the Sarah Matheson Trust with this study. 
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 3.4: Cardiovascular Responses to Water Ingestion in MSA and PAF 
 
 
 
Introduction 
 
 
The ingestion of water increases seated blood pressure (BP) in chronic autonomic failure 
[Jordan et al 1999]. This pressor effect first occurs between 5 and 15 minutes after water 
ingestion, reaches a peak effect at about 30-35 minutes, and lasts for just under an hour. The 
volume of water ingested influences the pressor response; 480ml producing greater effect than 
240ml, but temperature (9oC and 24oC) of ingested water does not seem to be an important 
factor [Jordan et al 2000]. Although the underlying mechanisms of the pressor action of water 
in AF had not previously been determined, possible mechanisms include partial residual 
sympathetic activity, baroreflex dysfunction, gastric distension or fluid redistribution. 
Multiple system atrophy (MSA) and Pure Autonomic Failure (PAF) provide contrasting 
models of chronic autonomic failure. In MSA the underlying lesion site is central and pre-
ganglionic, whilst in PAF it is distal and post-ganglionic [Polinsky et al 2002]. The detailed 
haemodynamic response to water ingestion while seated has been studied in detail in PAF 
[Cariga & Mathias 2000], but there have been no comparisons with MSA. We postulated that 
differences in pressor response to water between the two groups would relate to the different 
lesion site in PAF and MSA, and may provide information on the mechanism of the pressor 
effect. The results of these studies have been published [Young & Mathias 2004a; Young & 
Mathias 2004b]. 
 
Remarkably for such a fundamental process as water drinking, the pressor effects of water 
ingestion have only been described recently. The first suggestion that water ingestion could 
increase blood pressure in autonomic failure was reported in 1983 with improvement of 
orthostatic symptoms in a subject with autonomic failure who drank large quantities of 
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seawater. [Frewin & Bartholomeusz 1983], although a pressor effect in autonomic failure was 
only confirmed at the end of the 1990s. Jordan et al first reported the pressor effect of 
drinking 480ml of tap water in 1999. They observed that in seated young healthy subjects 
there was no change in blood pressure (BP) following water ingestion. Older healthy subjects 
showed an 11mm Hg rise in systolic BP following ingestion of the same volume of water. A 
more substantial rise in Systolic BP was observed in seated subjects with chronic autonomic 
failure. In some the increase was in excess of 30mm Hg. The pressor effects described above 
began a few minutes after ingestion of water and peaked around 20 minutes. As tap water 
contains small quantities of cations, which could conceivably be a factor in pressor responses, 
the effects of similar volumes of distilled water were studied in patients with severe 
sympathetic denervation due to pure autonomic failure (PAF) [Cariga & Mathias 2001] and in 
multiple system atrophy (MSA) [Young & Mathias 2004a]. Distilled water also resulted in a 
pressor effect of similar magnitude and time course to that observed with tap water. Whilst 
the pressor effects of oral water are likely to last for no more than about an hour, the potential 
of water ingestion as a therapy for orthostatic hypotension has been suggested (Mathias 
2000). Suggestions of a smaller rise in BP have been made in spinal cord injury patients 
following water ingestion (Tank et al 2003). Interestingly possible improvements in 
orthostatic tolerance in intermittent autonomic dysfunction such as vasovagal syncope and in 
normal subjects exposed to negative lower body pressure in upright posture or blood donation 
(Lu et al 2003; Schroeder et al 2002; Hanson & France 2004). 
 
Orthostatic hypotension (OH), common to both PAF and MSA, may cause severe symptoms, 
and often is inadequately controlled by medication. We determined if water ingestion would 
improve standing BP and OH symptoms in these subjects. Previous work suggested that OH 
in chronic autonomic failure improved 35 minutes after drinking 480ml of water, although the 
effects on symptoms were not known [Jordan et al 2000]. As water increases seated BP 5-15 
minutes after ingestion, OH may be improved at this time also. We therefore measured 
standing BP 15 and 35 minutes after water ingestion in our subjects. 
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It has recently been suggested that the effects of swallowing itself might also be an important 
factor [Endo et al 2002] in the water pressor effect. The only comparison of the 
haemodynamics of oral water with those of water directly instilled into the stomach was 
performed in young control subjects in whom water does not produce a sustained pressor 
effect. As a follow-up study we therefore set out to record the effects of instilling 480ml of 
distilled water via a gastrostomy tube into a PAF subject to compare the haemodynamic 
response with those found in previous studies of oral water ingestion in PAF [Cariga & 
Mathias 2000].  
 
 
Physiology of water ingestion water ingestion 
 
 
Water drinking is a fundamental aspect of animal life. In man typically 2-3 litres of fluid is 
ingested each day, either in response to thirst stimuli or as a result of direct volition. The 
volume of the typical stomach is typically only 50ml when empty but can expand to a 
capacity of approximately 1 litre after a meal [Sherwood L 2004] although this varies 
considerably with age and body size. The stomach is distensible to a point, although ingested 
volumes much in excess of 500ml typically start to lead to sensations of fullness or 
discomfort [Penagini et al 1998], usually giving rise to a sensation of satiety inhibiting further 
intake until the contents is reduced by gastric emptying. Usually fluid is taken in the form of 
hypotonic solutions (tap water, tea, carbonated beverages etc), often in association with 
eating. The mix of ingested fluid and food is termed chyme. The fluid/food ratio of chyme 
and its volume can significantly influence gastric emptying. This is important because the 
tight junctions of the gastric mucosa markedly limit the absorption of water whilst the chyme 
is still within the stomach. Once the chyme clears the pyloric junction and enters the vast 
surface area of the permeable small intestine water absorption from the gut lumen to the 
extracellular and then intracellular spaces is rapid. The marked differences in gastric 
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emptying between water and mixed meal ingestion is illustrated in Figure 3.4.1 in normal 
subjects, using scintography, which has now largely superseded other radiological methods 
[Lawaetz et al 1989; Lin et al 2005]. The situation is slightly more complex for mixed 
meal/fluid ingestion as the different components tend to be released from the stomach to the 
small intestine at different rates with fluids often preceding the solid components [Lin et al 
2005]. Furthermore the volume and tonicity of chyme may be significantly altered by 
secretions and absorption, additional components in determining gastric emptying.  
 
There is a basic peristaltic reflex in the gut whereby local luminal dilation results in an 
ascending muscular excitation pathway and descending inhibition. The higher co-ordination 
of the movement of chyme from the stomach to small intestine is provided by a vagally 
mediated reflex originating in the brainstem, whilst additional control is provided by a 
prevertebral reflex arc responding to stomach visceral afferents [Thompson DG 2003].  
Normally a vagally mediated reflex on ingestion inhibits the periodic Migrating Motor 
Complex, which periodically propagates distally from the stomach in the fasted state. For 
water ingestion in normal subjects the net result is a fairly rapid gastric emptying as shown in 
the upper graph of Figure 3.4.1. Greater stomach volumes are emptied more rapidly [Noakes 
et al 1991; Doran et al 1998].  
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Figure 3.4.1: Measurement of gastric emptying in normal subjects following ingestion of 
300 ml water (above) or a similar volume of mixed meal (120ml water, 2 large scrambled 
eggs, a piece of toast and a teaspoon of butter) (below) at time ‘0’ by use of by Gamma 
Scintigraphy (Ref Lin et al 2005). 
 
 
 
 
 
Following gastric emptying, chyme enters the duodenum (the portion of the intestine from the 
pyloric sphincter to the ligament of Treitz). This part of the gut is highly permeable with 
evidence suggesting that pure water is absorbed at least as fast as isotonic 6% carbohydrate-
electrolyte drink, possibly because the duodenum tends to bring the chyme towards 
isotonicity by means of secretions/absorption [Lambert et al 1997]. These results suggest that 
the rate of tracer accumulation in the blood after ingestion of different volumes of test drinks 
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is not a reliable indication of the availability of the ingested fluid, but gives at least a 
qualitative measure of the sum of the effects of gastric emptying and intestinal water 
absorption [Lambert et al 1997]. 
 
 
Although the physiology of gastric emptying has been extensively studied in normal subjects, 
the situation in autonomic failure is less clear, with initial evidence suggestive of accelerated 
gastric emptying in PAF [Mathias and Bannister 2001]. However, the possibility of slowing 
of gastric emptying in primary autonomic failure has recently been reported [Maule et al 
2002]. These authors used 13CO2-octanoid acid breath test (OBT) and electrogastrogram 
(EGG) to assess gastric emptying following a standard test meal of one scrambled egg, two 
slices of bread, 50 g ham and 10 g butter in 3 PAF and 9 MSA subjects. The egg yolk was 
labeled with 0.1 ml of 13CO2-octanoid acid. 13C-octanoid acid is rapidly absorbed in the 
duodenum, but not stomach, and metabolized in the liver; following oxidation, the resulting 
13CO2 is excreted in the breath. Breath samples were collected at baseline and at 15-min 
intervals analyzed by isotope-selective nondispersive infrared spectrometry. Half time gastric 
emptying (T1/2) was thus calculated with T1/2 ≤144 minutes considered normal. Gastric 
emptying was found to be delayed in 5/9 MSA and 1/3 PAF. In contrast 2/3 PAF had 
relatively fast gastric emptying with gastric emptying t ½ of 97 and 80 minutes. EGG found 
normogastria in 6/9 MSA and bradigastria in 3/9. In PAF 2/3 showed bradigastria and 1/3 
(same subject with gastric emptying t ½ of 80 minutes) showed tachigastria. Thus the gastric 
emptying rates in MSA and PAF appears to be abnormal in many cases, but whether this is 
consistently delayed or accelerated is not clear at present. In particular it should be noted that 
the study by Maule et al utilised oral food and the gastric emptying with water may well be 
different as with normal subjects.  
 
 
 
Water ingestion thus has cardiovascular effects in both normal and diseased man.  The 
mechanisms of the pressor response remain unclear. Better understanding of the aetiology of 
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the water pressor effect would be likely to aid both understanding of the pathophysiology of 
autonomic failure, and the treatment of orthostatic hypotension which can be so debilitating in 
these patients. As alluded to above, patients with other causes of orthostatic intolerance such 
as PoTS and vasovagal syncope and hypotension related to exercise or food may also benefit 
by oral ingestion of water, although more confirmatory studies are needed in this regard. 
Finally it should be remembered that the importance of the cardiovascular effects of water 
drinking potentially extends well beyond the field of autonomic medicine. Even the small 
increases in blood pressure noted in older “healthy” subjects after water drinking could be 
significant in the long term in the western world where hypertension is endemic- certainly the 
very limited studies available so far would suggest a transient effect greater than that seen 
with the addition of table salt to food which has been extensively targeted as a cause of 
hypertension in the last few decades. In addition early phase drug trials incorporate the 
ingestion of water with study medication as if it were inert, yet subsequently monitor 
cardiovascular responses including heart rate and postural hypotension. That water ingestion 
has very real cardiovascular effects has now been established; to attempt to unravel the 
mechanisms by which water exerts these effects is now therefore the next very important step 
ahead. 
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Initial study: Effects of oral water on seated and standing 
haemodynamics in MSA and PAF 
 
 
 
 
Subjects and Methods 
 
 
 
A total of 14 patients with chronic autonomic failure were studied (7 MSA, 7 PAF). The mean 
age of MSA was 62 +/- 9.5 (4 males, 3 females) and PAF 59 +/- 10 (3 males and 4 females). 
MSA and PAF were diagnosed using existing criteria [Gilman et al 1998, Mathias 2004]. All 
patients had documented sympathetic and parasympathetic dysfunction with severe 
orthostatic hypotension (Table 3.4.1). PAF had greater supine BP than MSA. There were no 
differences in the vasoactive medication between the 2 groups; 3 in each were on 
fludrocortisone, 2 in each on ephedrine, 1 PAF took midodrine and 2 subjects in each group 
were on no medication. No subjects were on anti-parkinsonian medication. Vasoactive 
medication was withdrawn the night prior to the study. All patients gave informed consent to 
participate in the study. The study had ethical approval from the National Hospital for 
Neurology & Neurosurgery. 
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       MSA 
      
      PAF 
      
 
Normal range 
 
Supine SBP 
 
139.4    (24.0) 
 
157.4    (25.0) 
 
 
 
 
Standing SBP 
 
  99.4    (16.9) 
 
  96.9    (33.3) 
 
 
Standing 
 
 -40.0    (28.0) 
 
 
 -60.1   (25.0) 
 
 
< -20 
 
Hand grip 
 
 
    6.2      (5.2) 
 
 
    7.0     (5.9) 
 
 
≥17 
 
 
 
 
 
 
 
Change in SBP 
 
 
 
 
 
Cold Pressor 
 
 
    8.7   (19.0) 
 
 
 
    2.6     (6.9) 
 
 
 
≥15 
 
 
 
Supine DBP 
 
  82.0   (11.2) 
 
  86.9     (9.7) 
 
 
 
Standing DBP 
 
  60.6   (12.7) 
 
  52.7   (11.3) 
 
 
Standing 
 
 -22.3   (16.1)          
                             
 
 -33.4     (8.5) 
 
 
<-10 
 
Hand grip 
 
 
    4.2    (7.1) 
 
 
    0.7     (6.4) 
 
 
≥11 
 
 
 
 
 
 
 
Change in DBP 
 
Cold Pressor 
 
 
    5.3   (10.1) 
 
 
 
   -0.7    (2.7) 
 
 
 
≥10 
 
 
 
Sinus Arrhythmia Ratio 
 
1.11      (0.05) 
 
 1.06     (0.06) 
 
>1.2 
 
Valsalva Ratio 
 
1.27      (0.18)  
 
 
1.19      (0.24) 
 
 
>1.4 
 
 
 
Table 3.4.1: Autonomic Function testing on study patients (7 MSA, 7PAF); 
SBP=Systolic Blood Pressure mmHg (SD); DBP=Diastolic Blood Pressure mmHg (SD) 
 
 
 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      166                                            
Study design 
 
On the morning of the study the patients fasted after a light breakfast at 0800 hours. The study 
took place in a dedicated autonomic laboratory between 1000 and 1300. After emptying the 
urinary bladder, the patient was seated and BP was recorded both intermittently and 
continuously. Intermittent brachial BP values were obtained every 3 minutes using an 
automated Dinamap (Critikon) sphygmomanometer on the left arm. Continuous measurement 
of beat-to-beat BP was obtained non-invasively throughout the study with the Portapres II 
device (Figures 3.4.2 & 3.4.3) on the middle finger of the right hand.  Subsequent calculation 
of cardiac output (CO), total peripheral resistance (TPR), and stroke volume (SV) using 
Model flow analysis was made. This has previously been validated at rest and in relation to 
stimuli such as head up tilt [Harms et al 1999, Jellema et al 1999a, Jellema et al 1999b, 
Langewouters et al 1998, Voogel et al 1997]. After 30 minutes of baseline recordings, the 
patient stood for 5 minutes (stand 0), and brachial BPs were recorded 3 and 5 minutes after 
standing up. The patient then returned to the seated position. Following standing the patient 
was questioned on the presence and severity of orthostatic symptoms. After baseline BP had 
been re-established, the patient drank 480ml of distilled water at room temperature within a 
target time of 5 minutes (mean time taken in MSA was 3 minutes 47 seconds, for PAF 
3minutes 4 seconds with no significant difference between groups). On completion of water 
ingestion the patient remained seated for a further 15 minutes. The patient then stood in an 
identical manner to Stand 0; this was termed Stand 1, the first after water ingestion. On 
completion of Stand 1, the patient returned to the seated position for a further 15 minutes. 
After this time (now 35 minutes after water ingestion) the patient stood for 5 minutes (Stand 
2) in an identical manner to the previous stands. During each episode of standing hypotensive 
symptoms were assessed [Mathias et al 1999] 
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Data Analysis 
 
 
Dinamap values for systolic and diastolic BP (SBP, DBP) were compared at 3 and 5 minutes 
into each stand before and after water. Patients acted as their own controls with BPs for stands 
1 and 2 being compared with their own stand 0 values. Paired Student’s t-test was used with 
statistical significance being taken as p<0.05.  Mean beat-to-beat data for each minute post 
water ingestion was calculated and the results compared using repeated measures of ANOVA 
with Bonferroni correction for multiple testing, utilising the same statistical approach as had 
been performed in the only previous beat-to-beat study of water ingestion in PAF [Cariga & 
Mathias 2001]. 
 
 
 
 
Results 
 
 
 
Pooled Dinamap data for all 14 patients, before and during standing: 
 
 
 
The 14 AF subjects showed a significant fall in SBP and DBP (Dinamap data) on standing 
compared to seated values. There was no significant change in the drop on standing after 
water ingestion, but, as seated SBP and DBP rose significantly over this time, the net result 
was a significant increase in standing SBP and DBP at both 15 and 35 minutes after water 
ingestion as compared with baseline. These results are shown in Table 3.4.2.  
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Pooled Beat-to-beat data for all 14 patients, before and during standing: 
 
 
 
Mean seated baseline values for all 14 subjects were compared with mean values for the 5-
minute stands before and after water.  Pre-stand values of 103.3 (SD 35.5) / 60.9 (SD 19.3) 
showed a significant drop on Stand 0 to 79.4 (SD 30.0) / 48.5 (SD 19.5) (Table 3.4.3). As 
with the Dinamap data, a significant increase in standing SBP and DBP compared to Stand 0 
was seen during both periods of standing after water. Standing SBP for Stand 1 was 99.0 (SD 
25.0) / 61.0 (SD 16.9); for Stand 2: 103.3 (SD 29.8) / 64.9 (SD 19.5). As for the seated 
baseline, there was an increase in TPR in each stand after water, although this did not reach 
significance. In addition there was a smaller increase in CO, which also failed to reach 
significance.  
 
 
             Stand 0  
   before water  
       Stand 1       
15 min after water 
      Stand 2  
35 min after water 
 
Seated value 
just prior to  
Stand 
 
 
SBP 
 
DBP  
 
 HR 
 
110.6        (25.1) 
 
 69.6         (12.9) 
 
 73.7         (11.2) 
 
122.9       (29.0) 
 
 76.4        (13.9) 
 
 70.5          (8.6) 
 
133.9       (25.5) 
 
80.4  (14.1) 
 
70.0          (9.7) 
 
 
3min of Stand 
 
 
 
SBP 
 
DBP 
 
 HR 
 
 79.5***    (21.5) 
 
 51.5***    (15.0) 
 
 82.9         (15.2) 
 
101.0***  (23.3) 
 
 63.6**     (13.0) 
 
 75.8**      (13.1) 
 
 99.6***   (24.0) 
 
 64.0**     (14.0) 
 
 77.2**      (13.2) 
 
 
5min of Stand 
 
 
 
SBP 
 
DBP 
 
 HR 
 
 77.4***    (25.6) 
 
 49.6***    (16.3) 
 
 81.9         (16.2) 
  
 95.3**     (23.0) 
 
 63.4**     (16.1) 
 
 76.6**     (14.6) 
 
 95.4***    (22.9) 
 
 60.4**      (16.1) 
 
 78.9         (14.1)      
 
 
Table 3.4.2: Dinamap Blood Pressure (SBP and DBP) and Heart Rate (HR) in 14 
patients with AF   (7 MSA, 7 PAF) on standing, before and after ingestion of 480ml 
water.  Values in mmHg +/- (SD) and beats per minute +/- (SD): Stand 1 and 2 
compared with Stand 0.   *= p< 0.05;   **= p< 0.01;   ***= p< 0.001.  
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Symptoms Experienced on standing 
 
 
 
After standing on each occasion the subjects were questione
of 3 common symptoms of OH: light-headedness, visual dis
pain in the occipital and shoulder region [Mathias et al 1999
the 14 subjects, 11 experienced one or more of these sympto
subjects symptomatic on Stand 0 noted subjective improvem
during Stands 1 and 2. There were 3 asymptomatic subjects
remained without symptoms during both subsequent standin
 
 
 
 
 
 
Table 3.4.3: Beat-to-beat haemodynamics in MSA and P
after water. Values +/- (SD): SBP=systolic blood pressur
pressure mmHg; CO=cardiac output l/min; TPR=total p
SV=stroke volume ml; HR=heart rate bpm.   Stand 1 an
 
*
= p< 0.05;   **= p< 0.01;   ***= p< 0.001. 
 
                                                                                MSA 
 Seated Stand 0 Seated Stand 1 
SBP 102.8 (28.9)  93.7  (32.2) 113.0  (28.5) 102.4*  (2
DBP 
 59.7  (17.4)  56.6  (21.4)   69.0  (19.5)  63.3*   (1
CO 
   5.2    (1.7)    4.4    (1.3)    4.7     (1.7)    4.4      (
TPR 
   1.0    (0.5)    1.1    (0.6)     1.3    (0.7)    1.1      (
SV 
 68.7  (20.4)  51.7  (17.1)     74.4    (8.6)  54.5      (
HR 
 76.1  (10.2)  87.2  (17.6)   63.0  (16.8)  81.3    (1
                                                                                 PAF 
 Seated Stand 0 Seated Stand 1 
SBP 102.8 (67.2)  67.2  (23.6) 130.3  (39.2)  95.6**  (2
DBP 
  62.1 (41.5)    41.5  (15.9)   77.3  (17.7)  58.6*   (1
CO 
   3.5    (1.5)    2.8    (0.9)     3.7    (1.9)    3.5      (
TPR 
   1.7    (1.1)    1.3    (0.9)     1.8    (0.8)    1.6      (
SV 
 47.9  (18.5)  38.4  (13.8)   67.8    (6.1)  49.1    (1
HR 
 72.1  (11.2)  76.2  (13.3)   53.6  (24.5)  71.4      (
                                                       POOLED DATA FOR ALL 14
 Seated Stand 0 Seated Stand 1 
SBP 103.3 (35.5)  79.4  (30.0) 121.7  (34.1)  99.0*   (2
DBP 
  60.9 (19.3)    48.5  (19.5)   73.1  (18.4)  61.0*   (1
CO 
   4.3    (1.8)    3.5    (1.3)    4.2     (1.8)    4.0      (
TPR 
   1.3    (0.9)    1.2    (0.8)     1.6    (0.8)    1.3      (
SV 
 58.3  (21.6)  44.6  (16.3)   71.1    (7.9)  51.8    (1
HR 
 74.1  (10.5)  81.3  (15.8)   58.3  (20.8)  76.4*   (1
 d about the presence and severity 
turbance and “coat hanger” neck 
, Bleasdale-Barr et al 1998]. Of 
ms during Stand 0. All 11 of the 
ent in their orthostatic symptoms 
 (2 MSA and 1 PAF) who 
g periods.  
AF on standing, before and 
e mmHg; DBP=diastolic blood 
eripheral resistance MU; 
d 2 compared with Stand 0. 
Seated Stand 2 
4.6) 118.9  (28.2) 108.2*   (33.7) 
7.6)   71.2  (19.1)  68.3*    (22.4) 
0.9)     4.8    (2.0)    3.5       (1.1) 
0.4)     1.1    (0.5)    1.4       (0.7) 
8.7)   72.6  (10.5)  49.5     (11.1) 
4.9)   65.2  (19.6)  82.0       (9.4) 
Seated Stand 2 
6.9) 131.6  (40.4)  98.4**  (26.9) 
7.2)   80.0  (20.3)  61.5*   (17.2) 
1.5)     3.6    (2.2)    3.3      (1.5) 
0.8)     1.9    (1.2)    1.7      (1.0) 
9.0)  67.3     (7.3)  45.6    (18.2) 
8.0)   52.2  (27.6)  71.1      (9.4) 
 PATIENTS                          
Seated Stand 2 
5.0) 125.2  (34.1)  103.3*  (29.8) 
6.9)   75.4  (19.4)  64.9*    (19.5) 
1.3)     4.2    (2.1)    3.7       (1.4) 
0.7)     1.5    (1.0)    1.6       (0.8) 
4.5)   69.9    (9.1)  47.6     (14.6) 
2.6)   58.7  (24.0)  76.6*    (12.6) 
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Subset analysis (MSA and PAF dat ): 
 
 
 
a) Dinamap data 
 
Baseline seated BP did not differ significantly between MSA (117.3 +/-18.6 / 73.0 +/-
13.8mmHg) and PAF (103.9 +/-30.1 / 66.3 +/-11.9), as shown in Tables 3.4.4 and 3.4.5.  
Stand 0 resulted in a significant drop in BP at 3 and 5 minutes in both MSA and PAF with no 
significant difference between MSA and PAF patients. Subgroup analysis showed a similar 
increase in standing BP after water ingestion in the 7 MSA and 7 PAF patients, with no 
significant difference between MSA and PAF. 
 
 
 
             Stand 0  
   before water  
       Stand 1       
15 min after water 
      Stand 2  
35 min after water 
 
Seated value 
just prior to  
Stand 
 
 
SBP 
 
DBP  
 
 HR 
 
103.9       (30.1) 
 
66.3 (11.9) 
 
 71.1        (11.4) 
 
126.4      (32.9) 
 
78.7 (10.8) 
 
 66.0         (5.2) 
 
137.9      (30.5) 
 
81.1 (14.2) 
 
 65.3         (6.8) 
 
 
3min of Stand 
 
 
 
SBP 
 
DBP 
 
 HR 
 
 68.4***   (18.5) 
 
 43.4***   (10.7) 
 
 77.0        (13.9) 
 
 97.3*     (25.4) 
 
 61.0*     (16.3) 
 
 69.7*       (8.2) 
 
 96.9*     (26.2) 
 
 63.3**    (16.0) 
 
 69.9*       (8.1) 
 
 
5min of Stand 
 
 
 
SBP 
 
DBP 
 
 HR 
 
 64.4***   (20.8) 
 
 40.4***   (12.1) 
 
 75.1        (13.1) 
  
 88.9*     (22.5) 
 
 59.4*     (16.5) 
 
 69.1         (8.9) 
 
 92.1**    (25.1) 
 
 57.7*     (17.2) 
 
 70.7        (8.8) 
 
 
Table 3.4.4: Dinamap Blood Pressure (SBP and 
with PAF on standing, before and after ingestion
(SD) and beats per minute +/- (SD): Stand 1 and
*
= p< 0.05;   **= p< 0.01;   ***= p< 0.001.   
 
 
 
 
 
 
 aDBP) and Heart Rate (HR) in 7 patients 
 of 480ml water.  Values in mmHg +/- 
 2 compared with Stand 0. 
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             Stand 0  
   before water  
       Stand 1       
15 min after water 
      Stand 2  
35 min after water 
 
Seated value 
just prior to  
Stand 
 
 
SBP 
 
DBP  
 
 HR 
 
117.3       (18.6) 
 
73.0 (13.8) 
 
 76.7        (11.1) 
 
119.4      (26.7) 
 
74.1 (17.0) 
 
 75.7         (9.3) 
 
129.9      (21.0) 
 
79.7 (15.1) 
 
 75.0       (10.4) 
 
 
3min of Stand 
 
 
 
SBP 
 
DBP 
 
 HR 
 
 90.6***   (19.5) 
 
 59.6***   (14.8) 
 
 89.8        (14.6) 
 
106.0**   (22.2) 
 
66.3 (10.4) 
 
 82.8*      (14.8) 
 
102.3*    (23.6) 
 
64.7  (13.0) 
 
 85.8       (14.7) 
 
 
5min of Stand 
 
 
 
SBP 
 
DBP 
 
 HR 
 
 90.3***   (24.5) 
 
 58.9***   (15.2) 
 
 89.8        (16.8) 
  
101.7*     (23.3) 
 
 67.3**    (15.9) 
 
 85.3*      (15.7) 
 
 98.6**    (21.9) 
 
 63.0*      (15.9) 
 
 88.5       (13.5) 
  
 
 
Table 3.4.5: Dinamap Blood Pressure (SBP and DBP
with MSA on standing, before and after ingestion of
(SD) and beats per minute +/- (SD): Stand 1 and 2 co
 
*
= p< 0.05;   **= p< 0.01;   ***= p< 0.001.   
 
 
 
 
 
 
b) Beat-to-beat haemodynamic data: 
Beat-to-beat data were assessed before and during the 1
water ingestion, during which time the patients remaine
SBP and DBP was recorded after water ingestion, whic
post-water ingestion (Figure 3.4.4) and remained so unt
increased first reaching significance 5 minutes after wat
end of the study. Seated CO, SV and EF did not signific
was a non-significant reduction in seated HR over the fi
both subsets (PAF baseline HR +/- SD: 73.5 +/- 10.1; P
6.1; for MSA: baseline 78.2 +/- 9.7; MSA 15 minutes p
  
 
 
  ) and Heart Rate (HR) in 7 patients 
 480ml water. Values in mmHg +/- 
mpared with Stand 0. 
5 minutes immediately following 
d seated. In PAF an increase in seated 
h first reached significance 5 minutes 
il the end of the study. Seated TPR 
er ingestion and remaining so until the 
antly change during the study. There 
rst 15 minutes post water ingestion in 
AF 15 minutes post water: 67.8 +/-
ost water: 74.4 +/-8.6 bpm). Beat-to-
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beat data during each stand (Table 3.4.3) showed no significant difference between MSA and 
PAF. 
 
In the MSA subjects an increase in seated SBP and DBP was recorded after water ingestion, 
which first reached significance 13 minutes post-water ingestion (Figure 3.4.5) and remained 
so until the end of the study. Seated TPR increased first reaching significance 13 minutes after 
water ingestion and remaining so until the end of the study. Seated HR showed a reduction, 
which failed to reach statistical significance. Seated CO, SV and EF did not significantly 
change during the study. 
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Figure 3.4.2 seated beat-to-beat haemodynamics in PAF during the first 15 minutes 
post-water ingestion. Upper left panel: Systolic BP (SBP); upper right panel: diastolic 
BP (DBP); lower panel: Total Peripheral Resistance (TPR). “0” minutes =Mean baseline 
seated value;  *=First significant increase as compared with baseline 
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Figure 3.4.3 seated beat-to-beat haemodynamics in MSA during the first 15 minutes 
post-water ingestion. Upper left panel: Systolic BP (SBP); upper right panel: diastolic 
BP (DBP); lower panel: Total Peripheral Resistance (TPR). “0” minutes =Mean baseline 
seated value;  *=First significant increase as compared with baseline 
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Follow up study: Haemodynamic effects of instilling 480ml water 
directly into stomach in PAF 
 
 
 
Introduction 
 
 
 
The exact mechanisms of the pressor action of water in AF are unclear, although possible 
mechanisms include partial residual sympathetic activity, baroreflex dysfunction, gastric 
distension or fluid redistribution. It has recently been suggested that the effects of swallowing 
itself might also be important .The only comparison of the haemodynamics of oral water with 
those of water directly instilled into the stomach was performed in young control subjects in 
whom water does not produce a sustained pressor effect factor [Endo et al 2002].  This study 
found a brief increase in BP during water drinking which lasted for 90 seconds after 
completion of water ingestion. In the first part of this study no increase in BP over baseline 
was found in the first 60 seconds after completion of drinking in 14 subjects with AF. 
Subjects with AF often demonstrate a brief fall in blood pressure on performing a valsalva 
manoeuvre. It is therefore possible that a partial valsalva manoeuvre during drinking may 
have masked any transient BP rise in these subjects during drinking.  Thus the process of 
swallowing might still be important in the generation of the water pressor effect in AF. We 
therefore set out to record the effects of instilling 480ml of distilled water via a gastrostomy 
tube into a PAF subject to compare the haemodynamic response with those found in previous 
study of oral water ingestion in PAF  [Cariga & Mathias 2001].   
 
 
 
Subject and Methods 
 
 
 
Our subject was a 69 year old female with a longstanding (>20 years) diagnosis of PAF 
confirmed with clinical and biochemical investigations using existing criteria [Mathias 2004]. 
She had had a gastrostomy tube placed in the previous year because of dysphagia, an 
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occasional complication of PAF. She had documented sympathetic and parasympathetic 
dysfunction with severe orthostatic hypotension (Table 3.4.6). Vasoactive medication was 
withdrawn the night prior to the study and informed consent obtained.  
 
 
 
 
      
 Subject 
      
 
Normal range 
 
Supine SBP 
 
131 
 
 
 
 
60o Head up tilt SBP 
 
  66 
 
 
Head up tilt 
 
  -75 
 
 
< -20 
 
Mental arithmetic 
 
    -7 
 
>  13 
 
Hand grip 
 
 
  -13 
 
 
≥  17 
 
 
 
 
 
 
Change in SBP 
 
 
 
 
 
Cold Pressor 
 
 
   11 
 
 
≥  15 
 
 
Supine DBP 
 
   80 
 
 
 
Standing DBP 
 
   47 
 
 
Head up tilt 
 
 -33 
 
 
<  -10 
 
Mental arithmetic 
 
     8 
 
>    9 
 
Hand grip 
 
 
   -9 
 
 
≥   11 
 
 
 
 
 
 
Change in DBP 
 
Cold Pressor 
 
 
    8 
 
 
≥   10 
 
 
Sinus Arrhythmia  
 
 Not present 
 
12 bpm 
  
Table 3.4.6: Autonomic Function testing on study patient  SBP=Systolic Blood Pressure  
mmHg; DBP=Diastolic Blood Pressure mmHg 
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Study Design 
 
 
On the morning of the study the subject fasted after a light breakfast at 0800 hours. The study 
took place in our dedicated autonomic laboratory between 1000 and 1300. After emptying the 
urinary bladder, the subject was seated and BP was recorded both intermittently and 
continuously. Intermittent brachial BP values were obtained every 3 minutes using an 
automated Dinamap (Critikon) sphygmomanometer on the left arm. Continuous measurement 
of beat-to-beat BP was obtained throughout the study with the Portapres II device on the 
middle finger of the right hand. Subsequent calculation of cardiac output (CO), total 
peripheral resistance (TPR), and stroke volume (SV) using Model flow analysis was made. 
This has previously been validated at rest and in relation to stimuli such as head up tilt 
[Harms et al 1999, Jellema, Imholz et al 1999, Jellema et al 1999, Langewouters et al 1998, 
Voogel et al 1997]. After 20 minutes of stable baseline recordings, 480ml of distilled water at 
room temperature was instilled into her gastrostomy tube over a period of 5 minutes. The 
subject remained seated for a further 40 minutes with continued haemodynamic recordings as 
described above. Orthostatic symptoms were assessed before and after water. [Young and 
Mathias 2004b] 
 
 
 
Results 
 
 
Dinamap baseline seated BP was 67 (1.5) /   45 (1.2) with HR of 77 (1.2).  Values during 
instillation of water were similar to those at baseline (Table 3.4.7).  An increase in SBP and 
DBP was observed from 5-8 minutes post water and peaked between 20 and 35 minutes post 
water with mean values of 103.8 (2.6) /  68.8 (1.7). This rise in SBP and DBP was confirmed 
with the beat-to-beat data. There was no significant change in heart rate throughout the study.  
Analysis of the beat-to-beat data with Modelflow showed no change in cardiac output, stroke 
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volume or heart rate, but an increase in TPR, which mirrored the increase in BP (Figures 3.4.6 
& 3.4.7). At no stage either during or after the water instillation did the subject experience 
any pain or discomfort. Prior to the water the subject experienced symptoms of orthostatic 
hypotension, light headedness and “coat hanger” distribution neck and shoulder pain 
[Bleasdale-Barr et al 1998] in the seated position. These symptoms were typical for this 
subject after sitting or standing in the morning. These symptoms fully resolved 10 minutes 
after the water was instilled and did not return for the duration of the study. 
 
 
 
 Before water During water 
instillation  
2-5 minutes post 
water 
5-8 minutes 
post water 
20-35 minutes 
post water 
Dinamap 
SBP 
 
67.3 (1.5) 
 
66.7 (1.5) 
 
74.0 (7.7) 
 
83.0 (5.7) 
 
103.8 (2.6) 
Dinamap 
DBP 
 
44.5 (1.2) 
 
42.3 (3.2) 
 
51.0 (4.2) 
 
57.0 (4.2) 
 
  68.8 (1.7) 
Dinamap 
HR 
 
71.3 (1.5) 
 
71.0 (0.0) 
 
71.0 (0.0) 
 
75.0 (4.7) 
 
  70.0 (0.6) 
Portapres 
SBP 
 
65.4 (3.8) 
 
74.6 (6.0) 
 
84.1 (6.6) 
 
98.2 (3.3) 
 
129.0 (4.9) 
Portapres  
DBP 
 
48.0 (2.3) 
 
54.1 (7.6) 
 
59.4 (3.6) 
 
66.4 (1.5) 
 
  83.4 (2.4) 
Portapres 
TPR 
 
  1.9 (0.2) 
 
  2.2 (1.0) 
 
  2.3 (0.2) 
 
  2.4 (0.2) 
 
    3.3 (0.2) 
 
Table 3.4.7: Haemodynamic changes before, during, and after gastric instillation of 
water in PAF subject.  Values given as means +/- (SD). TPR=Total Peripheral resistance 
in MU. 
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      Figure 3.4.4: Seate
480ml of distilled 
BP and HR respo
time period. water
        
 
 
 
 
 
 
 
 
 
 Time in minutes after water instilled (time “0”) Time in minutes after water instilled (time “0”)
 
d haemodynamic responses before, during and after instillation of 
water through gastrostomy tube. Upper trace shows Dinamap brachial 
nses. Lower trace shows beat-to-beat Portapres data over the same 
 instillation finished at time “0”. 
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Figure 3.4.5: Total Peripheral Resistance in MU (Y-axis) as calculated from Portapres 
data with Model flow analysis. Water instillation finished at time “0”. 
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Discussion 
 
 
 
We have shown that water can induce a pressor effect in autonomic failure when instilled 
directly into the stomach. Furthermore, the magnitude and timescale of the rise in BP was 
similar to that seen in the first part of the study when oral water of the same volume was 
ingested in PAF. Thus with either oral or directly instilled water, seated BP in PAF seems to 
start to increase 5 minutes after water with an increase in TPR being a likely underlying 
factor. Apart from a transient increase in TPR (Figure 3.4.7), the instillation process itself did 
not correspond with clear haemodynamic changes.  It is possible that movement artefact may 
have been important in producing the brief increase in TPR during water instillation. 
 
The subject experienced typical orthostatic symptoms even in the seated position, and noted 
resolution of these symptoms after water. These findings were thus consistent with the 
symptomatic improvement noted in the 14 subjects in the first part of this study. A possible 
confounding factor might have been a pain induced pressor response due to instillation of 
480ml of water with subsequent gastric distension. This is improbable for two reasons; firstly, 
pressor responses to painful stimuli such as the cold pressor test are reduced in PAF. Secondly 
this subject felt no discomfort either during or after the water instillation. Our study has 
therefore shown similar haemodynamic and symptomatic effects to those previously noted 
with oral ingestion of water in PAF. Although this study was limited to a single subject it 
provides evidence that the water pressor effect in chronic autonomic failure is related to 
gastric effects rather than oropharyngeal ones. 
 
 
The results from the initial study have shown that oral ingestion of 480ml of distilled water 
results in subjective and objective improvements in OH on standing in both MSA and PAF 
subjects when measurements were made at 15 and 35 minutes after water. In addition the 
detailed analysis, utilising continuous haemodynamic measurements pre- and post-water, 
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indicate that there are temporal differences in the pressor response between MSA and PAF. In 
previous studies [Jordan et al 1999, Shannon et al 2002] there did not appear to be 
differences, and it may be that intermittent measurements every 3 or 5 minutes without 
continuous recordings may have made comparisons difficult.  
 
 
The apparent haemodynamic differences between MSA and PAF while seated warrant 
discussion. In PAF the pressor effect occurred sooner (within 5minutes) unlike MSA where it 
occurred 13 minutes after ingestion. This may provide further light on the mechanisms 
responsible for the pressor response, as in PAF all the subjects had clear evidence of 
substantial peripheral sympathetic denervation; in MSA the predominant lesion was likely to 
be preganglionic. The pressor response to water is known to be dependant on the volume 
ingested, and may be the result of gastric distension increasing sympathetic nerve activity by 
reflex mechanisms, as has been described in normal subjects [Rossi et al 1998]. This response 
is likely to be dependant on residual sympathetic activity, and is therefore expected to be 
minimal in PAF, and greater in MSA. This would be consistent with the effects previously 
described of yohimbine, an α2 agonist that is dependant on sympathetic activity and where the 
pressor response was related to the pressor response of water [Jordan et al 2000]. However, 
this was not the case in our studies as the response was as great in PAF with a more rapid 
onset than in MSA An alternative may be that the pressor response in PAF was related to 
denervation supersensitivity, which has been well documented in this group, and is greater 
than in MSA [Polinsky 2002]. It is possible that in PAF, even a small amount of NA released 
could have acted on supersensitive receptors, although this seems less plausible than the 
release of other vasoconstrictor substances, including factors such as endothelin, which may 
then exert the pressor response. These possibilities may explain the rise in peripheral 
resistance found in this study.  A further substance to be considered is vasopressin, which is 
known to be released in PAF but not MSA in the head up position [Kaufmann et al 1992]. 
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Another factor to be considered with water ingestion is the effect of fluid repletion, in patients 
who are known to be prone to salt and water loss, especially when they are recumbent 
[Mathias et al 1986]. It may be that in MSA there is greater disruption of vasopressin 
secretion, rendering them even more fluid depleted. It is conceivable that the longer time 
taken to reach a pressor response, in MSA, was a reflection of greater intra- and extra vascular 
fluid depletion.  It is not clear how quickly after ingestion water is absorbed from the gut in 
MSA or PAF and in particular how much would have been absorbed in PAF within 5 minutes 
after ingestion, when the pressor effect of water first occurred.  
 
 
Mechanisms of the pressor effect of water ingestion 
 
The exact mechanism by which water ingestion results in a pressor response remains 
uncertain. Various factors are important in determining blood pressure; these include cardiac 
output, tone in resistance vessels (influenced by either circulating or locally produced 
constrictor or dilator substances), the state of capacitance vessels, intravascular volume and 
overall fluid status. The sympathetic nervous system acting on a beat-by-beat basis through 
the baroreceptor reflex to allow rapid adjustment of blood pressure. There have been various 
studies attempting to determine the precise mechanisms by which water exerts its pressor 
effect. The studies outlined above suggest the importance of increased total peripheral 
resistance in the generation of the water pressor effect as well as providing evidence on the 
latency of the effect; in PAF a prompt response within 5 minutes of ingestion in seen whilst in 
MSA a slower response was observed. 
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Effects of water temperature and volume 
To determine if there was temperature and volume dependency, four subjects with autonomic 
failure were studied [Jordan et al 2000].  There was no difference in the pressor response 
when water at either 9oC or 24oC was administered.  The pressor response was related to the 
volume ingested, as systolic blood pressure increased by up to 50mm Hg after 480 ml water, 
and by 30mm Hg after 240 ml when studied in 4 subjects with chronic autonomic failure, 
raising the possibility of reflex sympathetic activation from stomach distension in the 
generation of the pressor response. In an initial study in one MSA study I found that an even 
lower volume (around 200ml) was sufficient to generate a marked pressor response. This 
subject was relatively small and felt a sensation of fullness at this volume. Studies in healthy 
animals and humans have demonstrated that graded gastric balloon distension causes a rise in 
Muscle Sympathetic Nerve Activity MSNA and blood pressure [Rossi et al., 1998]. However, 
in normal subjects, oral water ingestion was shown to raise MSNA but not elevate blood 
pressure [Scott et al., 2001].  Conflicting results were later shown in another group of normal 
young subjects where oral water ingestion caused an initial transient rise in blood pressure 
and heart rate but a decrease in MSNA [Endo et al., 2002]. In that study the same volume of 
water administered by a stomach tube over 20 min, caused no change in either MSNA or 
blood pressure, raising the possibility that the initial pressor response resulted from the 
pharyngeal/oesophageal phase of water drinking. The degree of distension may be a factor in 
explaining this discrepancy-it is known that excessive dilatation the stomach may result in 
extreme bradycardia and even hypotension presumably via vasovagal mechanisms [Hmouda 
et al 1994]. The swallowing stage of drinking does not appear to be involved in generating the 
pressor effect in chronic autonomic failure, with a pressor effect to water having been 
demonstrated when water is instilled directly into the stomach of a patient with PAF [Young 
& Mathias 2004b] or MSA [Lipp et al 2005].  
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Recent comparisons between haemodynamic responses to gastric distension with a barostat 
have been made in 8 young and 8 older normal subjects [van Orshoven et al 2004]. In this 
study the older subjects tended to show a higher increase in mean arterial pressure, heart rate 
and total peripheral arterial resistance despite showing a significantly attenuated increase in 
MSNA compared to the young subjects. The older subjects reported less symptoms of 
stomach distension, although there was no significance in stomach compliance between the 
young and older subjects. Possible reasons for these results might include the known 
reduction in central arterial compliance with ageing suggesting that even the attenuated 
increase in MSNA seen in the older group could still result in a significant pressor effect. An 
alternative possibility would be that the attenuation of sympathetic outflow in response to 
gastric distension in older normal subjects and in autonomic failure alters the local effect of 
locally released vasoactive substances akin to the known vasopressor supersensitivity known 
to occur in PAF. 
 
That volume alone is insufficient to produce a pressor effect is clear from the fact that food 
consumption is associated with post-prandial hypotension in chronic autonomic failure. Thus 
with the same PAF patient in whom a pressor effect was shown following instillation of water 
via a gastrostomy tube, instillation of food resulted in a reduction in blood pressure; the 
nocturnal instillation of food in this patient actually resulted in the reversal of her pre-existing 
supine hypertension at night. There are several possible factors in explaining the discrepancy 
in blood pressure response to ingestion of food or water. Food, especially carbohydrates, 
results in splanchnic vasodilatation in AF as a result of insulin release and subsequent Nitric 
Oxide release. Secondly the presence of food substantially slows gastric emptying, thus 
delaying the absorption of water from the small bowel (FIGURE 1). Final additional factors 
such as osmoceptor activation would be more likely with relatively hypotonic chyme 
following water ingestion alone. 
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Effects of water osmolality 
The first publication suggesting that water ingestion may lead to pressor response in chronic 
autonomic failure described a patient who had noted that the ingestion of seawater improved 
their postural hypotension symptoms [Frewin & Bartholomeusz 1983]. Subsequent 
investigations confirmed that a pressor effect occurs in chronic autonomic failure after 
ingestion of either tap water [Jordan et al 1999] or distilled water [Cariga & Mathias 2001]. 
The studies detailed in this chapter utilised distilled water. In dogs data have suggested that 
gastric distension with saline results in a pressor response, but that the magnitude of BP 
increase is twice as great when distilled water is used [Haberich 1968]. In humans 
hypoosmolar water infused through a nasogastric tube induces greater sweating than isomolar 
saline, and it had been suggested that this might reflect greater sympathetic activation by 
hypo-osmolar solutions [Haberich 1968].  More recently the possible effects of osmolarity 
have been studied in MSA [Lipp et al 2005]. A total of 10 patients were studied in a semi 
supine position with 500ml of either normal saline (iso-osmotic) or distilled water (hypo-
osmotic) infused into the stomach over 5 minutes through a nasogastric tube. There was fairly 
marked variability in response. However there was a significant difference in the BP response 
between the 2 groups, with distilled water but not saline producing a pressor effect between 
10 and 40 minutes post-ingestion. Whilst varying osmolarity may effect the BP response to 
ingested water by osmoreceptor mechanisms, confirmatory studies of these provisional results 
would be helpful given the small size and variability in the studies so far. 
  
 
 
Vasoactive neurohumoral substances 
The pressor effect to water occurs after a latency of at least 5 minutes, and I have 
demonstrated an association with increased TPR in both MSA and PAF in the studies of this 
chapter. These observations raise the possibility of local or systemic vasoconstrictor 
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substances in its aetiology. The time course of the rise in blood pressure and total peripheral 
vascular resistance after water ingestion in PAF is slow (over minutes), with an even later rise 
in MSA.  This is considerably slower than after activation of reflexes that are known to raise 
blood pressure.  In tetraplegics with high spinal cord lesions, in whom central sympathetic 
outflow is interrupted but vagal efferents preserved, activation of viscera (such as the urinary 
bladder and large bowel), or induction of skeletal muscle spasms, results in autonomic 
dysreflexia with a rapid rise in blood pressure, often within a few seconds, as a result of 
activation of spinal sympathetic reflexes below the segmented level of lesion [Mathias et al 
1976a].  The response to water ingestion recently has been reported in tetraplegics [Tank et al 
2003].  The pressor response to water varied; mean supine finger blood pressure rose from 
123+8/165+4 to 138+8/73+4 mmHg after 40 minutes, while heart rate fell from 64+2 to 60+2 
bpm.  In some there was no pressor response.  The reasons for this are unclear.  In this study, 
the patients were studied supine, with the upper body at 15o; in previous studies patients were 
seated.  The pressor response to water, without a gravitational stimulus, would be expected to 
be as great or greater, if sympathetic activation was responsible, especially in tetraplegics who 
are known to response briskly to such stimuli.  The latency of the response was unlike that of 
autonomic dysreflexia, and similar to the slower time course in autonomic failure, raising the 
probability that similar mechanisms accounted for the pressor response to water in the 
different groups.  Thus reflex sympathetic activity seems unlikely to adequately explain the 
latency of the water pressor response. Could a neurohumoral response better fit the observed 
time course? 
 
Systemic circulating hormones, such as vasopressin and angiotensin-II are powerful 
vasoconstrictors.  However, in normal subjects, plasma vasopressin and renin activity did not 
change following water ingestion, and levels were not reported in autonomic failure except 
for plasma renin, which was reported unchanged in 2 subjects with autonomic failure [Jordan 
et al 2000]. Plasma noradrenaline levels increased after water ingestion in both young and 
older normal subjects [Jordan et al 2000 & Scott et al 2001], but there was no correlation 
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between the rise in plasma noradrenaline levels and the changes in blood pressure. Younger 
normal subjects do not change BP in response to oral water despite a rise in plasma 
noradrenaline [Scott et al 2001]. The increase in circulating plasma noradrenaline in these 
subjects following water ingestion is more likely to reflect the increase in sympathetic nerve 
activity suggested by increased MSNA than have direct vascular effects [Scott et al 2001].  
The noradrenaline responses to water ingestion in autonomic failure are not known. 
 
Locally released vasoactive substances also warrant discussion in the context of water 
ingestion. Inhibition of vasodilators or increased levels of vasoconstrictors such as endothelin 
could theoretically cause locally mediated pressor effects. It is known that distension of an 
isolated rat stomach results in release of somatostatin and reduced release of gastrin [Li 2003]. 
Both somatostatin and intrinsic cholinergic pathways were involved distention-induced 
inhibition of gastrin release. Although the effect of water ingestion on these hormones in man 
is not known, the combination of release of somatostatin and reduced release of gastrin is 
interesting as somatostatin causes splanchnic arteriolar vasoconstriction by PKC-dependent 
vasoconstrictors, possibly via SSTR2 receptors [Reynaert & Geerts 2003], and enhances 
endothelin-1-induced vasoconstriction [Huang et al 2002]. Gastrin on the other hand is a 
vasodilator. Gastrin is released by gastrin-releasing peptide, which has recently been shown to 
be a potent systemic vasodilator in healthy human subjects [Clive et al 2001]. The effects of 
gastrin on blood pressure are not as clear, although pentagastrin, a synthetic analogue, appears 
to increase BP and HR in man [Tavernor et al 2000]. The situation in chronic autonomic 
failure is complicated by the fact that basal gastrin and release following hypoglycaemia may 
be increased in PAF, but reduced in MSA [Polinsky et al 1988] 
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Pharmacological Studies 
Pharmacological studies have been used at both ganglionic and pre-synaptic sympathetic 
levels. The possibility that residual sympathetic nerve activity may have been a factor in 
generating the pressor effect to water has been studied with trimethaphan ganglionic block 
[Jordan et al 2000]. Plasma noradrenaline was measured in two MSA patients, before and 
after ganglionic blockade. In both MSA subjects plasma noradrenaline levels fell, indicating 
suppression of residual sympathetic nerve activity.  In neither was there a pressor response 
when water was administered after ganglionic blockade.  The lack of a pressor response to 
water in MSA after ganglionic blockade raised further the possibility of activation of 
sympathetic neural mechanisms.  Further evidence in normal subjects was considered to 
favour this, as the pressor response to water was also absent after ganglionic blockade [Jordan 
et al 2000].  However, this was performed only in younger subjects, who did not have a 
pressor response to water. Furthermore the pressor response is clearly seen in PAF subjects 
with extensive sympathetic denervation [Cariga & Mathias 2001].  
 
Yohimbine acts on α-2 pre-synaptic receptors resulting in noradrenaline release and thus its 
effect is dependent on the integrity of sympathetic nerve terminals.  In patients with primary 
autonomic failure there was a correlation between the pressor response to yohimbine and to 
water, suggesting that those with less sympathetic denervation had a greater pressor response 
[Jordan et al 2000]. This would be in keeping with a previous report where it was observed 
that patients with PAF with the greatest increase in blood pressure after water had a normal or 
even exaggerated pressor response [Jordan et al 1999].   This also implies the reverse, that 
patients with substantial sympathetic failure are less likely to have a pressor response to 
water.  However, in later studies [Cariga & Mathias 2001] and in my studies outlined in this 
chapter, a marked pressor response to water ingestion also occurred in PAF with marked 
sympathetic dysfunction.  Furthermore, in spinal cord injury tetraplegics, who have preserved 
sympathetic nerve terminals and have exaggerated pressor responses to vasoactive drugs and 
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a range of visceral and other stimuli [Mathias & Frankel 2002], the pressor response to water 
was similar or less than patients with autonomic failure.  This suggests that other possibilities 
are needed to explain the pressor response. Finally it should be noted that Yohimbine is not a 
pure α-2 antagonist. It also displays partial agonist activity at cloned human 5-HT1A 
receptors, significant affinity for 5-HT1B and 5-HT1D receptors and antagonist properties at 
dopaminergic D2 receptors [Millan et al 2000]. Of these the D2 effect might be especially 
significant given the known action of other D2 antagonists such as domperidone and gastric 
motility and blood flow. 
 
 
Correction of Fluid depletion 
For a variety of reasons fluid depletion is more likely to occur in patients with autonomic 
failure. Tubular absorption of sodium and other solutes, is influenced by sympathetic nerve 
activity, and may account for the urinary sodium and water loss in such patients [DiBona & 
Wilcox 2002].  When supine patients with autonomic failure often develop raised blood 
pressure, sometimes to a marked extent.  This in turn increases renal perfusion pressure and 
probably contributes to recumbency-induced polyuria [Schalekamp 1985, Kooner et al 1988].  
Overnight, if lying flat their body weight can fall by 1-1.5 kgs, which worsens both the 
symptoms and degree of orthostatic hypotension in the morning [Mathias et al 1986].  
Correction of this deficit is the basis for nocturnal use of the vasopressin-2 agonist 
desmopressin, which reduces water loss, overnight weight loss, improves morning orthostatic 
hypotension as well as reducing symptoms [Mathias et al 1986, Mathias & Young 2003].  It is 
possible that this might have been a factor in my studies as the protocol required that the 
subjects fasted after a light breakfast at 0800 on the day of the study. This was comparable 
with earlier studies and reduced the confounding variables of residual pressor effect from 
fluid consumption, or post-prandial hypotension from food. However, it also meant that early 
dehydration might have been present for the reasons outlined above. 
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An important consideration when considering possible correction of fluid depletion is the 
speed with which water is absorbed from the gut, given that the pressor effect is observed as 
rapidly as 5 minutes post-ingestion. As significant volumes of water are not absorbed into the 
portal circulation until water leaves the stomach to enter the duodenum, gastric emptying is a 
key concept.   In normal subjects, the emptying half time of 800 ml of water is 21 minutes 
[Ploutz-Snyder et al 1999], as measured with magnetic resonance imaging.  With smaller 
volumes of 500 ml this is likely to be different. In normal subjects, water alone increases 
portal blood flow, measure by Doppler sonography [Host et al 1996].  Extrapolating from 
studies in normal subjects, who are well hydrated, may be erroneous if compared to relatively 
dehydrated autonomic failure patients.  In normal subjects, hydration is recognised as 
reducing orthostatic responses.  Gastric emptying in autonomic failure may be more rapid 
than in normal subjects [Mathias & Bannister 2001], and absorption of even a small fluid 
volume could create a sufficient pressor effect in patients because of impaired baroreflex 
function. In studies on rehydration after fluid restriction in normal subjects, the importance of 
extravascular hydration was thought to be of greater importance than intravascular hydration, 
in determining orthostatic tolerance [Harrison et al 1986].  
  
Water ingestion initially may raise plasma volume, but it is likely that redistribution then 
occurs with subsequent movement of fluid from intravascular into extravascular spaces.  
Saline has advantages over water alone, because it is stored extracellularly and causes greater 
explosion of both extra- and intravascular spaces (Harrison 1986).  This explains the benefit 
of saline drinking in autonomic failure (Frewin & Bartholomeusz 1983), although ingestion of 
salt and water often causes side effects, including diarrhoea.  Recent work on the effects of 
different osmolarities of water however suggests that hypo-osmolar water produces a greater 
pressor response on ingestion in MSA than isotonic saline [Lipp et al 2005]. The haematocrit, 
as a measure of plasma volume was measured in normal subjects before, 30 and 60 minutes 
after water ingestion [Jordan et al 2000].  No significant changes in the haematocrit were 
observed, seemingly excluding increases in intravascular volume as a factor.  A variety of 
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factors can influence interpretation of haematocrit in this context, especially in subjects with 
denervation [DiBona & Wilcox 2002].  Furthermore, the pressor effect of water occurred after 
5 minutes and peaked at 30 minutes, making it likely that water redistribution had occurred 
when the first measurements were made post-water ingestion.  To measure the direct effects 
of plasma expansion, intravenously administered 5 % dextrose was infused into five PAF, but 
over a 60-minute period [Jordan et al 2000].  After infusion, plasma volume increased by 
5.3% and blood pressure by 18mm Hg, compared to 52mm Hg with oral water.   Patients with 
autonomic failure usually have a brisk pressor response to intravenous fluid replacement, 
although normal saline usually is used for rehydration and to raise blood pressure.  However, 
carbohydrate is known to lower blood pressure in autonomic failure [Mathias et al 1989], and 
the potential hypotensive effect of dextrose may have negated the pressor effect of this 
volume of water intravenously. Finally the time course of water infusion in this study is 
difficult to interpret, as the time taken to fully absorb ingested water into the systemic 
circulation in PAF is not known.  
  
The reasons for the differential responses to water ingestion in young and older normal 
subjects remains unclear.  Older subjects are more likely to have a degree of refractoriness of 
their renal tubules to vasopressin, and thus may be relatively less fluid replete than younger 
normals.  However, other factors, greater vascular responses to pressor stimuli, or less 
effective baroreceptor reflexes are also possible.  This also may account for the pressor 
response to water (13 to 29 mmHg) observed in four cardiac transplant recipients who lacked 
cardiac autonomic innervation [Routledge et al 2002]. The pressor response to gastric 
distension with a barostat appears to be greater in older normals despite an attenuation in 
MSNA increase compared to younger normals. Reduced compliance of central arteries with 
aging may explain this apparent discrepancy. 
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The beneficial effects of water ingestion in autonomic failure 
 
The early observations of the pressor effect of water prompted suggestions of potential 
therapeutic effects on orthostatic and post-prandial and exercise-induced hypotension, in 
autonomic failure [Mathias 2000]. Subsequent studies have confirmed the therapeutic 
potential of water ingestion.  In autonomic failure, water ingestion raises standing blood 
pressure (83+6/53+3mm Hg pre water to 114+30/66+18), 35 minutes after water when 
measurements were made 1 minute after standing [Shannon et al 2002].  Post-prandial 
hypotension (reduction of 43/20mm Hg after 90 minutes) was reduced when water was 
ingested immediately before a meal (reduction of 22/12mm Hg after 90 minutes). In a further 
study comparing PAF and MSA, similar observations have been made in relation to the 
effectiveness of water in reducing orthostatic hypotension in the different groups; 
furthermore, in this study there was objective evidence of a reduction in orthostatic symptoms 
[Young & Mathias 2004]. The effects of repeated water ingestion are not known. Topping up 
with subsequent smaller drinks of water maintains a large gastric volume thus keeping gastric 
emptying at a high rate in healthy subjects [Noakes et al 1991]. It is not known whether 
“topping up” with subsequent small drinks of water can prolong the pressor effect in 
autonomic failure.  However, water ingestion does not appear to raise blood pressure, supine 
or standing, in Parkinson’s disease with autonomic failure [Senard et al 1999] and its effects 
in the other diseases causing orthostatic hypotension requires further study. 
 
 
Haemodynamic effects of water ingestion in other autonomic diseases 
 
 
Water ingestion may benefit disorders such as neurally-mediated syncope and the postural 
tachycardia syndrome where there is intermittent autonomic dysfunction.  Vasovagal syncope 
is the most common form of neurally-mediated syncope [Mathias et al 2000] with cardio-
inhibitory, vasodepressor and mixed components.  Oral water drinking was suggested as a 
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treatment in children with vasodepressor syncope [Younoszai et al 1998].  In normal subjects 
water ingestion increases orthostatic tolerance (by up to 5 minutes) when tested with a 
combination of head-up tilt (to 60o) and lower body negative pressure (at levels of -20, -40 
and -60mm Hg for 10 minutes each, or until pre-syncope occurred) [Schroeder et al 2000].  
Water increased peripheral vascular resistance and reduced the fall in stroke volume.  Thus, 
water may benefit subjects with vasovagal syncope prone to episodes especially whilst 
standing still or in hot weather. 
 
 
In the postural tachycardia syndrome (PoTs) there is a substantial rise in heart rate (of over 30 
bpm), usually without a fall in blood pressure, on sustaining an upright posture.  Following 
water ingestion standing levels of blood pressure were not affected, but standing heart rate 
was lowered, from 123+23 bpm after 3 minutes of standing pre water, to 108+21 bpm after 
water [Shannon et al 2002]. The effects of water ingestion on symptoms however, were not 
reported. 
 
 
Concluding Remarks 
 
Substantial data now clearly indicate that ingestion of 480-500 ml of water result in a pressor 
response in older normal subjects and an even greater response in autonomic failure due to 
PAF and MSA whilst not changing blood pressure in young normal subjects. A variable 
pressor response also occurs in tetraplegics with high spinal cord lesions.  The mechanisms of 
this pressor response to water remain unclear. However, water is effective in autonomic 
failure in reducing both orthostatic and post-prandial hypotension and also improves 
symptoms resulting from orthostatic hypotension. Longer-term effects remain to be 
established, especially in MSA where an expected later diuresis might offset some of these 
early benefits.  
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Although much work has been performed over the last few years in both confirming and 
investigating the aetiology of the pressor effect of water, its mechanisms remain elusive. 
Further work is needed in this area including in the measurement of vasoactive neurohumeral 
substances resulting from water ingestion in both normal subjects and those with autonomic 
failure. Improved understanding of the pressor effect would be of benefit in aiding better 
understanding of the pathophysiology of autonomic failure. In addition, the pressor effects 
observed in older subjects prompt the important question of the possible role water ingestion 
may play in hypertension, an endemic problem in our aging population. 
 
These studies therefore indicate that, although the magnitude of pressor response is similar in 
PAF and MSA, there are differences in the speed of response. The reasons for this could be 
multiple, and need to be dissected further. In both PAF and MSA water increased the standing 
BP as compared to baseline, and reduced symptoms due to OH. In previous studies in 
autonomic failure orthostatic challenge was compared at 35 minutes only after water 
ingestion; in our subjects we predicted that the beneficial response on standing might occur 
earlier, as in previous studies in PAF the seated pressor response was observed within 5 
minutes of water ingestion. The haemodynamic analysis indicated that the pressor response 
was associated with an increase in TPR, again favouring vasoconstrictor mechanisms as being 
responsible. However, the increase in standing BP appeared to be related to the increase in 
baseline BP after water rather than to increased sympathetic nerve activation following 
standing, as the differences in absolute falls of BP following standing at 15 and 35 minutes 
post-ingestion were similar to those found at baseline. Regardless of the mechanisms, water 
improved symptoms in all the patients who had been symptomatic pre-water ingestion. Thus 
water ingestion may be a valuable adjunct in the management of OH, especially in the 
morning when patients are usually most affected by OH. 
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3.5: Cardiovascular Responses on Tilt-Reversal in MSA and PAF 
 
 
 
 
ABSTRACT 
Objective: To assess the effects of tilt reversal back to supine after head up tilt (HUT) on 
blood pressure (BP), heart rate (HR) and plasma Arginine Vasopressin (AVP) in multiple 
system atrophy (MSA) and in pure autonomic failure (PAF).  
Background: In MSA and PAF Head up Tilt (HUT) is associated with significant orthostatic 
hypotension. On tilt reversal back to supine posture there may be an initial overshoot in the 
blood pressure in PAF not MSA, resulting in transiently higher supine values than those 
obtained prior to HUT. AVP is a hormone produced in the hypothalamus and released from 
the posterior pituitary in response to head-up posture and may be important in helping to 
maintain BP in the upright position by virtue of its vasopressor actions. As a previous study 
had suggested that this AVP response may be preserved in PAF but not in MSA (where 
central lesion sites include the hypothalamus), this study sought to ascertain if there was a 
difference in the BP overshoot between MSA and PAF, and if so whether this was related to 
the AVP response. The working hypothesis was that HUT would result in a significant AVP 
release in PAF but not MSA and that on subsequent return to supine, the residual AVP action 
would cause an exaggerated pressor response in PAF, in whom there is a known pressor 
supersensitivity. Thus the expected result would be an initial rise in plasma AVP in PAF but 
not MSA, and on tilt reversal back to supine a brief BP overshoot in PAF but not MSA. 
Methods: An initial pilot study was performed to confirm the presence of BP overshoot in 
PAF not MSA. A further study was then performed to help ascertain if this BP overshoot 
appeared to be correlated to plasma AVP levels. In the second study 14 subjects, 7 MSA and 
7 PAF were studied. BP was recorded both intermittently and continuously with Dinamap and 
Portapres II devices respectively. The subject lay supine for 20 minutes then underwent 10 
minutes of head up tilt (HUT), immediately following which was a tilt reversal back to supine 
where the subject remained for the rest of the study. Plasma AVP levels were taken from the 
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intravenous line at baseline, at the end of 10 minutes HUT, and then 10 and 20 minutes 
following the return to supine position.  
Results: Both studies demonstrated a similar decrease in SBP and DBP in MSA and PAF 
during HUT, with MSA but not PAF demonstrating a significant increase in HR. In both 
studies following tilt-reversal there was an increase in supine SBP, compared to pre HUT 
values, in PAF but not MSA. This increase reached a peak at about 7 minutes post tilt 
reversal. Following tilt-reversal there was a non-significant increase in DBP and TPR in PAF 
in both studies and a trend towards HR reduction in the MSA group. Although the mean 
plasma AVP basal level and increase following HUT was greater in PAF, differences did not 
reach significance. 
Conclusions:   
These studies confirm the presence of transient BP overshoot in PAF not MSA following tilt 
reversal, and have identified that SBP rather than DBP increase appeared to explain the MAP 
increase in PAF [Chandler and Mathias 2002]. The mechanism, however, is less clear with 
factors such as TPR and HR likely to contribute to differences in the SBP to tilt-reversal 
between MSA and PAF. The increased levels of plasma AVP in PAF may be an additional 
factor. These results have practical implications in the management of BP in PAF. 
 
 
 
Introduction 
 
 
Although much work has been performed on the effects of HUT in MSA and PAF, less 
attention has been paid to the subsequent tilt reversal to supine. Both MSA and PAF patients 
have impaired baroreflexes [Omboni et al 1996]. Because of this the normal buffering of the 
tendency to hypertension on change from tilt-up to supine posture would be impaired. Thus 
an overshoot in BP on resumption of supine position might be expected. In provisional case 
studies we have shown that, when returning PAF patients back to supine after head-up tilt, 
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there is an increase in systolic BP compared to their pre-tilt values (see Figs 3.5.1 & 3.5.2). 
This is greater than in MSA patients who return to supine after tilt. Normal subjects do not 
usually show either a decrease in BP on HUT, or a BP overshoot after head-up tilt reversal 
[Wieling et al 1998; Chandler & Mathias 2002; Toska & Walløe 2002], although they may 
show a spiky increment above pre-tilt baseline levels within the first few seconds after tilt 
reversal [Wieling et al 1998]. However, the situation appears to be different in PAF where 
one earlier study had suggested a transient increase in supine BP after tilt-reversal compared 
to supine values before head-up tilt (HUT) [Chandler & Mathias 2002]. This study by 
Chandler and Mathias had noted a possible overshoot of MAP in PAF but not MSA subjects 
during the tilt-reversal following a 10-minute HUT. Although supine hypertension is a well 
recognized complication in both MSA and PAF, MSA supine BP did not appear to be 
significantly altered following tilt reversal. The mechanism was postulated to involve TPR, as 
TPR was increased by about 12% from baseline values in PAF following tilt-reversal but was 
unchanged in MSA. In view of this, speculation of the involvement of systemic 
vasoconstricting agents was undertaken; given the extensive sympathetic denervation in PAF 
this seemed highly unlikely to be related to increased sympathetic activity. Postganglionic 
sympathetic dysfunction appears to enhance the pressor effect of AVP, as shown  in rats 
pretreated with 6-hydroxydopamine,a drug which destroys peripheral sympathetic 
postganglionic nerve terminals [Laycock and Lightman 1989]. Additional evidence had 
seemingly discounted significant adrenomedullary involvement [Polinsky 1999]. Studies in 
rats have shown an enhanced pressor response to AVP.  Whilst other systemic 
vasoconstrictors such as angiotensin II or endothelin could theoretically be involved, there did 
not seem to be a clear reason why this should involve PAF and not MSA subjects.  
 
As AVP has a potent pressor effect in AF, it may well be that this hormone explains the 
discrepancy in overshoot on return to supine [Mohring et al 1980]. The central involvement of 
MSA, including the hypothalamus, leads to the impaired secretion of substances such as 
Growth Hormone (GH) and AVP [Kimber et al 1997; Ozawa et al 1999]. AVP secretion in 
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AF has not been examined as fully as with GH. The pressor actions of AVP seem to be 
greatly enhanced in autonomic failure [Mohring et al 1980]. AVP secretion is increased on 
upright posture in healthy subjects, and increases can be detected within 4 minutes of upright 
tilt in these subjects [Davies et al 1976]. Because of the central involvement in MSA, this rise 
would be expected to be impaired. Indeed, although the osmotic-induced increase in AVP 
appears to be preserved in MSA, the ability to increase AVP secretion in response to 
orthostatic stimulus is impaired [Lightman et al 1992].  Kaufmann et al have shown that 
upright AVP levels do not increase in MSA, but did so in 4 PAF subjects [Kaufmann et al 
1992]. The AVP levels on returning the subject to supine horizontal are not known, and 
would be important in establishing the pathophysiology of supine BP overshoot in PAF, as 
this reaches a maximum 5-8 minutes after returning to the supine position in our provisional 
studies. We would thus expect to confirm increased AVP in PAF but not MSA patients on 
head-up tilt, and will assess the AVP levels on return to the supine position. Such a finding 
would not only help in the differential of MSA and PAF as well as having potential important 
clinical importance; the long term consequences of supine hypertension in autonomic failure 
is known to be associated with the development of ventricular hypertrophy as seen in essential 
hypertension whilst theoretical concerns about acute elevation of BP and intracerebral 
haemorrhage also deserve attention.   
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Figure 3.5.1: Continuous Haemodynamics following Head-up Tilt for 10 minutes (black 
arrow= start) and Tilt Reversal (white arrow= start) in a PAF subject. Upper Trace: BP 
(red); Middle Trace HR (blue); Lower Trace: Cardiac Output (green) and TPR (black). 
X-Axis Time in minutes. 
Head up tilt Head down tilt 
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Figure 3.5.2: Continuous Haemodynamics following Head-up Tilt for 10 minutes (black 
arrow= start) and Tilt Reversal (white arrow= start) in an MSA subject. Upper Trace: 
BP (red); Middle Trace HR (blue); Lower Trace: Cardiac Output (green) and TPR 
(black). X-Axis Time in minutes. 
 
Head up tilt Head down tilt 
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Pilot Study 
 
An initial pilot study was performed [Asahina & Young  et al 2005] primarily using 
retrospective analysis of cases. Sixteen patients with chronic orthostatic hypotension (fall of 
BP>20mmHg) were studied, including 8 PAF (6 males and 2 females; mean age 64±13 years) 
and 8 MSA patients (4 males and 4 females; 66±10 years). Both MSA and PAF patients had 
characteristic clinical manifestations according to the criteria established by the consensus 
statement on the diagnosis of MSA and PAF 1998 [Gilman et al 1999]. Table 3.5.1 shows 
clinical profiles of the PAF and MSA patients. Mean disease duration in PAF (9±5 years) was 
significantly higher than that in MSA (4±2 years; p<0.05). One PAF and one MSA patient 
was on no drug treatment; 7 PAF and 6 MSA patients were on drug treatment for orthostatic 
hypotension (fludrocortisone 0.05–0.2 mg/day in 7 PAF and 6 MSA patients; ephedrine 15–
90 mg/day in 3 PAF and 3 MSA patients; midodrine 7.5–10 mg/day in one PAF and one 
MSA patient). Three MSA patients took oxybutynin (5–10 mg/day), with two MSA patients 
on levodopa with dopadecarboxylase inhibitor (200–400 mg/day). No patients were taking 
antihypertensive medicine; all MSA patients and 7 out of 8 PAF patients had supine 
hypertension (systolic BP>140mmHg). Systolic and diastolic BP and heart rate (HR) were 
measured intermittently, using the automatic sphygmomanometer (Dinamap, Critikon A, 
UK), on the right arm. In addition, the Portapres model 2 device (TNO-TPD Biomedical 
Instrumentation, the Netherlands) continuously measured beat-to-beat arterial pressure 
through a cuff wrapped around the middle phalanx of the left middle finger, and stroke 
volume (SV), cardiac output (CO) and total peripheral resistance (TPR) were derived using 
the Beatscope Software for Windows, ver. 1 Pre-tilt supine values (baseline) for SV, CO and 
TPR were set at 100%, and changes were expressed in percentages from baseline. As values 
of SV, CO and TPR, 30-seconds averages were used. Vasoactive medication was omitted the 
evening before the study. Subjects were studied following an overnight fast. Patients rested 
supine until the BP and HR stabilised, following which baseline (pre-tilt) HR and BP were 
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recorded. After 5 minutes of baseline measurements, patients underwent HUT to 60° on an 
electrical tilt table for 10 minutes, and then returned to the horizontal supine position (tilt 
reversal). Measurements in the tilt reversal supine position were performed until BP was 
stabilized.  Mann-Whitney U tests were used to compare the PAF and MSA groups. The level 
of significance was set at p-value<0.05.Data were reported as mean ± SD. 
 
 
Table 3.5.1: Characteristics of the MSA and PAF subjects studied for pilot study. From: 
Asahina M, Young TM, Bleasdale-Barr K, Mathias CJ  Differences in overshoot of 
blood pressure after head-up tilt in two groups with chronic autonomic failure: pure 
autonomic failure and multiple system atrophy  J Neurol 2005;252:72–77  
 
 
There were no significant differences in mean baselines of systolic and diastolic BP between 
the two groups. Baseline HR in MSA was higher than that in PAF, although there was no 
statistically significant difference. During HUT, both PAF and MSA had similar mean falls of 
systolic and diastolic BP. The mean HR increase in MSA was significantly greater than PAF. 
After tilt reversal, 5 out of 8 PAF patients showed a systolic overshoot of 15mmHg between 5 
and 11 min after tilt reversal compared with pre-tilt readings, while one of the 8 MSA patients 
had a BP overshoot. In patients with BP overshoot, BP reached a peak around 5–11 minutes 
after tilt reversal, followed by a plateau, and gradually returned to baseline readings between  
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10 minutes and 35 minutes after tilt reversal. In the PAF group, means of systolic and 
diastolic BP passed over pre-tilt supine readings after tilt reversal, while those in the MSA 
group returned to baseline readings without overshoot (Fig. 3.5.3). The mean increments in 
systolic BP at the peak of systolic BP overshoot after tilt reversal in PAF (17±9mmHg) were 
significantly greater than those in MSA (5±10mmHg) (p<0.05), although there was no 
significant difference in the mean increments in diastolic BP between the PAF (8±7mmHg) 
and MSA (6±8mmHg) groups. HR during the post-tilt period did not differ from pre-tilt 
readings between the PAF and MSA groups, and there was no significant difference in a mean 
change of HR from the baseline level to the post-tilt readings between the PAF (1±3 
beats/min) and MSA (–1±6 beats/min) groups. SV and CO decreased during HUT in both 
PAF and MSA. The fall of SV in MSA was greater than in PAF. However, there was no 
difference in the fall of CO between the 2 groups, because HR increased in MSA during 
HUT, unlike PAF. TPR decreased in PAF during HUT, while it did not change in MSA. After 
tilt-reversal, SV and CO returned to the baseline levels without overshoot in both PAF and 
MSA. There were no significant differences in changes in SV and CO from the baseline level 
to the post-tilt supine level between the PAF and MSA groups. Although TPR increase over 
baseline was greater in PAF (19±16%) than MSA (6±14%), this did not reach significance. 
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Figure 3.5:3  SBP in 7 MSA and 7 PAF subjects before, during and after HUT. Values = 
mmHg +/- SD. From Asahina M, Young TM, Bleasdale-Barr K, Mathias CJ  Differences 
in overshoot of blood pressure after head-up tilt in two groups with chronic autonomic 
failure: pure autonomic failure and multiple system atrophy  J Neurol 2005;252:72–77 
[Ref 12] 
 
 
 
Follow Up Study: BP Overshoot and plasma AVP: 
 
 
 
Subjects and Methods 
 
 
Fourteen patients with chronic orthostatic hypotension (fall of BP>20mmHg), including 7 
PAF (3 males and 4 females; mean age 67.4±2.5 years) and 7 MSA patients (4 males and 3 
females; 54.3 ±3 years) were studied. The PAF patients had no neurological symptoms or 
signs except for autonomic dysfunction. The MSA patients had characteristic clinical 
manifestations according to the criteria established by the consensus statement on the 
diagnosis of MSA in 1999 [Gilman et al 1999]. One PAF and two MSA patients were on no 
drug treatment; 6 PAF and 5 MSA patients were on drug treatment for orthostatic hypotension 
(fludrocortisone 0.05–0.2 mg/day in 6 PAF and 5 MSA patients; ephedrine 15–90 mg/day in 3 
PAF and 2 MSA patients; midodrine 7.5–10 mg/day in two PAF and one MSA patient). Two 
MSA patients took oxybutynin (5–10 mg/day), with no MSA patients on anti-parkinsonian 
medication. No patients were treated with antihypertensive medicine; 6 out of 7 MSA patients 
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and 6 out of 7 PAF patients had supine hypertension (systolic BP>140mmHg). Systolic and 
diastolic BP and heart rate (HR) were measured intermittently, using the automatic 
sphygmomanometer (Dinamap, Critikon, UK), in the right arm. In addition, the Portapres 
model II device (TNO-TPD Biomedical Instrumentation, the Netherlands) continuously 
measured beat-to-beat arterial pressure through a cuff wrapped around the middle phalanx of 
the left middle finger, and stroke volume (SV), cardiac output (CO) and total peripheral 
resistance (TPR) were derived using the Beatscope Software for Windows, Version. 1 (TNO-
TPD Biomedical Instrumentation). Pre-tilt supine values (baseline) for SV, CO and TPR were 
set at 100%, and changes were expressed in percentages from baseline. For values of SV, CO 
and TPR, 60-seconds averages were used. Vasoactive medication was omitted the evening 
before the study. Subjects were studied after an overnight fast. The studies were performed in 
dedicated autonomic laboratories between 9:00 and 14:00 hours. Patients rested in the supine 
position until the BP and HR stabilised, following which baseline (pre-tilt) HR and BP were 
recorded. After 5 minutes of baseline measurements, patients were tilted head up at a level of 
60° on an electrical tilt table for 10 minutes, and then returned to the horizontal supine 
position (tilt reversal). Measurements in the tilt reversal supine position were performed until 
BP was stabilized. 
 
A 20G (Venflon) intravenous line was inserted into the subject’s right antecubital 
fossa before baseline and kept patent with 0.9% saline. The subject then lay quietly 
supine for 20 minutes to obtain a stable baseline. Baseline plasma AVP was taken 
after 20 minutes supine and the patient then underwent a 600 head-up tilt for 10 
minutes. AVP levels were taken after 10 minutes of HUT, and the patient 
underwent tilt reversal back to supine position. Further AVP samples were taken 
after 10 and 20 minutes after tilt reversal as illustrated below: 
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                     Head up                     Tilt back 
 Supine…… Tilt (600)                    to supine   Supine………………………. 
                           ↓                            ↓ 
 
 
 
 
Baseline             0 minutes               10                         20                           30 
 
                          
AVP Sample   ↑                             ↑                            ↑                             ↑                                            
 
                                             
Figure 3.5:4  Graphical layout of study design 
 
 
 
 
Results 
 
 
 
Dinamap data: 
 
 
i)         Values for SBP, DBP and HR before and during HUT: 
 
Baseline Supine values for MSA and PAF were similar (Tables 3.5.2-3.5.7). Baseline SBP in 
MSA was 172.1 +/- 10.4 vs. 167.1 +/- 10.7mmHg in PAF with no significant difference. 
There was also no significant difference in the DBP between groups, although baseline HR 
was higher in MSA (78.1 +/- 3.4bpm) vs. than PAF (65.7 +/- 4.2 bpm). After 10 minutes of 
HUT there were similar drops in SBP (MSA –82.1 +/- 13.7 mmHg vs. PAF -87.0 +/- 10 
mmHg) and DBP (MSA –38.7 +/- 7.9 mmHg vs. PAF –35.1 +/- 3.1 mmHg). There was a 
greater increase in HR in MSA (11.7 +/- 2.1 bpm) compared with PAF (5.6 +/- 3.4 bpm).  
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 Supine  HUT  HUT HUT 
 SBPBase SBP3min SBP5min SBP10min 
     
MSA 1 145 94 98 91
MSA 2 174 120 121 112
MSA 3 193 113 103 82
MSA 4 212 93 90 76
MSA 5 134 106 107 105
MSA 6 186 126 107 95
MSA 7 161 111 101 67
     
Mean 172.1 109.0 103.9 89.7
Standard Error 10.4 4.7 3.6 6.0
Standard Deviation 27.5 12.4 9.6 15.9
 
Table 3.5.2: Dinamap SBP in mmHg before and during HUT in 7 MSA subjects. 
(SBPBase  = supine baseline value pre-tilt; SBP3min = SBP after 3 minutes of HUT; 
SBP5min = SBP after 5 minutes of HUT; SBP10min = SBP after 10 minutes of HUT) 
 
 
 Supine  HUT  HUT HUT 
 SBPBase SBP3min SBP5min SBP10min 
     
PAF 1 175 79 65 66
PAF 2 176 122 136 122
PAF 3 205 106 100 84
PAF 4 131 72 79 73
PAF 5 155 72 67 58
PAF 6 134 66 70 65
PAF 7 194 120 111 93
     
Mean 167.1 91.0 89.7 80.1
Standard Error 10.7 9.2 10.2 8.3
Standard 
Deviation 28.4 24.2 26.9 22.0
 
Table 3.5.3: Dinamap SBP in mmHg before and during HUT in 7 PAF subjects. 
(SBPBase  = supine baseline value pre-tilt; SBP3min = SBP after 3 minutes of HUT; 
SBP5min = SBP after 5 minutes of HUT; SBP10min = SBP after 10 minutes of HUT) 
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 Supine  HUT  HUT HUT 
 DBPBase DBP3min DBP5min DBP10min 
     
MSA 1 80 64 63 57
MSA 2 105 81 83 77
MSA 3 103 68 60 50
MSA 4 117 52 51 46
MSA 5 88 78 75 79
MSA 6 103 78 74 67
MSA 7 95 66 68 44
     
Mean 98.7 69.6 67.7 60.0
Standard Error 4.6 3.9 4.0 5.5
Standard Deviation 12.2 10.2 10.7 14.5
 
Table 3.5.4:  Dinamap DBP in mmHg before and during HUT in 7 MSA subjects. 
(DBPBase  = supine baseline value pre-tilt; DBP3min = DBP after 3 minutes of HUT; 
DBP5min = DBP after 5 minutes of HUT; DBP10min = DBP after 10 minutes of HUT) 
 
 
 
 Supine  HUT  HUT HUT 
 DBPBase DBP3min DBP5min DBP10min 
     
PAF 1 92 55 48 44
PAF 2 88 66 72 70
PAF 3 90 63 63 57
PAF 4 77 47 49 44
PAF 5 86 52 48 44
PAF 6 84 43 47 43
PAF 7 104 90 83 73
     
     Mean 88.7 59.4 58.6 53.6
     Standard Error 3.1 6.0 5.4 5.0
     Standard Deviation 8.3 15.8 14.4 13.2
 
Table 3.5.5: Dinamap DBP in mmHg before and during HUT in 7 PAF subjects. 
(DBPBase  = supine baseline value pre-tilt; DBP3min = DBP after 3 minutes of HUT; 
DBP5min = DBP after 5 minutes of HUT; DBP10min = DBP after 10 minutes of HUT) 
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 Supine  HUT  HUT HUT 
 HRBase  HR3min HR5min HR10min 
     
MSA 1 74 77 80 83
MSA 2 76 86 87 85
MSA 3 93 96 98 102
MSA 4 80 86 85 85
MSA 5 68 86 86 90
MSA 6 71 80 88 87
MSA 7 85 94 94 97
     
Mean 78.1 86.4 88.3 89.9
Standard Error 3.3 2.6 2.3 2.7
Standard Deviation 8.6 6.8 6.0 7.1
 
Table 3.5.6:  Dinamap Heart rate in bpm before and during HUT in 7 MSA subjects. 
(HRBase  = supine baseline value pre-tilt; HR3min = HR after 3 minutes of HUT; 
HR5min = HR after 5 minutes of HUT; HR10min = HR after 10 minutes of HUT) 
 
 
 Supine  HUT  HUT HUT 
 HRBase  HR3min HR5min HR10min 
     
PAF 1 68 70 70 70
PAF 2 58 61 63 58
PAF 3 86 82 79 82
PAF 4 72 84 81 77
PAF 5 65 79 83 84
PAF 6 53 53 53 53
PAF 7 58 74 76 75
     
      Mean 65.7 71.9 72.1 71.3
      Standard Error 4.2 4.3 4.1 4.5
      Standard Deviation 11.1 11.4 10.9 11.8
 
Table 3.5.7:  Dinamap Heart rate in bpm before and during HUT in 7 PAF subjects. 
(HRBase  = supine baseline value pre-tilt; HR3min = HR after 3 minutes of HUT; 
HR5min = HR after 5 minutes of HUT; HR10min = HR after 10 minutes of HUT 
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Portapres beat-to-beat values for SBP, DBP and HR before and during HUT were very similar 
to those obtained with the Dinamap as outlined above. Mean Portapres values for the 7 MSA 
subjects and 7 PAF subjects were as follows: 
 
 
 
Table 3.5.8: Mean Portapres values for SBP, DBP, HR (+/- SE) for pre-HUT supine 
baseline and at the end of 10 minute HUT 
 
 
 
 
i) Dinamap values for SBP, DBP and HR following tilt-reversal  
 
Following tilt-reversal 1 out of the 7 MSA subjects showed a SBP overshoot of at least 
15mmHg in the first 11 minutes compared with baseline versus 6 out of 7 PAF who showed a 
SBP overshoot of at least this magnitude in this time. Mean values of delta SBP showed a 
significantly greater increase in the 7 PAF subjects compared to MSA with maximum 
difference occurring at 7 minutes post tilt-reversal (p=0.03 Mann-Whitney U test). Wilcoxan 
matched pairs (mean for group compared with baseline) confirmed a significant (p=0.02) SBP 
overshoot in PAF with maximum increase again at 7 minutes post-tilt-reversal. By contrast 
there was no significant SBP overshoot in the MSA group. As with the study by Chandler & 
Mathias and the pilot study, DBP did not show overshoot in either group [Chandler & 
Mathias 2002]. Comparison of HR response showed no significant difference between the 
MSA and PAF, although MSA showed a significant reduction in HR compared with baseline 
 SBPBase SBP10min DBPBase DBP10min   HRBase   HR10min 
MSA 158.2 +/- 12.7 83.2 +/- 4.5   78.0 +/- 3.5   49.4 +/- 3.6   80.8 +/- 3.9   91.1 +/- 2.3 
PAF 156.4 +/- 11.2 81.1 +/- 11.1   81.4 +/- 6.5   48.6 +/- 4.4   67.2 +/- 3.0   71.7 +/- 3.5 
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following tilt reversal-mean –6 +/- 1.1 bpm at 7 minutes post-tilt-reversal (p=0.02), whilst 
PAF showed little change (-0.6 +/- 1.5 bpm) 
 
 
SBP 
BASE 
SBP 
1min 
SBP 
2min 
SBP 
3min 
SBP 
4min 
SBP 
5min 
SBP 
6min 
SBP 
7min 
SBP 
8min 
SBP 
9min 
SBP 
10min 
 
          
MSA 
          
145 105 122 136 123 137 116 128 132 131 108 
174 164 168 178 182 188 188 169 178 186 184 
193 148 168 182 185 194 192 195 188 193 193 
212 142 165 194 209 215 219 219 219 216 217 
134 127 144 151 136 146 137 135 139 145 136 
186 169 175 180 184 181 178 176 168 171 164 
161 77 129 156 152 159 157 159 155 162 162 
145 105 122 136 123 137 116 128 132 131 108 
MEAN           
172.1 133.1 153.0 168.1 167.3 174.3 169.6 168.7 168.4 172.0 166.3 
+/-SE 12.5 8.0 7.8 11.7 10.6 13.3 12.1 11.3 11.0 13.7 
           
           
PAF 
          
175 136 162 184 185 189 191 188 181 182 181 
176 171 191 202 203 198 195 201 201 199 201 
205 168 194 216 221 213 221 222 219 217 218 
131 145 193 187 174 164 157 148 145 136 142 
155 143 163 169 172 163 162 157 153 155 152 
134 110 116 128 142 147 149 149 149 146 147 
194 186 202 196 195 196 208 203 207 197 192 
175 136 162 184 185 189 191 188 181 182 181 
MEAN           
167.1 151.3 174.4 183.1 184.6 181.4 183.3 181.1 179.3 176.0 176.1 
+/- SE 9.7 11.4 10.8 9.6 9.0 10.4 11.2 11.6 11.6 11.2 
 
Table 3.5.9: Dinamap SBP from baseline supine for each minute post-tilt reversal in 7 
MSA and 7 PAF. (mmHg +/- SE); N/S difference for MSA compared with baseline; 
significant increase in SBP vs. baseline in PAF, maximum at 7 minutes post tilt-reversal 
(p=0.02 Wilcoxan Matched pairs) 
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SBP 
BASE 
∆SBP 
1min 
∆SBP 
2min 
∆SBP 
3min 
∆SBP 
4min 
∆SBP 
5min 
∆SBP 
6min 
∆SBP 
7min 
∆SBP 
8min 
∆SBP 
9min 
∆SBP 
10min 
 
          
MSA 
          
145 -30 -23 -9 -22 -8 -29 -17 -13 -14 -37 
174 -10 -6 4 8 14 14 -5 4 14 10 
193 -45 -25 -11 -8 1 -1 -2 -5 0 0 
212 -70 -47 -18 -3 3 7 7 7 4 5 
134 8 10 17 2 12 3 1 5 11 2 
186 -17 -11 -6 -2 -5 -8 -10 -18 -15 -18 
161 -84 -32 -5 -9 -2 -4 -2 -6 1 1 
           
MEAN           
172.1 -35.4 -19.1 -4.0 -4.9 2.1 -2.6 -4.0 -3.7 0.1 -5.3 
+/- SE 12.5 7.0 4.3 3.6 3.1 5.2 2.9 3.6 4.2 6.2 
           
           
PAF 
          
175 -39 -13 9 10 14 16 13 6 7 6 
176 -5 15 26 27 22 19 25 25 23 25 
205 -37 -11 11 16 8 16 17 14 12 13 
131 14 62 56 43 33 26 17 14 5 11 
155 -10 8 14 17 8 7 2 -2 0 -3 
134 -24 -18 -6 8 13 17 17 15 12 13 
194 -8 8 2 1 2 14 9 13 3 -2 
           
MEAN           
167.1 -15.6 7.3 16.0* 17.4** 14.3* 16.4** 14.3*** 12.1** 8.9 9.0 
+/- SE 7.2 10.3 7.7 5.3 3.9 2.1 2.7 3.2 2.9 3.7 
 
Table 3.5.10: Change (∆) in SBP from baseline supine for each minute post-tilt reversal 
in 7 MSA and 7 PAF. PAF showed significantly greater increase in SBP over this 10 
minute time period (Mann-Whitney max at 7 minutes post tilt-reversal p= 0.03) (PAF 
versus MSA) 
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DBP 
BASE 
DBP 
1min 
DBP 
2min 
DBP 
3min 
DBP 
4min 
DBP 
5min 
DBP 
6min 
DBP 
7min 
DBP 
8min 
DBP 
9min 
DBP 
10min 
 
          
MSA 
          
80 71 77 78 74 85 66 79 75 81 68 
105 97 102 111 104 107 110 106 112 109 107 
103 98 104 112 113 115 115 110 105 109 113 
117 87 105 122 121 126 124 124 120 119 119 
88 87 91 89 90 89 85 87 89 87 89 
103 101 100 101 101 99 103 97 96 94 93 
95 48 77 91 86 87 82 81 82 83 89 
80 71 77 78 74 85 66 79 75 81 68 
MEAN 
          
98.7 84.1 93.7 100.6 98.4 101.1 97.9 97.7 97.0 97.4 96.9 
+/- SE 7.1 4.6 5.8 6.1 5.9 7.8 6.3 6.2 5.6 6.6 
           
           
PAF 
          
92 90 98 105 102 100 97 97 93 92 93 
88 89 85 103 94 89 92 99 90 100 95 
90 84 94 100 100 100 102 101 100 99 97 
77 88 104 103 99 88 84 80 80 76 79 
86 91 94 97 96 92 91 89 87 87 80 
84 81 77 84 80 81 85 78 86 83 84 
104 101 98 106 105 99 101 99 104 103 104 
92 90 98 105 102 100 97 97 93 92 93 
MEAN           
88.7 89.1 92.9 99.7 96.6 92.7 93.1 91.9 91.4 91.4 90.3 
+/- SE 3.1 2.4 3.4 2.9 3.1 2.8 2.7 3.6 3.1 3.8 
 
Table 3.5.11: Dinamap DBP compared with baseline supine for each minute post-tilt 
reversal in 7 MSA and 7 PAF. (mmHg +/- SE). No significant difference with either 
MSA or PAF. 
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DBP 
BASE 
∆DBP 
1min 
∆DBP 
2min 
∆DBP 
3min 
∆DBP 
4min 
∆DBP 
5min 
∆DBP 
6min 
∆DBP 
7min 
∆DBP 
8min 
∆DBP 
9min 
∆DBP 
10min 
 
          
MSA 
          
80 -9 -3 -2 -6 5 -14 -1 -5 1 -12 
105 -8 -3 6 -1 2 5 1 7 4 2 
103 -5 1 9 10 12 12 7 2 6 10 
117 -30 -12 5 4 9 7 7 3 2 2 
88 -1 3 1 2 1 -3 -1 1 -1 1 
103 -2 -3 -2 -2 -4 0 -6 -6 -9 -10 
95 -47 -18 -4 -9 -8 -13 -14 -13 -12 -6 
           
MEAN 
          
98.7 -14.6 -5 1.9 -0.3 2.4 -0.9 -1 -1.6 -1.3 -1.9 
+/- SE 2.8 1.8 2.4 2.6 3.7 2.8 2.6 2.5 2.9 2.8 
           
           
PAF 
          
-2 6 13 10 8 5 5 1 0 1 -2 
1 -3 15 6 1 4 11 2 12 7 1 
-6 4 10 10 10 12 11 10 9 7 -6 
11 27 26 22 11 7 3 3 -1 2 11 
5 8 11 10 6 5 3 1 1 -6 5 
-3 -7 0 -4 -3 1 -6 2 0 0 -3 
-3 -6 2 1 -5 -3 -5 0 0 0 -3 
           
MEAN           
88.7 0.43 4.1 11 7.9 4 4.4 3.1 2.7 3 1.6 
+/- SE 2.2 4.4 3.3 3.1 2.4 1.8 2.6 1.3 2.0 1.7 
 
Table 3.5.12: Change (∆) in DBP from baseline supine for each minute post-tilt reversal 
in 7 MSA and 7 PAF. No significant difference between MSA and PAF 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      226                                            
 
 
 
 
 
 
 
 
HR 
BASE 
HR 
1min 
HR 
2min 
HR 
3min 
HR 
4min 
HR 
5min 
HR 
6min 
HR 
7min 
HR 
8min 
HR 
9min 
HR 
10min 
 
          
MSA 
          
74 61 55 58 63 68 71 64 74 74 71 
76 71 72 70 68 71 71 74 76 73 74 
93 86 82 81 80 81 85 84 86 85 87 
80 77 77 72 74 74 76 77 78 78 79 
68 70 60 62 61 60 60 63 64 65 65 
71 61 62 63 64 68 67 65 68 68 67 
85 94 80 70 74 80 77 78 81 85 86 
           
MEAN 
          
78.1 74.3 69.7 68.0 69.1 71.7 72.4 72.1 75.3 75.4 75.6 
+/- SE 4.7 4.0 2.9 2.7 2.8 3.0 3.1 2.8 2.9 3.3 
           
           
PAF 
          
68 71 70 70 69 69 69 69 69 68 69 
58 57 53 56 56 54 57 58 61 61 58 
86 85 84 84 82 84 85 85 86 87 86 
72 87 75 77 78 82 78 78 74 72 72 
65 61 60 64 64 63 61 60 63 64 64 
53 53 53 53 53 54 54 54 54 54 54 
58 53 51 50 51 47 53 52 52 52 54 
68 71 70 70 69 69 69 69 69 68 69 
MEAN           
65.7 66.7 63.7 64.9 64.7 64.7 65.3 65.1 65.6 65.4 65.3 
+/- SE 5.5 4.8 4.8 4.6 5.4 4.7 4.8 4.5 4.5 4.4 
 
Table 3.5.13: HR from baseline supine for each minute post-tilt reversal in 7 MSA and 7 
PAF. MSA showed significant increase in HR vs. baseline (Wilcoxan matched pairs 
p=0.02) but no significant difference from PAF where HR increase was N/S 
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HR 
BASE 
∆HR 
1min 
∆HR 
2min 
∆HR 
3min 
∆HR 
4min 
∆HR 
5min 
∆HR 
6min 
∆HR 
7min 
∆HR 
8min 
∆HR 
9min 
∆HR 
10min 
 
          
MSA 
          
74 -13 -19 -16 -11 -6 -3 -10 0 0 -3 
76 -5 -4 -6 -8 -5 -5 -2 0 -3 -2 
93 -7 -11 -12 -13 -12 -8 -9 -7 -8 -6 
80 -3 -3 -8 -6 -6 -4 -3 -2 -2 -1 
68 2 -8 -6 -7 -8 -8 -5 -4 -3 -3 
71 -10 -9 -8 -7 -3 -4 -6 -3 -3 -4 
85 9 -5 -15 -11 -5 -8 -7 -4 0 1 
           
MEAN 
          
78.1 -3.9 -8.4 -10.1 -9 -6.4 -5.7 -6 -2.9 -2.7 -2.6 
+/- SE 2.8 2.1 1.6 1.0 1.1 0.8 1.1 0.9 1.0 0.8 
           
           
PAF 
          
68 3 2 2 1 1 1 1 1 0 1 
58 -1 -4 -2 -2 -4 -1 0 3 3 0 
86 -1 -2 -2 -4 -2 -1 -1 0 1 0 
72 15 3 5 6 -10 6 6 2 0 0 
65 -4 -5 -1 -1 -2 -4 -5 -2 -1 -1 
53 0 0 0 0 1 1 1 1 1 1 
58 -5 -7 -8 -7 -11 -5 -6 -6 -6 -4 
           
MEAN           
65.7 1.0 -1.9 -0.9 -1.0 -3.9 -0.4 -0.6 -0.1 -0.3 -0.4 
+/- SE 2.5 1.4 1.5 1.5 1.8 1.4 1.5 1.1 1.1 0.6 
 
Table 3.5.14: Change (∆) in HR from baseline supine for each minute post-tilt reversal 
in 7 MSA and 7 PAF. N/S difference between MSA and PAF 
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Figure 3.5.5: Change in systolic BP (Dinamap; delta mmHg) relative to baseline supine 
value +/- SE in 7 PAF and 7 MSA immediately following tilt-reversal from HUT. 
Significantly greater increase in SBP relative to baseline in PAF vs. MSA-maximal at 7 
minutes post tilt-reversal 
 
 
 
 
 
 
 
 
 
 
 
 
 
2) Portapres Beat-to-beat data following tilt-reversal 
 
Portapres data for this study were primarily used to allow calculation of additional 
haemodynamic variables, including TPR, SV and CO, using the Beatscope software for 
windows. The Beatscope results also demonstrated a SBP overshoot in PAF but not MSA 
(Table 3.5.15). Between 7 & 8 minutes corresponding to the greatest BP overshoot in PAF, 
TPR increase compared with baseline was 7% in MSA and 16% in PAF. 
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SBP 
BASE 
∆SBP 
1min 
∆SBP 
2min 
∆SBP 
3min 
∆SBP 
4min 
∆SBP 
5min 
∆SBP 
6min 
∆SBP 
7min 
∆SBP 
8min 
∆SBP 
9min 
∆SBP 
10min 
 
          
MSA 
          
           
157.9 -31.6 -9.4 -4.9 -1.2 3.4 6 6.7 5.8 5.4 6.7 
+/- SE 14.4 9.3 6.9 4.6 3.8 4.5 5 5.7 5.6 3.7 
           
PAF 
          
           
156.4 -35.3 8.5 17 19.2 19.5 18.6 14.7 18.2 17 17.1 
+/- SE 11.6 7.2 6.5 5.5 5.8 5.1 5.1 4.9 6.4 11.6 
 
Table 3.5.15: Mean Portapres ∆SBP mmHg (+/- SE) for 7 MSA and 7 PAF subjects for each 
minute post-tilt-reversal. Significantly greater increase in SBP vs. baseline in PAF vs. MSA 
(Mann-Whitney U test p=0.04) 
 
 
 
 
 
 
 
 
 
 
 
DBP 
BASE 
∆DBP 
1min 
∆DBP 
2min 
∆DBP 
3min 
∆DBP 
4min 
∆DBP 
5min 
∆DBP 
6min 
∆DBP 
7min 
∆DBP 
8min 
∆DBP 
9min 
∆DBP 
10min 
 
          
MSA 
          
           
78.0 -8.0 1.5 2.4 3.4 3.6 3.3 3.0 2.8 2.4 1.8 
+/- SE 5.0 2.9 2.4 1.3 1.5 1.9 2.2 1.9 2.4 1.9 
           
PAF 
          
           
81.5 -1.6 2.4 2.2 0.7 0.1 -2.4 -0.9 -4.0 3.7 -1.6 
+/- SE 8.2 8.2 8.2 8.3 8.0 7.5 9.1 8.5 2.8 8.2 
 
Table 3.5.16:  Mean Portapres  ∆DBP mmHg (+/- SE) for 7 MSA and 7 PAF subjects for 
each minute post-tilt-reversal. N/S difference MSA vs. PAF 
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TPR 
BASE 
∆ TPR 
1min 
∆ TPR 
2min 
∆ TPR 
3min 
∆ TPR 
4min 
∆ TPR 
5min 
∆ TPR 
6min 
∆ TPR 
7min 
∆ TPR 
8min 
∆ TPR 
9min 
∆ TPR 
10min 
 
          
MSA 
          
0.9 0.7 0.2 0.2 0.1 0 -0.1 -0.1 -0.1 -0.1 -0.2 
0.7 0.1 0.2 0.2 0.3 0.1 0.1 0.1 0.1 0 0 
0.9 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0 0 0 
0.8 0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 
0.8 0 0.1 0 0 0 0 0 0 0 0 
0.7 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 
1.0 -0.2 -0.1 -0.1 0.2 0 0 0.1 0.1 0 0.1 
           
MEAN 
          
0.8 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 
+/- SE 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 
           
           
PAF 
          
1.8 -0.4 0.2 0.5 0.6 0.4 0.4 0.3 0.3 0.2 0.2 
4.3 -3.4 -3.3 -3.3 -3.4 -3.4 -3.4 -3.4 -3.4 -3.4 -3.4 
1.6 -0.4 0.1 0.4 0.5 0.4 0.6 0.3 1.5 0.2 0.1 
0.8 0.1 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 
0.8 -0.1 0.1 0.3 0.2 0.2 0.1 0.1    
1.8 -0.2 0 0.1 0.1 0.1 0 -0.1 -0.1 -0.2 -0.2 
1.6 -0.2 0.5 0.4 0.3 0.2 0.1 0.1 0.1 0 0 
           
MEAN           
1.8 -0.7 -0.3 -0.2 -0.2 -0.3 -0.3 -0.4 -0.2 -0.5 -0.5 
+/- SE 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.7 0.6 0.6 
 
Table 3.5.17: Change (∆) in TPR from baseline supine for each minute post-tilt reversal 
in 7 MSA and 7 PAF. There was no significant overall difference, although at 7-8 
minutes post tilt-reversal (time of maximal SBP overshoot) PAF demonstrated a 16% 
increase over baseline vs. 7 % for MSA 
 
 
 
 
 
 
 
Plasma AVP levels were variable with the greatest increase in both MSA and PAF. Overall 
levels did not show a clear trend of increase in either group (Friedman ANOVA showing p = 
0.28 in MSA and p = 0.31 for PAF. However, the greatest increase in AVP occurred at the 
end of 10 minutes HUT as would be expected by the underlying mechanism of AVP release 
in response to postural challenge. A more important statistic therefore appears to be the 
comparison of AVP levels at the end of the 10-minute HUT with baseline in both groups. 
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This showed a non-significant increase in AVP levels in both groups with Wilcoxan match 
pairs (AVP level end of HUT vs. baseline) producing a p = 0.13 for MSA and 0.07 PAF.  
 
 
 
 
Patient number AVP 1 
(baseline) 
AVP 2 
(after 10min of 
HUT) 
AVP 3 
(10 minutes after 
tilt-reversal 
AVP 4 
(20 minutes after 
tilt-reversal) 
MSA 1 1.03 5.42 1.00 1.91 
MSA 2 5.43 5.16 4.73 5.98 
MSA 3 6.60 12.42 4.28 2.28 
MSA 4 3.00 1.15 5.63 2.06 
MSA 5 2.04 2.67 2.28 1.88 
MSA 6 6.33 12.38 8.83 5.08 
MSA 7 3.03 4.79 3.25 3.21 
     
Mean MSA +/- SE    3.9 +/- 0.8       6.3 +/- 1.7         4.3 +/-1.0        3.2 +/- 0.6 
     
PAF 1 GROSSLY 
HAEMOLYSED 
GROSSLY 
HAEMOLYSED 
GROSSLY 
HAEMOLYSED 
GROSSLY 
HAEMOLYSED 
PAF 2 7.63 5.17 3.75 8.75 
PAF 3 6.21 8.69 5.88 5.46 
PAF 4 3.95 20.53 23.98 12.60 
PAF 5 3.77 34.32 7.21 6.19 
PAF 6 2.44 11.57 5.05 15.50 
PAF 7 4.83 6.20 4.17 2.25 
     
Mean PAF    4.8 +/- 0.8    14.4 +/- 4.6        8.3 +/- 3.2        8.5 +/- 2.0 
 
Table 3.5.18: Plasma AVP (pg/ml) in 7 MSA and 7 PAF subjects before HUT (AVP 1), 
at the end of 10 minutes HUT (AVP 2) and at 10 and 20 minutes post-tilt-reversal (AVP 
3 & 4 respectively). Wilcoxan matched pair AVP after 10 minute HUT vs. Base line: p= 
0.13 MSA and p= 0.07 (PAF) 
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 Baseline 
10 min head up 
tilt 
10min tilt-
reversal 
20 min tilt-
reversal 
MSA     
1 100.00 526.20 99.90 185.40 
2 100.00 95.00 87.10 110.10 
3 100.00 188.20 64.80 34.50 
4 100.00 38.30 187.70 68.70 
5 100.00 130.90 111.80 92.30 
6 100.00 195.60 139.40 80.30 
7 100.00 158.10 107.30 105.90 
Mean +/- SE 100.00 190.3 +/ 59.7 114.0 +/- 15.0 96.7 +/- 17.6 
 
    
PAF     
1 
GROSSLY 
HAEMOLYSED 
GROSSLY 
HAEMOLYSED 
GROSSLY 
HAEMOLYSED 
GROSSLY 
HAEMOLYSED 
2 100.00 67.80 49.10 114.70 
3 100.00 139.90 94.70 87.90 
4 100.00 519.70 607.10 319.00 
5 100.00 910.30 191.20 164.20 
6 100.00 474.20 207.00 635.20 
7 100.00 128.40 86.30 46.60 
Mean +/- SE 100.00 328.2 +/- 120.9 183.2 +/- 74.7 198.7 +/- 81.6 
 
Table 3.5.19: Plasma AVP levels expressed as percentage of baseline in 7 MSA and 7 
PAF at baseline, after 10 minutes head up tilt and then supine 10 and 20 minutes after 
tilt-reversal 
 
 
 
Wilcoxan comparing AVP 1 and AVP 2 showed a non-significant increase (p=0.13) for MSA and 
PAF (p=0.07). This is likely to reflect the haemolysed PAF sample from PAF patient 1, thus 
reducing the n number to 6 for the study. Spearman correlation between the AVP values   
following 10 minutes of HUT and peak increase in SBP in PAF failed to show correlation (p=0.7). 
Thus this provisional assessment of AVP and BP overshoot could not demonstrate a clear 
relationship between AVP and SBP overshoot despite a trend towards correlation. 
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Figure 3.5.6: Plasma AVP as a percentage of baseline (Value 1) at end of 10 minute HUT 
(Value 2), after 10 minutes of tilt-reversal (Value 3) and after 20 minutes of tilt-reversal 
(Value 4).  
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Figure 3.5.7: Upper Graph: Systolic BP (Dinamap; mmHg) +/- SE in 7 PAF and 7 MSA 
during the 10 minutes of HUT, and subsequent 10 minutes supine following tilt reversal; 
Lower Graph: Plasma AVP values for MSA and PAF at corresponding time points. 
Spearman’s correlation was non-significant between SBP overshoot and increase in 
ADH in MSA and PAF. 
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Discussion 
 
 
Both the pilot and subsequent AVP study primarily focussed on tilt-reversal. The baseline 
values and drop in BP on HUT were consistent with expected results. There was not a 
significant difference between the BP values in MSA and PAF either before or during HUT. 
Baseline HR was higher in MSA (78.1 +/- 3.4bpm) vs. than PAF (65.7 +/- 4.2 bpm) 
consistent with the findings described elsewhere in this thesis (chapter 3.2: Validating 
Standardised Pressor Responses in MSA and PAF). Similarly the HR variability was greater 
in MSA than in PAF (shown as greater increase of HR on HUT in MSA not PAF, in keeping 
with results elsewhere in this thesis.)  
 
Following tilt-reversal, in the provisional pilot study, the PAF group showed a significant 
increase in SBP compared to pre HUT baseline unlike MSA. Within the group 5 PAF patients 
(62.5 %) had a BP overshoot (increase in supine SBP by at least 15mmHg 5–11 minutes after 
tilt reversal, with only one MSA patient (12.5 %) demonstrated BP overshoot. There were 
similar findings in the follow-up AVP study with only 1/7 MSA but 6/7 PAF showing at least 
15mmHg SBP overshoot in the first 11 minutes following tilt-reversal.  Both studies showed a 
significantly greater increase in SBP in the first 11 minutes post tilt-reversal in PAF compared 
to MSA. Neither study showed a significant change in DBP however. There were no prior 
reports specifically about BP overshoot after tilt reversal, except for incidental observations 
by Chandler and Mathias , who noted that mean arterial pressure in the post-tilt period was 
higher than in the pre-tilt period in PAF patients in a study primarily concerned with the 
cardiovascular changes during the HUT period rather than the subsequent post-tilt supine 
period. Furthermore, the differences in degree of BP overshoot between patients with PAF 
and MSA were not analysed. It appears likely that this original observation of MAP overshoot 
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in PAF reflected the SBP only overshoot shown in both the pilot study and subsequent AVP 
study described in this thesis. 
 
In all three studies on overshoot to date (Chandler & Mathias and the two studies forming  
this chapter), there appears to be a consistent, small increase in TPR of about 12-19% from 
baseline. SV and CO in the post-tilt supine period did not differ from those in the pre-tilt 
supine period in either PAF or MSA. This leads to speculation regarding the possible 
existence of systemic vasopressor factors released during HUT in PAF but not in MSA. 
Increased sympathetic nerve activity seems unlikely to be important as PAF subjects have 
post-ganglionic lesions, low noradrenaline levels, and do not respond to pressor stimuli that 
work by increasing sympathetic nerve activity. Humoral factors may have a role in the 
observed overshoot, with AVP the candidate investigated in this chapter. It is known that 
upright posture and hypotension elicit AVP release in normal subjects, and that it produces 
potent pressor effect in autonomic failure [Mohring et al 1980; Williams et al 1986]. 
Furthermore, whilst this hypotension-induced release of AVP appears to be preserved in PAF, 
it is blunted in MSA [Kaufmann et al 1992; Kimber et al 1999] where the lesions are central. 
In addition, adrenoreceptor and pressor supersensitivity in PAF is often greater than in MSA 
[Polinsky et al 1999], reflecting the postganglionic lesions. Even though basal plasma 
noradrenaline levels are characteristically very low in PAF, and do not increase on standing, 
noradrenaline clearance is reduced in patients with PAF [Mathias et al 1990; Gilman et al 
1999; Mathias & Bannister 2002; Chandler & Mathias 2002],. A combination of 
adrenoreceptor supersensitivity and delayed noradrenaline clearance may contribute to the 
prolonged pressor effect and BP overshoot after tilt reversal in PAF. However, nearly all 
subjects in both the pilot and subsequent AVP study had been taking fludrocortisone 
medication for postural hypotension previously. This tends to suppress the renin-angiotensin-
aldosterone system, making it even less likely to play an important role in generating the BP 
overshoot on tilt-reversal. Theoretically a reduction of existing vasodilators might explain a 
BP overshoot effect, but the rapid time course of the overshoot makes this also seem 
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implausible. Finally, the possible role of other systemic vasoconstrictors such as endothelin 
must remain speculative whilst we do not yet know whether levels and activity are 
comparable to those seen in normal subjects. 
 
AVP levels were expected to be greater in PAF than MSA based on previous results. Given 
that upright posture is the mechanism resulting in AVP release, maximal levels at the end of 
HUT would have been predicted as indeed was found (see Figure 5). The increase in AVP 
relative to baseline was greater in PAF than MSA but just missed significance, possibly 
related to one set of PAF values being insubmissible because of excessive haemolysis of the 
blood sample. Overall however the relatively small subject numbers employed in all three BP 
overshoot studies to date have been sufficient to consistently show a significant SBP 
overshoot in PAF whilst TPR increase from baseline was not as clear-cut. Given additional 
factors such as the increase in HR in MSA during HUT but reduction in HR on tilt-reversal, 
the possible contribution of more severely affected baroreceptors needs consideration. It may 
be that the preservation of AVP response to HUT exaggerates the tendency towards BP 
overshoot caused by impairment of the baroreflexes. In MSA however AVP levels appear to 
be lower than MSA following upright posture, and there appears to be at least some residual 
buffering capacity provided by reduced heart rate to further lessen any BP overshoot.  
  
Regarding the limitations of the studies outlined above, the use of medication by subjects 
needs consideration. Because of ethical considerations it was not possible to withhold 
medication for longer than in the protocol. However, MSA and PAF subjects were fairly well 
matched by medication use, and the consistent findings of BP overshoot across three 
consecutive studies make it seem unlikely that this resulted in significant bias. It is 
unclear if disease duration, which in PAF was longer than in MSA, is a factor. As elsewhere 
in this thesis a major difficulty inherent in eliminating this problem is the relatively long 
period of time before PAF subjects are diagnosed after the onset of their symptoms. As the 
mean life expectancy in MSA is under 10 years, it is therefore almost inevitable that a random 
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PAF sample will have had longer disease duration where patients can live for decades post-
diagnosis.  
 
Whether BP overshoot reflects differences in sites of lesions, partial lesions in MSA, degree 
of pressor supersensitivity, changes in associated vascular hormones or other factors is 
unclear. It is possible that MSA subjects may partially compensate for a relative lack of AVP 
by enhanced sensitivity to the pressor actions of NA and Angiotensin II as seen in Diabetes 
Insipidus subjects on upright tilt [Williams et al 1988]. What does seem certain however is 
that these findings have potential clinical relevance. Increased hypertensive load, as 
experienced during BP overshoot, is likely to have deleterious effects. As already mentioned 
PAF subjects may survive for decades and so the accumulative effect of BP overshoot 
(presumably happening at least several times a day with normal positional change) is of 
concern. It is known that MSA or PAF patients who have supine hypertension, like patients 
with essential hypertension, have been reported to develop ventricular hypertrophy 
[Vagaonescu et al 2000]. Long term damage in different vascular territories (such as renal and 
retinal) should be considered. More acute deleterious effects of sudden SBP increase are 
known from general medicine such as intracerebral haemorrhage. These studies reinforce the 
need for head-up tilt while resting and sleeping, for long-term preventative as well as short-
term therapeutic reasons. It has been customary to advise patients with PAF (as with MSA) to 
assume the upright posture only gradually to reduce the risks of symptomatic hypotension. 
The results of the studies outlined in this study suggest that similar care should be exercised in 
returning to the supine position, at least in PAF. In conclusion, we report BP overshoot after 
tilt in PAF but not MSA. The underlying mechanisms need to be evaluated further and their 
clinical relevance considered when treating orthostatic hypotension. 
 
 
With gratefully acknowledgment to the Sarah Matheson Trust for their support with this 
study. 
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3.6:  Vasomotor Responses to Sympatho-excitatory stimuli in MSA  
and PAF  
 
Abstract 
 
Background & Aim: A variety of stimuli such as deep inspiration, isometric exercise and 
mental arithmetic, result in a transient vasoconstriction, mediated by sympathetic efferent 
nerves, in the skin of the fingers and toes of healthy controls [Skin Vasomotor Reflex: SkVR]. 
Multiple system atrophy (MSA) and pure autonomic failure (PAF) provide contrasting 
models of autonomic failure. In MSA the lesion is central and preganglionic, whilst in PAF 
the lesion site is peripheral and postganglionic. We evaluated the SkVR in response to various 
stimuli in MSA and PAF, to determine differences in skin vasomotor involvement between 
these two patient groups. 
Methods: A total of 25 subjects (10 MSA, 7 PAF, 8 healthy controls) were studied. Baseline 
recordings of skin blood flow were obtained with a laser Doppler probe on the left index 
finger pulp and forearm. The subject then underwent a variety of stimuli with rest periods in 
between to re-establish baseline skin blood flow (SkBF). These stimuli were: single deep 
inspiration (inspiratory gasp); mental arithmetic; bilateral leg elevation and cutaneous cold. 
Results:  Healthy control subjects demonstrated marked SkVRs on the finger pulp to each of 
the stimuli of a magnitude similar to those seen in previous studies, but no SkVRs on the 
forearm. In MSA SkVRs to inspiratory gasp on the finger pulp were reduced relative to 
controls. In PAF SkVRs were reduced relative to controls or MSA. The magnitude of SkVR 
response to gasp and cutaneous cold in PAF was significantly less than in healthy controls. In 
addition, the magnitude of the response in PAF was significantly less than MSA for 
inspiratory gasp. 
Conclusions:  PAF showed a decreased SkVR response to all 4 stimuli, the response being 
significantly less than controls (for inspiratory gasp and cutaneous cold) or MSA (inspiratory 
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gasp).  The decreased responses in PAF may reflect the extensive postganglionic sympathetic 
denervation seen in this group.  
 
 
Introduction 
 
 
In healthy control subjects, a variety of stimuli elicit a rapid and transient increase in the 
cutaneous vasoconstriction of the finger tip pulps [Bolton et al 1936; Low et al 1983, Saad et 
al 2001, Asahina et al 2003]. These skin vasomotor reflex (SkVR) responses are mediated via 
vasoconstrictor sympathetic efferent fibres, which richly innervate the small blood vessels of 
the finger pulp with [Johnson et al 1995]. This reduction in skin blood flow (SkBF) can be 
measured non-invasively by use of Laser Doppler flowmetry [Low et al 1983; Asahina et al 
2003].  
 
Multiple system atrophy (MSA) and pure autonomic failure (PAF) provide contrasting 
models of chronic autonomic failure. In MSA the lesion site is central and preganglionic, 
whilst in PAF it is peripheral and postganglionic [Daniel 2002; Matthews 2002]. It recently 
has been reported that SkVR responses to a number of stimuli are relatively preserved in 
MSA [Asahina et al 2003]. There is extensive postganglionic denervation in PAF; however 
the SkVR response has not previously been studied in this group. We hypothesised that the 
SkVR response would be impaired in PAF, but partially preserved in MSA. We therefore set 
out to assess the SkVR response in MSA and PAF subjects and to determine if there was a 
difference in the SkVR response between these two disorders. 
 
 
Subjects  
 
 
We studied a total of 17 subjects with chronic autonomic failure: 10 MSA (6 females and 4 
males, mean age 58 ± 7 years) and 7 PAF (4 females and 3 males, 69 ± 6 years) patients and 8 
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healthy control subjects (3 female and 5 males, 54 ± 11years) (Table 3.6.1).  MSA and PAF 
patients had the diagnosis made using existing criteria [Gilman et al 1999, Mathias 2004]. All 
MSA and PAF patients had documented sympathetic and parasympathetic dysfunction with 
severe orthostatic hypotension. The mean disease duration was 5.5 ± 3 years in the MSA 
patients and 14.4 ± 6.5 years in the PAF patients. Supine BP was higher in PAF (175 ± 30 / 
92 ± 9) than MSA (152 ± 25 / 87 ± 15), but this difference did not reach statistical 
significance (Table 3.6.1). No subjects were on anti-parkinsonian medication. Vasoactive 
medication was withdrawn from the night prior to the study. All patients gave informed 
consent to participate in the study, which had ethical approval from the National Hospital for 
Neurology & Neurosurgery and St. Mary’s Hospital London. Studies were performed in 
accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. 
 
 
Methods 
 
 
All studies were performed in a dedicated, temperature controlled (24+/-10C), autonomic 
laboratory. Skin blood flow was measured by laser Doppler flowmetry [Periflux 5000/5010, 
Perimed, UK]. This method utilises fibreoptics to shine a laser light (780 nm wavelength) 
directly at the skin surface. The light is reflected back to the recording element of the probe 
from red blood cells in the skin capillaries. The wavelength of the reflected light is altered by 
the Doppler shift effect caused by the movement of the red blood cells relative to the probe. 
This altered wavelength is then used to calculate an arbitrary perfusion rate (“Perfusion 
units”; PU), rather than absolute flow, which is then visualised as a real-time trace.  
Cutaneous vasoconstriction will thus be shown as a reduction in perfusion units relative to 
baseline perfusion.  
 
With the subject supine, a small straight Laser Doppler probe was attached to the left index 
finger tip (pulp) and to the ventral forearm using double-sided adhesive tape, ensuring that the 
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probe was not placed under pressure. The forearm probe was used as a control to exclude 
movement or temperature artefact as forearm skin blood flow is under thermoregulatory 
rather than the “emotional” sympathetic regulation present in the finger tip skin [Johnson et al 
1995; Saad et al  2001]. The resulting SkBF signal data were stored for later analysis using 
PeriSoft for Windows software [Perimed, UK].  The subject remained supine throughout the 
study. Ambient noise was kept to a minimum for the duration of testing. After a 20-minute 
period to allow for a stable basal recording of SkBF the application of sympathetic activating 
procedures commenced:  
 
1) Inspiratory gasp (IG): The subject was asked to take the deepest breath they could, hold it 
in inspiration and then breathe out. 
2) Mental arithmetic (MA): The subject was required to give verbal answers to mathematical 
sums (Continually subtracting 7 from 100) for 15 seconds.  
3) Bilateral leg elevation (BLE): The subject raised both legs 200 off the couch for 10 seconds.  
4) Cutaneous cold (CC): An ice pack (-40C) was applied to the dorsum of the right hand for 
90 seconds.  
 
After each stimulus, SkBF was allowed to return to stable baseline levels before commencing 
the next stimulus. Each study was performed twice, allowing calculation of a mean SkVR 
reduction rate for each stimulus. The SkVR reduction rate was calculated as the reduction of 
SkBF seen after each stimulus as a percent of the baseline value. Comparison between groups 
was performed with ANOVA. Significances of individual differences were evaluated by the 
Scheffé test if ANOVA was significant.  
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Results 
 
 
Means of basal SkBF in the finger tip were 160 ± 115 PU in the MSA patients, 176±93 PU in 
the PAF patients, and 188±97 PU in the controls (Table 3.6.1), and there were no significant 
differences in three groups. Each procedure elicited distinct SkVRs on the finger pulp in 
every control subjects, as shown with the example of inspiratory gasp stimulus shown in 
Figure 3.6.1.  Figure 3.6.2 shows results of SkVR reduction rates. The SkVR reduction rate 
for IG was significantly less in either MSA (51 ± 16 %, p<0.05) or PAF (30 ± 7 %, p<0.0001) 
than the controls (69 ± 15 %), and significantly less in the PAF patients than in the MSA 
patients (p<0.05). The SkVR reduction rate for CC was significantly less in the PAF patients 
(28 ± 27 %) than the controls (63 ± 24 %) (p<0.05). Although the SkVR reduction rate for CC 
was less in the MSA patients compared with the controls, there was no significant difference. 
The SkVR reduction rate for MA or BLE was less in the PAF patients (27 ± 10 % and 37 ± 
20 %) than the controls (45 ± 30 % and 62 ± 31 %) or MSA patients (39 ± 12 % and 57 ± 
14 %), but this difference did not reach statistical significance. There were no significant 
differences in the SkVR reduction rate for MA or BLE between the MSA patients and 
controls. The SkVR reduction rate for IG was almost uniform in the controls (small SD). 
However, the SkVR reduction rates for other procedures were somewhat varied in the 
controls (large SD). 
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Figure 3.6.1: Skin Blood Flow in the finger tip (upper panel) and ventral forearm (lower 
panel) following inspiratory gasp (arrowed) in a healthy control subject. 
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Figure 3.6.2: Mean reduction rates (+ SD) in Skin Blood Flow (SKBF) in the finger tip 
after inspiratory gasp (IG), Mental Arithmetic (MA), bilateral leg elevation (BLE), and 
Cutaneous Cold (CC) in 10 MSA patients and 7 PAF patients and 8 healthy controls.  
 
 
Means of basal SkBF as recorded from the forearm probe were 19±25 PU in MSA, 22±14 PU 
in PAF, and 16±5 PU in controls (Table 3.6.1), and there were no significant differences in 
three groups. SkBF in the forearm, unlike the finger tip, did not show any significant changes 
during sympathetic activation procedures in any group (Figure 3.6.1).  
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Discussion 
 
 
In control subjects, the reduction in SkBF on the finger pulp following various vasomotor 
stimuli was similar in magnitude to previous reports [Low et al 1983, Khan et al 1991, 
Asahina et al 2003]. The lack of SkVR response in any group from the skin of the forearm is 
consistent with previous studies [Saad et al  2001]; unlike the finger pulp skin, the forearm 
vasomotor function is more strongly influenced by thermoregulatory factors than by stimuli 
such as IG and MA.  
 
The SkVRs to all procedures were severely attenuated in PAF, and to a lesser extent in MSA. 
However, the most significant differential between groups occurred with the SkVR to IG. In 
the controls, SkVR showed the greatest response to IG (Mean reduction rate of 69%). The 
response of controls to MA was the least marked (45%). IG may therefore be the best 
procedure to evoke SkVR. 
 
 
Although BLE has previously been demonstrated as a means to elicit SkVR in MSA, mild 
motor impairment in our MSA subjects (although none required anti-parkinsonian treatment), 
may have contributed to the greater variability of response seen with this test [Asahina et al 
2003].  A relationship between laser Doppler recordings of SkVR responses and direct 
intraneural recordings of skin sympathetic activity has been reported [Lundin et al 1990]. 
SkVR responses require intact peripheral sympathetic nerves as shown by studies in 
surgically sympathectomised subjects and temporary nerve blocks [Bolton et al 1936; Netten 
et al 1995; Rex et al 1998 Lehtipalo et al 2000]. In PAF, the lesion site affects the peripheral, 
postganglionic autonomic nerves, which is the final common pathway involved in all SkVRs 
[Matthews 2002]. Attenuated SkVR in patients with amyloidosis and peripheral autonomic 
neuropathy has been reported, but SkVRs in PAF had not previously been studied [Ando et al 
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1992]. Our findings of severely diminished SkVR in PAF may reflect involvement of 
postganglionic sympathetic neurons in this group.  
 
In MSA the postganglionic nerves appear to be spared both morphologically and functionally, 
while the central nervous system is involved [Matthews 2002, Dotson et al 1990]. Depletion 
of sympathetic pre-ganglionic neuron in the intermediolateral cell column (IML) is thought to 
be a major factor involved in sympathetic failure in MSA [Bannister & Oppenheimer 1972]. 
However, IML involvement does not correlate well with the degree of autonomic failure seen 
in MSA [Gray et al 1988]. This suggests that other lesion sites, besides the IML, contribute to 
autonomic failure in MSA. Particularly, depletion of catecholaminergic neurons in the rostral 
ventrolateral medulla (rVLM) may contribute to sympathetic vasomotor failure, such as 
orthostatic hypotension, in MSA [Benarroch et al.1998]. The rVLM, which in turn projects to 
the intermediolateral cell columns, is thought to be involved in control of sympathetic 
cardiovascular outflow [Guyenet 1989; Saper 1998]. However, rVLM may not participate in 
control of skin blood flow [Blessing et al.1999]. Although the central pathway of SkVR 
generation is still unclear, our findings suggest that the reflex arc of SkVR is comparatively 
preserved in MSA.  
 
SkVRs are highly localised to the palm or sole areas, and we recorded no SkVR from the 
forearm laser Doppler probe in any subject [Saad et al  2001]. Furthermore, skin vasomotor 
function on the palm or sole is independent of systemic blood pressure, [Lehtipalo et al 2000]. 
Therefore, systemic blood pressure was not measured in this study, or in several previous 
studies, although procedures, such as mental stress (MA), isometric exercise (BLE) and cold 
stimuli (CC), affect systemic blood pressure [Ando et al 1992, Asahina et al 2003].  
 
Mean age in PAF (69 ± 6 years) was significantly greater than in controls (54 +/- 11 years: p= 
0.007) or MSA (58 ± 7 years: p= 0.004). Whilst a previous study has suggested that SkVR to 
gasp and cutaneous cold is impaired in elderly compared to young healthy control subjects, 
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the age difference was far greater than in our study (young healthy control age 26 ± 5 years; 
older healthy controls 68 ± 4 years) [Khan et al 1992]. In addition, the mean SkVR in the 
older healthy controls to gasp (51%) and cutaneous cold (58%) was greater than we found in 
the PAF patients of a similar age (30% and 28% respectively). Difference in age therefore 
does not seem sufficient to explain the reduced SkVRs found in our study.  
 
Disease duration differed between MSA (mean duration 5.5 +/- 3 years) and PAF (14.4 +/- 
6.5 years). This difference may have affected our results as greater disease duration might be 
expected to result in a greater reduction in SkVR. However, several important points need to 
be made in this regard. Firstly the natural history of disease progression is different in MSA 
and PAF. In MSA mean survival time after diagnosis is 9 years and as such our subjects had 
relatively advanced disease state with severe autonomic dysfunction recorded on standard 
autonomic function tests. By contrast in PAF autonomic dysfunction is severe at initial 
diagnosis with little, if any progression from that time on. A major advantage of studying 
PAF subjects with long disease duration is that the diagnosis may then be considered secure. 
It is this point that also explains the need for improved differential testing of these conditions. 
As with existing tests used to define autonomic dysfunction, we did find variability of 
response of SkVR between subjects within each individual group. However, variability was 
not marked in respect to the SkVR to inspiratory gasp, resulting in significant differences 
between the groups. We have thus been able to demonstrate proof of concept in this study. 
Prospective studies of SkVR in chronic autonomic failure patients from the time of diagnosis 
would be required to explore possible clinical value in the differential diagnosis of MSA and 
PAF.  
 
In conclusion, the effects of vasomotor stimulation on skin blood flow in PAF have not 
previously been reported. We have found that SkVRs are impaired to a greater extent in PAF 
than in MSA. This may reflect the underlying pre- and post-ganglionic lesions in these 
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conditions. The measurement of changes in relative blood flow provides a non-invasive 
method which may help to distinguish MSA and PAF. 
 
 We gratefully acknowledge the support of the Sarah Matheson Trust for this study 
 
 
References: 
 
Ando Y, Araki S, Shimoda O, Kano T. Role of autonomic nerve functions in patients with 
familial amyloidotic polyneuropathy as analyzed by laser Doppler flowmetry, capsule 
hydrograph, and cardiographic R-R interval. Muscle Nerve 1992;15:507-512. 
 
Asahina M, Kikkawa Y, Suzuki A, Hattori T.  Cutaneous sympathetic function in patients 
with multiple system atrophy. Clin Auton Res 2002;13:91-95. 
 
Bannister R, Oppenheimer DR. Degenerative diseases of the nervous system associated with 
autonomic failure. Brain 1972;95:457-474. 
 
Benarroch EE. Smithson IL. Low PA. Parisi JE. Investigator: Low PA. Depletion of 
catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy 
with autonomic failure. Ann Neurol 1998;43:156-63. 
 
Blessing WW, Yu YH. Nalivaiko E. Raphe pallidus and parapyramidal neurons regulate ear 
pinna vascular conductance in the rabbit. Neurosci Lett 1999;270:33-36. 
 
Bolton B, Carmichael EA, Stürup G. Vaso-constriction following deep inspiration. J Physiol 
1936;86:83-94. 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      253                                            
 
Daniel SE. The neuropathology and neurochemistry of MSA. In Mathias CJ and Bannister R 
(eds) Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous 
System, Fourth Edition  2002 4th edition Oxford University Press, part IV Chapter 33. 
 
Dotson R, Ochoa J, Marchettini P, Cline M. Sympathetic neural outflow directly recorded in 
patients with primary autonomic failure: clinical observations, microneurography, and 
histopathology. Neurology 1990;40:1079-1085. 
 
Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, 
Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, 
Wenning GK Consensus statement on the diagnosis of multiple system atrophy. J. Neurol Sci 
1999:163:94-98 
 
Guyenet PG. Haselton JR. Sun MK. Sympathoexcitatory neurons of the rostroventrolateral 
medulla and the origin of the sympathetic vasomotor tone. Prog Brain Res 1989;81:105-116. 
 
Gray F, Vincent D, Hauw JJ. Quantitative study of lateral horn cells in 15 cases of multiple 
system atrophy. Acta Neuropath (Berl) 1988;75:513-518. 
 
Johnson JM, Pérgola PE, Liao FK, Kellogg DL, Jr, Crandall CG. Skin of the dorsal aspect of 
human hands and fingers possess an active vasodilator system. J Appl Physiol 1995;78:948-
954. 
 
Khan F, Spence VA, Wilson SB, Abbot NC. Quantification of sympathetic vascular responses 
in skin by laser Doppler flowmetry. Int J Microcirc Clin Exp 1991; 10:145-153 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      254                                            
Kimber JR, Watson L, Mathias CJ. Distinction of idiopathic Parkinson’s disease from 
multiple system atrophy by stimulation of growth hormone release with clonidine. Lancet 
1997; 349:1877-81 
 
Lehtipalo S, Winsö O, Koskinen L-O D, Johansson G, Biber B. Cutaneous sympathetic 
vasoconstrictor reflexes for the evaluation of interscalene brachial plexus block. Acta 
Anaesthesiol Scand 2000;44:946-952 
 
Low PA,Neumann C, Dyck PJ, Fealey RD, Tuck RG. Evaluation of Skin Vasomotor Reflexes 
by Using Laser Doppler Velocimetry.  Mayo Clin Proc 1983;58:583-592 
 
Lundin S, Kirnö K, Wallin BG, Elam M. Effects of epidural anesthesia on sympathetic 
discharge to the skin. Acta Anaesthesiol Scand 1990;34:492-497 
 
Mathias CJ.  Disorders of the autonomic nervous system.  In Bradley WG, Daroff RB, 
Fenichel GM, Marsden CD (eds) Neurology in Clinical Practice.  4th edition.   Butterworth-
Heinemann, Boston, USA 2004 pp.2131-2165 
 
Matthews MR Autonomic ganglia and preganglionic neurones in autonomic failure. In 
Mathias CJ and Bannister R (eds) Autonomic Failure: A Textbook of Clinical Disorders of 
the Autonomic Nervous System Fourth Edition  2002 4th edition Oxford University Press, part 
IV Chapter 34.  
 
Netten PM, Wollersheim H, Gielen MJM, Den Arend JACJ, Lutterman JA, Thien T. The 
influence of ulnar nerve blockade on skin microvascular flow. Eur J Clin Invest 1995;25:515-
522 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      255                                            
Rex L, Claes G, Drott C, Pegenius G, Elam M. Vasomotor and sudomotor function in the 
hand after thoroscopic transaction of the sympathetic chain: implications for choice of 
therapeutic strategy. Muscle Nerve 1998;21:1486-92 
 
Saad AR, Stephens DP, Bennettt LAT, Charkoudian N, Kosiba WA, Johnson JM. Influence 
of isometric exercise on blood flow and sweating in glabrous and nonglabrous human skin.  J 
Appl Physiol  2001;91:2487-2492 
 
Saper CB. "All fall down": the mechanism of orthostatic hypotension in multiple systems 
atrophy and Parkinson's disease. Ann Neurol 1998;43:149-151 
 
Wenning GK, Tison F, Shlomo YB, Daniel SE, Quinn NP. Multiple system atrophy: a review 
of 203 pathologically proven cases. Mov Disord 1997;12:133-147 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      256                                            
 
3.7: Acute Cardiovascular effects of CO2 Inhalation in MSA and PAF 
 
 
a) Effects on Systemic Haemodynamics 
 
 
 
Abstract 
We recorded the haemodynamic effects of inhaled CO2 in multiple system atrophy (MSA; 
where the lesion site is preganglionic, n=9), in pure autonomic failure (PAF; where it is 
postganglionic, n=9), and in normal subjects (n=5). Our hypothesis was that the pressor 
effects of inhaled CO2 seen in normal subjects are mediated via sympathetic activation, and as 
such the pressor effect would be impaired in chronic autonomic failure, as with MSA and 
PAF. As MSA and PAF provide naturally occurring models of pre-ganglionic and post-
ganglionic autonomic failure respectively, we set out to determine if additional differentiation 
in the degree of pressor response to inhaled CO2 could be made between these two 
contrasting types of autonomic failure.  
 
To determine the mechanisms involved, blood Pressure (BP) and heart rate (HR) were 
measured continuously with a Portapres II Device. A single, maximal, breath of room air was 
taken by each subject via a mouthpiece. This was compared with response to a single 
maximal breath of 35% CO2 in 65% oxygen. After air inhalation there was no significant BP 
change in any group. After CO2, BP increased in each group, with the peak value occurring 
after 32 seconds in controls.  
 
There were no significant haemodynamic effects of air inhalation in any group. With CO2 
inhalation normal subjects demonstrated an initial bradycardia 20 seconds post-inhalation, 
and then marked pressor response with tachycardia in keeping with previous studies. Neither 
MSA nor PAF subjects demonstrated significant changes in HR; however, in both MSA and 
PAF there was a significant pressor response. Compared with normal subjects, the pressor 
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effect was attenuated and occurred later than in controls. However, there was no significant 
difference either in magnitude or latency of the pressor response to inhaled CO2 between 
MSA and PAF. 
 
 
Thus, despite the absence of HR changes, a pressor response to CO2 inhalation was still seen 
in both MSA and PAF, albeit significantly attenuated and delayed. This may reflect either 
incompleteness of sympathetic denervation in these conditions, or alternative effector 
mechanisms for the CO2 pressor response. There were no significant differences between the 
BP changes seen in MSA and PAF, suggesting that both pre-and post-ganglionic autonomic 
mechanisms are important in generating the CO2 pressor response. 
 
 
 
 
Introduction 
 
 
In normal subjects maximal inhalation of a single breath of 35% CO2 in oxygen evokes a 
rapid pressor response, which is thought to result from stimulation of sympathetic outflow 
centrally [Kaye at al 2004]. The initial response is a transient bradycardia (thought to reflect 
direct vagal action of CO2), followed by tachycardia. The acute pressor response that follows 
is centrally mediated and associated with a significant increase in plasma noradrenaline.   We 
studied two physiological lesion models of chronic autonomic failure, multiple system 
atrophy (MSA) where the lesion is predominantly central and preganglionic, and pure 
autonomic failure (PAF) where it is postganglionic [Polinsky 2002]. The effects of air or CO2 
inhalation on systemic haemodynamics have not been determined in these two differing 
physiological models. We measured continuously the systemic haemodynamic responses 
before and after a single breath of CO2. Comparisons were made with inhalation of air.  
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Subjects 
 
 
A total of 23 subjects were studied (5 healthy controls, mean age 47+/- 6.8; 9 MSA, mean age 
57.1+/- 3.1; 9 PAF, mean age 66.4). The diagnosis of MSA and PAF was made using 
established criteria [Gilman et al 1998, Mathias 2004]. All had documented sympathetic and 
parasympathetic cardiovascular autonomic dysfunction (Table 3.7.1). Sequential subjects 
attending outpatients as well as inpatients were approached to ask if they would be happy to 
participate. Normal healthy subjects consisted of Research staff. Written, informed consent 
was obtained from all subjects, the studies conformed to the standards set by the Declaration 
of Helsinki, and the procedures had been approved by the local ethics committees (The 
National Hospital for Neurology and Neurosurgery, London and St Mary’s Hospital London). 
No patient was taking anti-parkinsonian medication and all medications were withdrawn from 
the night before the study. On the morning of the study subjects were fasted. 
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       MSA 
      
      PAF 
      
 
Normal range 
 
Age  
 
 
     57.1 ( 3.1) 
  
     66.4 ( 2.1) 
 
 
Supine SBP     (mmHg) 
 
  162.3 ( 8.6) 
 
   170.6 ( 9.9) 
 
 
 
 
Standing SBP  (mmHg) 
 
    79.9 ( 5.8) 
 
     83.3 ( 5.3) 
 
 
Standing 
 
   -82.4 ( 9.3) 
 
    -65.0 (21.8) 
 
< -20 
 
Hand grip 
 
 
      2.3 ( 2.6) 
 
 
       2.9 ( 3.6) 
 
≥17 
 
 
 
 
 
 
 
Change in SBP 
 
 
 
 
 
Cold Pressor 
 
 
    -3.9 ( 4.7) 
 
 
 
       2.6 ( 2.1) 
 
 
≥15 
 
 
 
Supine DBP     (mmHg) 
 
    93.3 ( 4.8) 
 
      94.7 ( 4.4) 
 
 
 
Standing DBP  (mmHg) 
 
    54.1 ( 3.5) 
 
      53.3 ( 3.9) 
 
 
Standing 
 
   -39.4 ( 6.3)   
                             
 
     -30.9 ( 8.8) 
   
 
<-10 
 
Hand grip 
 
 
    -0.3 ( 2.1) 
 
        1.7 ( 2.2) 
 
≥11 
 
 
 
 
 
 
 
Change in DBP 
 
Cold Pressor 
 
 
   -3.7 ( 4.3) 
 
 
        -0.2 ( 2.1) 
 
 
 
≥10 
 
 
 
DHR on Deep Breathing (beats per min) 
 
     6.3 ( 1.1) 
 
         3.2 ( 1.3) 
 
>9 
 
Table 3.7.1: Autonomic screening tests in 9 MSA and 9 PAF subjects: mean results 
shown +/- (SE)  
 
 
 
 
Methods 
 
 
All tests were conducted between 1000 and 1500 hours in a temperature (24 +/- 10C) 
controlled laboratory.  Upon arrival at the testing unit, a 20G (Venflon) intravenous line was 
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inserted into a subject’s right antecubital fossa and kept patent with 0.9% saline. A Portapres 
II device was applied to the middle finger of the right hand to provide continuous systolic and 
diastolic blood pressure (SBP and DBP) and heart rate (HR) readings. Subsequent calculation 
of cardiac output (CO), total peripheral resistance (TPR) and stroke volume (SV) was 
performed using Modelflow analysis [Wesseling et al 1995; Langewouters et al 1998]. These 
haemodynamic indices were calculated at 4 time points: 
 
i) Baseline 
ii) At time of peak BP change after air inhalation 
iii) Baseline 
iv) At time of peak BP change after CO2 inhalation 
 
The subjects remained seated throughout the study. After 30 minutes of quiet rest 
physiological monitoring and blood sampling commenced. A 10L silicone ‘Douglas’ bag  
(Hans-Rudolph, Kansas City, Missouri, USA) was filled with the gas mixture (35% CO2 and 
65% O2;  BOC Gases, Guildford, Surrey, UK). Inspired vital capacity (VC) was determined 
using an analogue flow meter (Ohmeda, USA) that was attached via a 3-way valve to a 3cm 
diameter silicone mouth-piece (Hans-Rudolf, Germany) at one end and the 10L silicone bag 
containing the CO2 at the other end. The subject took a single VC breath of room air through 
the mouthpiece whilst occluding their nose with a nose-clip.  Baseline inspired VC with a 
single breath of air was measured and a test breath of room air was considered adequate if it 
was more than 80% of this baseline breath [Kaye et al 2004].  Once the cardiovascular indices 
had returned to baseline, a single VC breath of CO2 was taken in an identical manner to that 
for room air. Venous blood sampling for catecholamines was performed at baseline and at 2, 
10 and 20 minutes after CO2 inhalation. Plasma levels of Noradrenaline (NA), Adrenaline 
(Ad) and Dopamine (DA) were measured at baseline and at 2, 10 and 20 minutes post- CO2. 
Electrochemical detection for NA, Ad and DA concentration was performed using high-
performance liquid chromatography [Smedes et al 1982; May et al 1988; Mathias et al 1990]. 
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The ethics committees of the National Hospital for Neurology and Neurosurgery, and St 
Mary’s Hospital approved the study and each subject provided written informed consent prior 
to participation. 
 
Statistics: Data are presented as mean +/- SEM.  Within-group differences were compared 
with paired two-tailed t-tests. One-way analysis of variance was used to determine between-
group differences with two-tailed t-tests used to compare single time-point data including 
baseline differences.  Cardiovascular responses for a particular time point were calculated as 
the mean of +/-3 beats from that point.  A p value of <0.05 was considered significant.  
 
 
 
 
 
 
 
Results 
 
 
Systemic haemodynamics and cardiac function 
 
Blood pressure, heart rate, stroke volume, cardiac output, and total peripheral resistance are 
described at baseline and following inhalation of either air or CO2.  
 
Baseline: 
There were no significant differences in baseline SBP (122.5 +/- 12.3 mmHg in controls; 
132.7 +/- 8.7 in MSA; 128.8 +/- 13.6 in PAF) or DBP (66.9 +/- 3.8 mmHg in controls; 76.1 
+/- 7.2 in MSA; 75.7 +/- 4.3 in PAF). Baseline HR was higher in MSA than in controls (77+/-
4.1 bpm and 60.9+/-3.9 bpm respectively, p=0.02); baseline HR in PAF was 66.8 +/- 2.6 bpm. 
In controls SV (82.6 +/- 6.1 ml), was not significantly different from MSA (65.9 +/- 0.9 ml) 
but was significantly higher than in PAF (43.5 +/- 7.6 ml). CO was similar in controls (4.9 +/- 
0.9 l/min) and MSA (4.7 +/- 0.6 l/min), but was significantly lower in PAF (2.8 +/- 0.4 l/min). 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      262                                            
TPR was similar in controls (1.3 +/- 0.2 MU) and MSA (1.5 +/- 0.3 MU), but was 
significantly higher in PAF (2.2 +/- 0.2 MU; p<0.05).  
 
Post-air inhalation: 
There were no significant changes in SBP, DBP, HR, TPR or CO in any group. 
 
Post- CO2 inhalation: 
In controls there was an increase in SBP (+60.2+/-13.9mmHg; +50.3+/-11.8% of baseline) 
and DBP (21.8+/-5.0mmHg; 32.3+/-7.4% of baseline), p=0.04, 0.04 respectively, with the 
peak increase at 32.4+/-2.1 seconds post inhalation. Despite a transient bradycardia within 20 
seconds of CO2, HR, CO and SV were not significantly altered at the time of the peak pressor 
effect. TPR was increased at the time of peak pressor effect although this just failed to reach 
significance (p=0.08). 
 
In MSA there were increases in SBP (18.3+/-2.7 mmHg; 15.1+/-2.5% of baseline) and DBP 
(10.5+/-2.7 mmHg; 18.7+/-2.9%) p=0.008 and 0.0015 respectively. However, pressor 
response peaked later (at 140.2 +/-35.5 seconds post-inhalation) and to a smaller extent than 
in controls (p<0.01). There was no change in HR, CO or SV. TPR increased at the time of 
peak pressor response, but did not reach significance (p=0.066). 
 
In PAF there was an increase in SBP (26.8+/-3.2mmHg; 23.2+/-3.9%) and DBP (13.7 +/-2.0 
mmHg; 14.7+/-3.1%), p=0.008. This pressor effect also occurred later (152.4+/-23.9 seconds) 
and to a lesser extent than in controls (p<0.01). In PAF, TPR was increased relative to 
baseline at the time of peak pressor response (p=0.008) but there was no significant change in 
CO, HR or SV.  
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Plasma Noradrenaline: 
 
Baseline: 
Baseline plasma NA levels were significantly lower in PAF (126.8+/-19.8pg/ml) than in 
controls (288.4+/-31.3pg/ml) or MSA (246.9+/-13.1pg/ml) (p<0.001)  
 
Post- CO2 inhalation: 
In controls there was a significant increase in NA levels (p<0.05), first reaching significance 2 
minutes post-inhalation (Figure 3.7.1). NA levels following CO2 inhalation did not increase in 
either MSA or PAF. 
 
 
Plasma Adrenaline: 
 
Baseline:   
Baseline Ad levels were significantly higher in controls (44.2 +/- SE 5.9 pg/ml) than in MSA 
(20.8 +/-SE 3.6 pg/ml): p<0.05. In PAF,  Ad levels were undetectable at baseline. 
 
Post- CO2 inhalation:   
In controls there was a significant increase in Ad levels (p<0.05), peaking at 90.4 +/- SE 14.0 
at 10 minutes post-inhalation. Plasma levels of Ad following CO2 inhalation did not increase 
in either MSA or PAF. 
 
 
Plasma Dopamine: 
In 2/5 controls, 5/9 MSA and 9/9 PAF, DA levels were undetectable at baseline. There was no 
significant change in any group Post- CO2 inhalation. 
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 Normal Subject PAF MSA P value compared 
with Normal (N) 
Noradrenaline 
(pg/ml) 
    
∆max 124.2+/-19.5 5.2+/-2.8 20.0+/-6.4 <0.001 (NvPAF) 
%∆max 41.7+/-7.1 4.2+/-2.2 8.0+/-2.4 <0.001 (NvMSA) 
 
    
SBP (mmHg)     
∆max 60.2+/-13.9 26.8+/-3.2 18.3+/-2.7 <0.01 (NvPAF) 
%∆max 50.3+/-11.8 23.2+/-3.9 15.1+/-2.5 <0.001 (NvMSA) 
DBP (mmHg)     
∆max 21.8+/-5.0 13.7+/-2.0 10.5+/-2.7 - 
%∆max 32.3+/-7.4 14.7+/-3.1 18.7+/-2.9  
HR (b/min)     
∆max -9.1+/-3.5 -4.3+/-2.3 -4.1+/-2.1 - 
%∆max -16.1+/-6.9 -7.1+/-3.7 -6.4+/-3.2  
CO (L/min)     
∆max -0.6+/-0.5 -0.1+/-0.1 -0.1+/-0.1 - 
%∆max -6.2+/-9.5 -4.5+/-3.7 -3.3+/-4.0  
    SV (ml)     
∆max 19.5+/-34.3 -1.7+/-1.4 0.6+/-2.4 - 
%∆max 18.4+/-14.5 -0.5+/-5.7 2.0+/-4.8  
   TPR (PRU)     
∆max 1.7+/-0.2 2.8+/-0.3 1.8+/-0.4 0.03 (NvPAF) 
%∆max 14.3+/-9.0 24.6+/-5.5 17.8+/-7.5  
 
Table 3.7.2: Comparison of Seated Noradrenaline and Potapres Cardiovascular indices 
between groups (only significant values displayed) 
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Figure 3.7:1 Changes in NA levels following inha
MSA and PAF.  *=p<0.05 relative to baseline lev
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Discussion 
 
 
 
We observed that the acute inhalation of air in controls, MSA and PAF, resulted in no 
significant changes in BP. However, following inhalation of 35% CO2, there was a pressor 
response in all groups, with the magnitude and speed of onset being greater in controls than in 
PAF and MSA. The inhalation of air did not result in significant changes in systemic 
haemodynamics in any of the groups. This was different from the effects observed following 
CO2 inhalation. In controls there was a pressor response, peaking at 32.4 seconds post-
inhalation. Although there was also a pressor response following CO2 in MSA and PAF, this 
was significantly smaller in magnitude and occurred later than in controls. There was no 
difference between these responses in MSA and PAF. In all 3 groups there was an increase in 
TPR at the same time as the pressor effect. The reduced pressor response in both MSA and 
PAF is likely to reflect underlying sympathetic denervation and impaired vasoconstriction. 
However, neither the magnitude nor latency of response in MSA and PAF differentiated 
between these pre- and postganglionic models of chronic autonomic failure.  
 
 
In controls, plasma NA levels were within the normal range and significantly increased 2-
minutes post-CO2 inhalation. This is likely to reflect an increase in sympathetic nerve activity 
following CO2. In MSA, baseline plasma NA levels were not significantly different to 
controls, in keeping with previous observations [Mathias et al 1990] and did not increase 
following CO2. In PAF, baseline plasma NA levels were lower than in controls and MSA, 
again consistent with the known postganglionic lesion site in PAF [Polinsky 2002], and did 
not change following CO2. These results provide additional evidence for the inability of CO2 
to increase sympathetic activity in MSA and PAF. The plasma NA response to CO2 did not 
differentiate MSA and PAF, suggesting that both pre- and postganglionic pathways are 
required to elicit an increase in NA following CO2 inhalation.  
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Limitations 
 
The mean ages of our subjects differed, being 47 +/- 6.8 years in controls, 57.1 +/- 3.1 years 
in MSA, and 66.4 +/- 2.1 years in PAF. This reflects the age of onset of disease in these 
disorders, and the shortened life expectancy in MSA. However, there was no significant 
difference between the responses seen in MSA or PAF, and thus if one speculated that age 
was important in the pressor response to CO2 inhalation, one would have to argue that a 
significant decrease was seen between a mean age of 47 and 57.1, yet no difference in 
response between 57.1 and 66.4 (with a non-significant increase in pressor response between 
these 2 age groups). This seems biologically implausible. 
 
Although the Modelflow provides a non-invasive method of obtaining CO estimation, aspects 
of its precision have been previously investigated. The principle of haemodynamic 
measurement with the Portapres 2 is based on the volume-clamp method, first described by 
Jan Penaz in 1973 and the Physiocal system of [Wesseling 1995]. The volume clamp method 
involves maintaining (clamping) the finger artery diameter, despite changing arterial BP, by 
means of a finger cuff with inflatable air bladder. Because the pulse contour depends mainly 
on the stroke volume (SV) of the left ventricle, SV estimates may be made via a mathematical 
model that makes assumptions of arterial distensibility. This mathematical model is the basis 
of Modelflow analysis, incorporated in the Portapres software, which also requires details of 
the subject’s age, sex, height and weight as these can influence arterial distensibility [Kelly et 
al 1989]. Subsequent calculation CO is then performed as part of the Modelflow software. 
 
Earlier validation studies have suggested that Modelflow does provide reliable values for 
cardiac indices such as SV, which have been validated in a variety of settings [Harms et al 
1999, Jellema, Imholz et al.1999 Langewouters et al.1998]. However, the reliability of the 
absolute values of CO have been questioned [Jellema et al 1999, Pitt et al 2004], with a view 
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      268                                            
that relative change of CO values in groups rather than individuals could still provide reliable 
data. In our study we found possible evidence of the limitation of CO reading by Modelflow 
in our normal controls in whom CO2 inhalation significantly raised BP but TPR was 
increased with a p value of 0.08. As there was a slight reduction in CO as estimated by 
Modelflow at the time of blood pressure peak, it could be suggested that the values of CO 
were inaccurate. However, in relatively small groups such as studied here, a more likely 
explanation is that the large variability in TPR response was more likely to have resulted in a 
less impressive p value than that seen for BP increase. An increase in TPR alone, with CO 
remaining constant or even falling slightly would still of course be entirely compatible with 
an increase in BP. It should be remembered, as pointed out by Pitt et al. [Pitt et al 2004], that 
even the supposed gold standard of CO measurement, namely thermodilution, has inherent 
errors of up to +/- 15% [Guyton et al 1973]. We therefore feel justified in using the 
considerably less invasive Portapres/Modelflow methods in investigating the changes of 
cardiac indices in this study whilst acknowledging the potentially reduced accuracy of CO 
values thus obtained.  
 
Conclusion 
 
Our results indicate that there was a pressor response following CO2 in MSA and PAF; 
however this was significantly smaller in magnitude and occurred later than in controls. There 
was no difference in the pressor responses seen in MSA or PAF. NA levels at baseline were 
similar to those previously reported in healthy subjects, MSA and PAF. Following CO2 NA 
rose within 2 minutes in controls but showed no change in either MSA or PAF. The lack of 
HR or NA change following CO2 is consistent with the suggested importance of autonomic 
nervous system activation in the haemodynamic response to CO2, and the known lesions in 
these two conditions. However, a pressor response still occurred, albeit of diminished 
magnitude and of greater latency to onset than that seen in normal subjects. These may reflect 
incomplete denervation in MSA and PAF, or alternative mechanisms by which CO2 might 
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result in an increase in BP. There was no significant difference between MSA and PAF in 
terms of the pressor response. This may well reflect the importance of both pre-and post-
ganglionic components of the autonomic nervous system in mounting the pressor response as 
seen in normal subjects.  
 
 
We gratefully acknowledge the Sarah Matheson Trust for supporting this study.  
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3.8: Acute Cardiovascular effects of CO2 Inhalation in MSA and PAF 
 
b) Effects on Regional Skin Blood Flow 
 
 
 
Abstract 
 
We recorded the haemodynamic effects of inhaled CO2 on the cutaneous vascular bed in 
multiple system atrophy (MSA; where the lesion site is preganglionic, n=9), in pure 
autonomic failure (PAF; where it is postganglionic, n=9), and in normal subjects (n=5). 
Inhalation of a single breath of CO2 (35% CO2 in 65% oxygen) evokes a rapid, transient 
increase in blood pressure (BP). In addition, it is known that the action of a deep voluntary 
gasp evokes a reduction in skin blood flow (SkBF) of the finger pulps in healthy subjects, an 
effect possibly related to activation of a reflex sympathetic vasoconstrictor pathway. To 
determine the mechanisms involved, acute inhalation of air or CO2 was compared between 
normal subjects and two naturally occurring models of chronic autonomic failure, MSA and 
PAF. Blood Pressure (BP) and heart rate were measured continuously with a Portapres II 
Device, and SkBF measured with a Laser Doppler probe.  
 
We hypothesised that acute air inhalation would produce less cutaneous vasoconstriction in 
chronic autonomic failure because of dysfunction of the sympathetic nervous system in these 
conditions. We furthermore felt it likely that acute inhalation of CO2 would effectively also 
act as a gasp stimulus with resultant cutaneous vasoconstriction. As PAF subjects have 
sympathetic postganglionic denervation with resultant supersensitivity to vasoactive 
compounds, we further hypothesised that inhalation of CO2 would in contrast lead to 
cutaneous vasodilatation as the enhanced direct vasodilatory actions of CO2 would be 
relatively unopposed by vasoconstriction from the gasp response.  
 
In controls, after either air or CO2, there was a rapid reduction in SkBF in keeping with the 
previously described gasp response. In MSA there was a diminished reduction in SkBF after 
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air or CO2. In PAF, after air there was a smaller reduction of SkBF than in either controls or 
MSA. After CO2, in PAF a transient increase in SkBF was observed seconds after inhalation. 
The increase in SkBF in PAF after CO2 was greater than in MSA.   
 
We conclude that these studies suggest that CO2 has both neural and non-neural 
cardiovascular autonomic actions. The former effects are diminished in MSA and PAF; the 
latter probably result in the increased SkBF in PAF. SkBF changes in response to CO2 may 
provide a novel means of differentiating pre- from postganglionic sympathetic denervation. 
 
 
 
 
 
 
 
Introduction 
 
 
In normal subjects maximal inhalation of a single breath of air results in a transient, marked, 
vasoconstriction in the finger pulp for up to 2 minutes, termed a gasp response [Bolton et al 
1936; Asahina et al 2004]. This is felt likely to reflect activation of sympathetic 
vasoconstrictor nerves in a reflex manner. The finger pulp is an area densely innervated by 
sympathetic vasoconstrictor nerves [Johnson et al 1995]. Previous studies have suggested that 
in the cutaneous vascular bed CO2 tends to cause vasodilatation [Nishimura et al 2002; 
Schnizer et al 1985; Ito et al 1989], probably by direct mechanism [Bullard 1964; Ito et al 
1989]. We anticipated that the inhalation of either air or CO2 would result in a similar gasp 
response in normal subjects. In addition we studied two physiological lesion models of 
chronic autonomic failure, multiple system atrophy (MSA) where the lesion is predominantly 
central and preganglionic, and pure autonomic failure (PAF) where it is postganglionic 
[Polinsky 2002]. Our hypothesis was that, in normal subjects, CO2 inhalation would act as a 
gasp stimulus as with air inhalation, also resulting in cutaneous vasoconstriction. In MSA and 
PAF where severe sympathetic dysfunction is present, we anticipated attenuation of the gasp 
response to either stimulus. Finally, in PAF where the postganglionic lesion site results in 
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supersensitivity to vasoactive substances, the direct vasodilatory effects of CO2 would be 
unmasked resulting in cutaneous vasodilatation with inhalation of CO2 as oppose to 
vasoconstriction expected in normal subjects. We measured continuously the systemic 
haemodynamic and regional skin blood flow responses before and after a single breath of 
CO2. Comparisons were made with inhalation of air.  
 
Subjects 
 
 
A total of 23 subjects were studied (5 healthy controls, mean age 47+/- 6.8; 9 MSA, mean age 
57.1+/- 3.1; 9 PAF, mean age 66.4). The diagnosis of MSA and PAF was made using 
established criteria [Gilman et al 1999, Mathias 2004]. All had documented sympathetic and 
parasympathetic cardiovascular autonomic dysfunction (Table 3.7.3) 
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Methods 
 
All tests were conducted between 1000 and 1500 hours in a temperature (24 +/- 10C) 
controlled laboratory.  Upon arrival at the testing unit, a 20G (Venflon) intravenous line was 
inserted into a subject’s right antecubital fossa and kept patent with 0.9% saline. A Portapres 
II device was applied to the middle finger of the right hand to provide continuous systolic and 
diastolic blood pressure (SBP and DBP) and heart rate (HR) readings. Subsequent calculation 
of cardiac output (CO), total peripheral resistance (TPR) and stroke volume (SV) was 
performed using Modelflow analysis [Wesseling et al 1995; Langewouters et al 1998]. These 
haemodynamic indices were calculated at 5 time points: 
 
v) Baseline 
vi) At time of peak SkBF change after air inhalation 
vii) Baseline 
viii) At time of peak SkBF change after CO2 inhalation 
 
A Laser Doppler (Perimed) [Khan et al 1991; Kooner et al 1991] probe was taped over the 
pulp of the left index finger with one additional probe over the left anterior forearm.  
 
Skin blood flow (SkBF) was measured by laser Doppler flowmetry [Perimed Periflux 
5000/5010 solid state diode laser set at 780nm with a 1mW maximal power output at the 
probe tip]. Fibre optics permit the Laser Doppler probe to shine a laser light directly at the 
skin surface. Light is reflected back to the recording element of the probe from red blood cells 
in the skin capillaries. Light reflected back to the probe has its wavelength altered by the 
Doppler shift caused by the movement of the red blood cells relative to the probe. This altered 
wavelength is then used to calculate an arbitrary perfusion rate (“Perfusion units”; PU), rather 
than absolute flow, which is then visualised as a real-time trace.  Cutaneous vasoconstriction 
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will therefore be shown as a reduction in perfusion units relative to baseline perfusion. The 
forearm probe was used as a control to exclude movement or temperature artefact, as forearm 
skin blood flow is under thermoregulatory rather than “emotional” sympathetic regulation, as 
present in the fingertip skin [Johnson et al 1995; Saad et al 2001].  
 
 
The subjects remained seated throughout the study. After 30 minutes of quiet rest 
physiological monitoring and blood sampling commenced. A 10L silicone ‘Douglas’ bag  
(Hans-Rudolph, Kansas City, Missouri, USA) was filled with the gas mixture (35% CO2 and 
65% O2;  BOC Gases, Guildford, Surrey, UK). Inspired vital capacity (VC) was determined 
using an analogue flow meter (Ohmeda, USA) that was attached via a 3-way valve to a 3cm 
diameter silicone mouth-piece (Hans-Rudolf, Germany) at one end and the 10L silicone bag 
containing the CO2 at the other end. The subject took a single VC breath of room air through 
the mouthpiece whilst occluding their nose with a nose-clip.  Baseline inspired VC with a 
single breath of air was measured and a test breath of room air was considered adequate if it 
was more than 80% of this baseline breath [Kaye et al 2004].  Once the SkBF had returned to 
baseline a single VC breath of the CO2 was taken in an identical manner to that for room air. 
Venous blood sampling for catecholamines was performed at baseline and at 2, 10 and 20 
minutes after CO2 inhalation. Plasma levels of Noradrenaline (NA), Adrenaline (Ad) and 
Dopamine (DA) were measured at baseline and at 2, 10 and 20 minutes post- CO2. 
Electrochemical detection for NA, Ad and DA concentration was performed using high-
performance liquid chromatography [Smedes et al 1982; May et al 1988; Mathias et al 1990]. The 
ethics committees of the National Hospital for Neurology and Neurosurgery, and St Mary’s 
Hospital approved the study and each subject provided written informed consent prior to 
participation. 
 
Statistics: From the individual perfusion unit data, the calculation of percentage reduction in 
SkBF following inhalation of air or CO2 was calculated as shown in Figure 3.7.5. This 
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allowed intra- and inter-groups comparisons. Skin Regional Vascular Resistance (SkRVR) 
was calculated from the equation: SkRVR = Mean Arterial BP/ SkBF [Lehtipalo et al 2000]. 
The percentage change in SkRVR before and after inhalation of air or CO2 was then compared 
between groups. Results (both for SkBF baseline and reduction ratios after gasp of air or CO2) 
were compared by ANOVA with Newman-Keuls post-hoc testing. Statistical significance 
taken as p<0.05. All mean data values given +/- SE. 
 
 
 
 
Figure 3.7:2 Calculation of % reduction in Skin Blood Flow (SkBF) following inhalation 
of air or CO2 
 
 
 
 
Results 
 
 
Skin blood flow and vascular resistance:   
 
 
 
Baseline: 
Baseline SkBF in the forearm was similar in all 3 groups, and did not change significantly in 
any group following inhalation of either air or CO2. Baseline finger SkBF was significantly 
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lower in PAF compared to controls (p=0.000006) and MSA (p=0.026) (Table 3.7.3). MSA 
baseline SkBF in the finger was lower than in controls (p=0.002).  
 
Post-air inhalation: 
In controls there was a reduction in finger SkBF beginning within 3.1+/-0.3 seconds of 
inhalation and lasting for 87.6 +/-28.9 seconds. In MSA the reduction in SkBF was less than 
controls (p<0.012). In PAF the reduction in SkBF was smaller than in either controls 
(p<0.0006) or MSA (p<0.04). 
 
Post- CO2 inhalation: 
In controls there was a reduction in finger SkBF (onset: 2.9 +/- 0.4 seconds after CO2; 
duration: 91 seconds +/- 41.3 seconds). (Figures 3.7.6 and 3.7.7). MSA showed a non-
significant reduction in finger SkBF after CO2 (Figure 3.7.7). In MSA the reduction in SkBF 
to either air or CO2 occurred over a similar time course to that seen in controls (for air: onset 
after 2.9 +/-0.3 seconds and duration of 87.6 +/-28.9 seconds). PAF showed no decrease in 
finger SkBF following CO2, but instead exhibited a transient increase in SkBF in a well 
defined peak at 45 seconds (+/- 1.1 seconds) post inhalation (Figures 3.7.6 and 3.7.7). 
Although no increase in SkBF had been noted in controls following CO2, in MSA there was a 
variable response with a small increase in SkBF in 5/9 MSA subjects (+28.5% +/- 12.4), 
which was less than that seen in PAF (p<0.06).  
 
Blood pressure, heart rate, cardiac output, stroke volume and total peripheral resistance 
43-47 seconds post-inhalation of air or CO2:   
 
The time point 43-47 seconds post-inhalation corresponded with the approximate mid-SVR 
response in all 3 groups, as well as encompassing the time period (45 +/- 1.1 seconds) at 
which the peak of fingertip vasodilatation was seen in PAF following CO2. The 
haemodynamics during this time period therefore was assessed in detail both after air and CO2 
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inhalation. Following air inhalation during this period there were no significant changes in 
SBP, DBP, HR, TPR or CO in any group.  
 
In controls following CO2 inhalation, there was a significant increase in SBP, DBP and HR at 
43-47 seconds post-inhalation compared to baseline (∆SBP: 43.7(+/-30.4mmHg); ∆DBP: 
11.3(+/-11.6mmHg); ∆HR: -12.5(+/-18.2bpm)). This was associated with a small increase in 
TPR (1.3 (+/- 0.6) to 1.6 (+/-0.7MU)). CO was reduced, although this did not reach 
significance (4.9 (+/-2.1) to 4.3 (+/-1.4). 
 
In MSA, 43-47 seconds post-inhalation following CO2 inhalation, there was no significant 
increase in SBP (∆SBP: 4.5(+/-25mmHg), DBP (∆DBP: 3.3(+/-9.2mmHg), or HR (∆HR: 
3.2(+/-11.5bpm) (Table 3.7.5). There was no change in TPR or CO. 
 
In PAF, 43-47 seconds post-CO2, there was no change in SBP (∆SBP: -3.3 (+/-11.3mmHg), 
DBP (∆DBP: -2.9(+/-5.7mmHg), or HR (∆HR: 1.7(+/-4.5bpm) (Table 3.7.5). TPR was 
reduced after CO2 (2.3 (+/-0.8) to 1.8 +/-0.5MU) and CO increase did not reach significance. 
 
The change in SkRVR from baseline in controls before and after inhalation of air or CO2 was 
similar, being 661% and 594% after air and CO2 respectively; for MSA these respective 
values were: 240% and 107%; and for PAF: 155% and -51%. 
 
 
Plasma Noradrenaline: 
 
Baseline: 
Baseline plasma NA levels were significantly lower in PAF (126.8+/-19.8pg/ml) than in 
controls (288.4+/-31.3pg/ml) or MSA (246.9+/-13.1pg/ml) (p<0.001). 
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Post- CO2 inhalation: 
In controls there was a significant increase in NA levels (p<0.05), first reaching significance 2 
minutes post-inhalation (Figure 3.7.8). NA levels following CO2 inhalation did not increase in 
either MSA or PAF. 
 
Plasma Adrenaline: 
 
Baseline:   
Baseline Ad levels were significantly higher in controls (44.2 +/- SE 5.9 pg/ml) than in MSA 
(20.8 +/-SE 3.6 pg/ml): p<0.05. In PAF, Ad levels were undetectable at baseline. 
 
Post- CO2 inhalation:   
In controls there was a significant increase in Ad levels (p<0.05), peaking at 90.4 +/- SE 14.0 
at 10 minutes post-inhalation. Plasma levels of Ad following CO2 inhalation did not increase 
in either MSA or PAF. 
 
Plasma Dopamine: 
 
In 2/5 controls, 5/9 MSA and 9/9 PAF, DA levels were undetectable at baseline. There was no 
significant change in any group Post- CO2 inhalation. 
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        Figure 3.7:3 Skin Blood Flow changes following inhalation of air or 35% CO2 in control 
subject (top), PAF (middle) and MSA (lower). Y-axis shows skin blood flow in Perfusion 
Units. 
 
 
 
 
AIR CO2 
CO2 
CO2 AIR 
CONTROL  
   MSA 
      PAF  
             
                 0              45             90            135                       0              45              90            135 
                                                        Time (in seconds) post inhalation of air or CO2 
AIR 
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 Baseline % Change in SkBF after air % Change in flow after CO2 
Controls 278.8 (18.2) -83.8 (  3.9)   -   79.0  (  5.6) 
MSA 143.7 (29.5) -52.7 (  8.6)  -     4.8  (15.9) 
PAF   59.8 (14.6) -31.7 (14.6) + 151.2 (40.2) 
 
Table 3.7:3 Fingertip Skin Blood Flow changes in perfusion Units (+/- SE) after single 
breath of air or CO2 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7:4 Fingertip Skin Blood Flow changes following inhalation of air or 35% CO2 
in control subjects (grey), MSA (white) and PAF (black). Error bars = SE.  Y-axis shows 
% change in SkBF relative to baseline. 
 
 
 
 
 
 
   MSA (n = 9) PAF (n = 9) 
 
  AIR   AIR AIR CO2    CO2 CO2 
 
Controls (n = 5) 
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 Controls MSA PAF 
SBP (mmHg) before air 124.9 (11.6) 120.4 (  6.0) 140.0 (14.1) 
SBP (mmHg) after air 132.0 (12.7) 121.4 (  6.4) 138.0 (12.8) 
∆SBP (mmHg) after air     7.1  ( 4.1)     1.1 (  1.9)   -2.2  ( 5.1) 
    
DBP (mmHg) before air   68.3  ( 4.1)   69.2  ( 5.9)   77.7  ( 4.9) 
DBP (mmHg) after air   69.9  ( 4.9)   70.1  ( 6.2)   78.4  ( 5.3) 
∆DBP (mmHg) after air    1.6   ( 1.4)     1.0  ( 1.0)    0.7   ( 1.8) 
    
HR (bpm) before air   62.0  ( 4.1)   80.7  ( 6.0)   73.4  ( 6.5) 
HR (bpm) after air   57.1  ( 7.0)   81.3  ( 6.3)   74.7  ( 6.2) 
∆HR  (bpm) after air  - 4.9  ( 3.2)     1.1  ( 0.8)     1.3  ( 1.0) 
    
SBP (mmHg) before CO2 122.5 (12.3) 132.7 ( 8.8) 128.8 (13.7) 
SBP (mmHg) after CO2 165.9 (17.9) 135.9 ( 6.1) 127.7 (13.9) 
∆SBP (mmHg) after CO2   43.7 (13.6)    4.5  ( 8.2)   -3.3  ( 3.8) 
    
DBP (mmHg) before CO2   66.9 ( 3.9)   76.2 ( 7.2)   75.7 ( 4.4) 
DBP (mmHg) after CO2   78.2 ( 6.9)   79.4 ( 7.6)   72.9 ( 4.8) 
∆DBP (mmHg) after CO2   11.3 ( 5.2)     3.3 ( 3.1)   -2.9 ( 1.9) 
    
HR (bpm) before CO2   60.9 ( 3.9)   77.1 ( 4.1)   66.8 ( 2.7) 
HR (bpm) after CO2   48.4 ( 7.9)   80.2 ( 6.0)   64.6 ( 2.8) 
∆HR  (bpm) after CO2  -12.5 ( 8.1)    3.2  ( 3.8)     1.7 ( 1.5) 
  
      Table 3.7:4 Portapres change in SBP, DBP and HR (+/- SE) 43-47 seconds post-
inhalation of air or CO2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
 
 
We observed that the acute inhalation of air in controls, MSA and PAF, resulted in no 
significant changes in BP. However, following inhalation of 35% CO2, there was a pressor 
response in all groups, with the magnitude and speed of onset being greater in controls than in 
PAF and MSA. The pressor response following identical application of 35% CO2 has 
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previously been described in normal subjects, being related to activation of central 
sympathetic pathways [Kaye et al 2004]. Forearm SkBF was unchanged. However, finger 
SkBF responded differently between normal subjects, MSA and PAF. Whilst inhalation of air 
reduced SkBF in the fingertip pulp in all groups, this response was greatest in controls and 
least marked in PAF, with significant differences between the 3 groups. Following inhalation 
of CO2 controls there was a reduction in SkBF similar to that seen after inhalation of air; in 
MSA the reduction in SkBF was less than in controls. However, in PAF a marked increase in 
SkBF followed inhalation of CO2, at 45 seconds post-inhalation. 
 
Following CO2, the period between 43-47 seconds post-inhalation corresponded both to the 
midpoint of the SkBF reduction seen in controls and to the peak of increased SkBF seen in 
PAF. Detailed analysis of systemic haemodynamics over this time period indicated that in the 
controls there was a significant increase in SBP, DBP, and HR, with a non-significant 
increase in TPR. Neither MSA nor PAF showed significant changes in BP at this time 43-47 
seconds post-CO2, as their peak pressor effect, albeit diminished, occurred later than controls. 
In PAF there was a non-significant reduction in TPR and increase in CO at the 43-47 seconds 
time point, not seen in controls or in MSA. This suggests vasodilatation at the same time that 
the Laser Doppler probe was recording an increase in finger SkBF. In contrast, there was no 
corresponding change in SkBF measured in the forearm in any group. This is in keeping with 
human studies following chronic surgical sympathectomy that suggest no major disruption in 
vascular function in the forearm [Eisenach et al 2002].  There thus was evidence for selective 
vasodilatation of cutaneous vascular beds in PAF following CO2 inhalation.  
 
 
Plasma Noradrenaline Responses 
 
 
In controls, plasma NA levels were within the normal range and significantly increased 2-
minutes post-CO2 inhalation. This is likely to reflect an increase in sympathetic nerve activity 
following CO2. In MSA, baseline plasma NA levels were not significantly different to 
controls, in keeping with previous observations [Mathias et al 1990] and did not increase 
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following CO2. In PAF, baseline plasma NA levels were lower than in controls and MSA, 
again consistent with the known postganglionic lesion site in PAF [Polinsky 2002], and did 
not change following CO2. These results provide additional evidence for the inability of CO2 
to increase sympathetic activity in MSA and PAF. The plasma NA response to CO2 did not 
differentiate MSA and PAF, confirming that both pre- and postganglionic pathways are 
required to elicit an increase in NA following CO2 inhalation.  
 
 
 
Fingertip Skin Blood Flow Responses 
 
Following inhalation of air there was a prompt and marked reduction in SkBF in controls; this 
was less marked in MSA, with an even smaller reduction in PAF. With inhalation of CO2, a 
similar reduction in SkBF to that seen with air was observed in controls. In MSA, the mean 
reduction in SkBF following CO2 was less than in healthy controls. In PAF, there was no 
reduction in SkBF following CO2; instead there was a transient increase in SkBF 45 seconds 
post-inhalation. This transient effect thus occurred when controls were still displaying a 
marked reduction in SkBF following CO2 inhalation. In controls we speculate that inhalation 
induced a marked cutaneous vasoconstriction to inhalation of air or CO2. In extensive post-
ganglionic sympathetic denervation, as in PAF, there is marked impairment of cutaneous 
vasoconstrictor response to stimuli that increase sympathetic activity [Asahina et al 2002; 
Young et al 2006]. In PAF the increase in arterial pCO2 following CO2 inhalation probably 
unmasked a transient cutaneous vasodilatation in PAF as it arrived in the fingertip 
microcirculation. In MSA, where sympathetic impairment may not have been as extreme as in 
PAF, these effects were not observed. 
 
Total SkBF can vary enormously, between 200ml/min and 8 litres/min with maximal 
vasodilatation [Rowell 1993]. Changes in SkBF thus have the potential to change BP and 
TPR. However, SkBF changes were only found at the fingertip and not the forearm in our 
study suggesting a more selective vascular bed response.  
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The mechanisms by which CO2 causes cutaneous vasodilatory properties warrants discussion, 
as it can cause cutaneous vasodilatation by a non-neural mechanism [Bullard 1964; Ito et al 
1989].  In humans, topical application of CO2 enriched water to the hands and feet leads to 
cutaneous vasodilatation [Irie et al 2005]. In the rat, cutaneous vasodilatation in the paw is 
also seen with topical CO2, and this effect is preserved following surgical sympathectomy 
[Nishimura et al 2002; Schnizer et al 1985; Ito et al 1989]. Continuous breathing of CO2, at 
concentrations between
 
5-30%, reduces forearm blood flow in healthy volunteers, but 
increases blood flow if the ulnar, radial and median nerves are initially treated with a local 
anaesthetic [Blair et al 1959].  The circulation time of CO2 (following inhalation of 35% CO2 
in 65% O2) is consistent with a local vascular effect of CO2 in PAF. In normal subjects, radial 
artery blood gases have been measured before and after a single breath of 35% CO2 in O2. 
Pre-CO2 levels of 40 mmHg pCO2 rose to over 90mmHg after 20 seconds and returned to 
baseline levels 50 seconds after CO2 [Ponto et al 2002]. Arterial blood gases sampled at 
greater frequency in normal subjects following a single maximal breath of 35% CO2 in O2, 
indicate that a bolus of pCO2 (up to 120mmHg) reaches the radial artery between 20 and 35 
seconds following inhalation [Ponto et al  unpublished data].  
 
Limitations 
 
In PAF, the baseline finger SkBF was lower than in MSA and controls. Skin temperature was 
not measured but this was unlikely to account for this observation, as there was no difference 
in baseline forearm SkBF between PAF, MSA and controls. In addition, all measurements 
were performed in a temperature-controlled laboratory (24 +/- 10C) after 30 minutes of 
baseline. Whilst acute peripheral sympathetic denervation causes an increase in SkBF in 
humans [Lehtipalo et al 2000], chronic peripheral denervation (as is expected in PAF) reduces 
skin perfusion [Barcroft et al 1949; Bentzer et al 1997]. Laser Doppler flowmetry provides 
relative and not absolute measures of SkBF, and so direct comparisons of absolute levels 
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alone were not considered, and comparisons between the groups were made on the basis of 
percentage change compared with baseline. 
 
The mean ages of our subjects differed, being 47 +/- 6.8 years in controls, 57.1 +/- 3.1 years 
in MSA, and 66.4 +/- 2.1 years in PAF. This reflects the age of onset of disease in these 
disorders, and the shortened life expectancy in MSA. A previous study suggested that SkVR 
to inspiratory gasp and cutaneous cold was impaired in older when compared to young 
healthy subjects; however, the age difference was far greater than in our study, being 68 ± 4 
compared to 26 ± 5 years [Khan et al 1992]. In addition, the mean SkVR in the older subjects 
to gasp (51%) was greater than in our PAF of a similar age (31.7 %). Thus it seems age 
difference alone does not explain the lower SkVRs seen with inhalation in our PAF subjects. 
Similarly, it seems unlikely that the supine baseline level of blood pressure is important in the 
SkVR following air inhalation, as baseline BPs were similar in all 3 groups.  
 
Conclusion 
 
Our results indicate that there was a pressor response following CO2 in MSA and PAF; 
however this was significantly smaller in magnitude and occurred later than in controls. There 
was no difference in the pressor responses seen in MSA or PAF. NA levels at baseline were 
similar to those previously reported in healthy subjects, MSA and PAF. Following CO2 NA 
rose within 2 minutes in controls but showed no change in either MSA or PAF.  
 
In Controls there was a similar reduction in fingertip SkBF following either air or CO2. In 
PAF the reduction in fingertip SkBF following air was markedly attenuated, and a transient 
increase in SkBF was found following CO2. In controls inhalation of CO2 may cause transient 
vasodilatation, but that this is not recorded because of the marked reduction in SkBF in 
response to inhalation itself (onset 18.8 +/- 2.7 seconds after CO2 inhalation, lasting 87.6 +/- 
12.9 seconds). Because this gasp reflex is impaired in PAF, but CO2 dilation occurs via non-
        Cardiovascular autonomic responses in pre- and post-ganglionic models of chronic autonomic failure      289                                            
neural mechanisms, the direct vasodilatation effect of CO2 may be unmasked in this group. 
Changes in Fingertip SkBF with CO2 may provide a useful non-invasive test to distinguish 
pre- from post-ganglionic lesions, especially in the early stages of MSA when the only 
clinical features may be those of autonomic failure. 
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3.9: Conclusions 
 
 
 
 
The studies performed in this thesis explored the differentiation of MSA and PAF based on 
the on the cardiovascular responses to various stimuli. These groups allowed comparison 
between a pre-ganglionic (MSA) and essentially post-ganglionic (PAF) lesion model of 
autonomic dysfunction. Although there is pathological evidence of some central involvement 
in PAF the overall evidence suggests a markedly predominant post-ganglionic 
pathophysiological condition. Inclusion bodies staining for α-synuclein have been identified 
in autonomic nerves in the epicardial fat and capsular nerves of the adrenal and 
parasympathetic nerves in the bladder wall, but not  in the cerebral cortex or dorsal motor 
vagal nucleus. [Kaufmann et al 2001]. Two autopsy cases suggested moderate neuronal loss 
in the substantia nigra, locus ceruleus and intermediolateral cell columns of the spinal cord; 
however in one of these cases previous embalming cast doubt on the relevance of a perceived 
moderate loss of neurons in these anatomical areas [Roessmann et al 1971]. Functional 
imaging has shown only one out of seven PAF to have evidence of central abnormalities of 
the nigrostriatal dopaminergic system, with a single case report suggesting straital 
involvement of the caudate and putamen with SPECT [Brooks et al 1990; Compta et al 2006]. 
The subtle and highly localised abnormalities of cerebral grey matter appear to be a 
compensatory change due to the post-ganglionic lesion sites rather than a primary area of 
pathology [Critchley et al 2003]. Whilst some doubt thus remains about the degree of central 
involvement in PAF, both pathological and physiological studies strongly the support the 
peripheral, postganglionic dysfunction of PAF [Bradbury and Eggleston 1927; Roessmann et 
al 1971; Ingelghem et al 1994; Mathias 2004].  
 
Before the studies comprising this thesis were performed it was known that both MSA and 
PAF demonstrated profound OH, and shared other aspects of autonomic dysfunction. It was 
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known that in MSA there was clear progression, with death occurring within a decade of 
diagnosis in most subjects [Ben-Shlomo et al 1997]. By contrast PAF subjects may well show 
a normal life expectancy, and yet the differentiation from MSA in the first few years of 
presentation is often very challenging. This not only has implications for prognostication, but 
increasingly for inclusion of subjects in therapeutic trials [Schroeder et al 2005; Geser et al 
2005].  
 
The first study of this thesis formed the largest study to date of the cardiovascular effects of 
pressor stimuli in MSA and PAF. There was no significant difference in baseline 
haemodynamics between the groups. Haemodynamic responses were attenuated in both 
groups to all pressor stimuli. In MSA HR increased following each pressor stimulus, whilst 
BP increased with IE and CP but not MA, which led to a fall in SBP and DBP. In PAF HR 
increased with CP and MA, but not with IE. There was no significant BP change with pressor 
stimuli in PAF subjects. Comparing groups showed a greater increase in HR following IE and 
CP in MSA than PAF and a greater increase in SBP in MSA following CP. SBP and DBP 
decreased to a greater extent in MSA following MA. 
 
These results are helpful in aiding interpretation of MSA and PAF. Autonomic function tests 
are a routine part of the work up of autonomic failure at presentation. Whilst the results of this 
study do not allow clear-cut differentiation, the results of the SBP change to cold pressor 
stimulation and to mental arithmetic in particular may provide suggestions to the underlying 
diagnosis. The reduction in SBP with MA in MSA is somewhat suprising, and may be related 
to peripheral vasodilation related to differential impairment of A and NA. 
 
As with pressor testing the intravenous clonidine test is widely used to help distinguish MSA 
subjects. In these subjects the preganglionic lesion site includes hypothalamic involvement 
resulting in a suppression of the normal increase in plasma growth hormone (GH) response 
with the selective α2-adrenoceptor agonist clonidine. GH testing is not universally available 
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however & results can take a significant length of time after testing, unlike the haemodynamic 
results which are immediately obtainable. The cardiovascular response to clonidine in MSA 
and PAF had not been well established however. The clonidine study in this thesis is the 
largest published series to focus on this aspect. Clonidine infusion reduces BP and HR in both 
MSA and PAF, but to a greater extent in MSA. The greater vasodepressor action of clonidine 
in MSA suggests that there is partial preservation of brainstem sympathetic outflow pathways 
in MSA, and may reflect its action at sites in the brainstem and spinal cord that were in part 
functionally preserved in MSA. Despite similar relative degrees of NA reduction after 
clonidine, the vasodepressor effect of clonidine was attenuated in PAF compared with MSA. 
This attenuation in PAF may represent a pressor effect of clonidine mediated by 
vasoconstriction resulting from activation of postsynaptic peripheral α2 adrenoceptors rather 
than α1 adrenoceptors [Kiowskiw et al 1983]. 
 
We have thus shown a differing BP response to clonidine, with a vasodepressor effect 
occurring earlier and to a greater extent, in MSA than in PAF. This occurs despite a similar 
relative reduction in NA levels in both groups following clonidine. The attenuation of BP 
drop in PAF compared with MSA may reflect a denervation supersensitivity to clonidine in 
PAF, resulting in vasoconstriction via peripheral α2 adrenoceptors. The greatest differential 
occurred with the SBP change from baseline at 30 minutes post-clonidine. Although there was 
some overlap in results between MSA and PAF, our results suggested that increases in the 
SBP over baseline at 30 minutes were specific to PAF whilst large falls in SBP at this time 
point would be more in keeping with a diagnosis of MSA.  Thus at this time point reductions 
in SBP greater than –32 mmHg, which occurred in 17/39 MSA subjects, were 100% specific 
for MSA but at low sensitivity (44%). At this same time point increases of SBP from baseline 
of ≥ 0 mmHg, which occurred in 9/19 PAF subjects, were 100% specific for PAF with a low 
sensitivity of 47%. Our results therefore suggest that 100% specificity is possible in just under 
half of our cases of MSA and PAF. As such we suggest that analysis of haemodynamic 
changes following this standardised test provides potentially useful information to aid the 
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differentiation of MSA and PAF. These BP differences may thus reflect the underlying lesion 
site in MSA and PAF, and the haemodynamic data following clonidine infusion may help 
differentiate these conditions.  
 
This thesis has added important data to the growing knowledge about the pressor effects of 
oral water in autonomic failure. We confirmed the finding of a significant pressor effect after 
oral ingestion of 480-500ml distilled water in both MSA and PAF. The studies of this thesis 
have been the first to directly compare detailed haemodynamic responses to oral water in 
MSA and PAF. There was a more rapid onset of pressor response in PAF although ultimate 
magnitude of response appeared similar in both groups. In PAF the pressor effect occurred 
sooner (within 5minutes) unlike MSA where it occurred 13 minutes after ingestion. The 
pressor response to water is known to be dependant on the volume ingested, and may be the 
result of gastric distension increasing sympathetic nerve activity by reflex mechanisms, as has 
been described in normal subjects [Rossi et al 1998]. This response has been claimed to be 
dependant on residual sympathetic activity, and should therefore be minimal in PAF, and 
greater in MSA. This would be consistent with the findings that the pressor actions of 
yohimbine, an α2 antagonist that is dependant on sympathetic activity, were related to the 
subject’s pressor response of water [Jordan et al 2000]. However, this was not the case in our 
studies as the response was as great in PAF with a more rapid onset than in MSA. An 
alternative may be that the pressor response in PAF was related to denervation 
supersensitivity, which has been well documented in this group, and is greater than in MSA 
[Polinsky 2002]. It is possible that in PAF, even a small amount of NA released could have 
acted on supersensitive receptors, although the release of other vasoconstrictor substances, 
including factors such as endothelin, which may then exert the pressor response. These 
possibilities may explain the rise in peripheral resistance found in this study and the delay 
(minutes) between ingestion and pressor action.   
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For the first time the pressor response to oral water  was shown to be associated with 
symptomatic improvement, highlighting the likely therapeutic value of oral water in MSA and 
PAF. As a result of these studies we suggested to both MSA and PAF subjects that cautious 
use of oral water could be useful in helping controlling OH. As the pressor effect may not last 
for much longer than an hour, and the effects of repeated dosing are unknown, we would 
suggest that this technique only be attempted a few times each day. Clearly much further 
work is required in this exciting area, not least of which includes elucidating the underlying 
aetiology. As suggested in the discussion of  Chapter 3.4: ‘Cardiovascular Responses to 
Water Ingestion in MSA and PAF’ the implications of this study could be of considerable 
importance to a wider selection of the population if the tantalizing suggestions of a mild 
pressor response to water ingestion in older ‘healthy’ subjects is borne out by future larger 
studies.  
 
In MSA and PAF head up tilt (HUT) is associated with significant orthostatic hypotension. 
On tilt reversal back to supine posture there may be an initial overshoot in the blood pressure 
in PAF not MSA, resulting in transiently higher supine values than those obtained prior to 
HUT. This had previously been suggested as a possibility in an earlier study focussing on the 
haemodynamics of HUT [Chandler & Mathias 2002]. The studies in this thesis confirmed the 
finding of a transient SBP overshoot on tilt-reversal in PAF but not MSA. Arginine 
Vasopressin (AVP) is a hormone produced in the hypothalamus and released from the 
posterior pituitary in response to head up posture and may be important in helping to maintain 
BP in the upright position by virtue of its vasopressor actions. As a previous study had 
suggested that this AVP response may be preserved in PAF but not in MSA (where central 
lesion sites include the hypothalamus), this study sought to ascertain if there was a difference 
in the BP overshoot between MSA and PAF, and if so whether this was related to the AVP 
response. The working hypothesis was that HUT would result in a significant AVP release in 
PAF but not MSA and that on subsequent return to supine, the residual AVP action would 
cause an exaggerated pressor response in PAF, in whom there is a known pressor 
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supersensitivity and the most likely mechanism of increased TPR based on Modelflow 
analysis of the Portapres data. Although the results showed a lower AVP level in MSA with a 
suggestion of a greater increase in PAF following HUT, there was not a significant 
correlation between AVP levels and SBP overshoot on tilt reversal. The confirmation of the 
existence of SBP overshoot in PAF however has important clinical implications. Given the 
relatively good long term prognosis in PAF, recently concern has been raised that the periods 
of marked hypertension (such as may occur on tilt reversal) may be associated with end organ 
damage [Vagaonescu et al 2000]. Thus simple steps such as gradual return to supine from 
standing may help reduce the peaks of SBP seen in these studies on tilt-reversal. 
 
The Laser Doppler has been used for decades to investigate cutaneous blood flow, but its use 
in primary autonomic failure is relatively novel. In Chapters 3.6 (Vasomotor Responses to 
Sympatho-excitatory stimuli in MSA and PAF) and 3.8 (Acute Cardiovascular effects of CO2 
Inhalation in MSA and PAF) the Laser Doppler was used to explore cutaneous blood flow 
from the finger pulp in MSA and PAF. Healthy control subjects demonstrated marked SkVRs 
on the finger pulp to each of the stimuli of a magnitude similar to those seen in previous 
studies. In MSA SkVRs to inspiratory gasp on the finger pulp were reduced relative to 
controls. In PAF SkVRs were reduced relative to controls or MSA. The magnitude of SkVR 
response to gasp and cutaneous cold in PAF was significantly less than in healthy controls. In 
addition, the magnitude of the response in PAF was significantly less than MSA for 
inspiratory gasp. PAF showed a decreased SkVR response to all 4 stimuli, the response being 
significantly less than controls (for inspiratory gasp and cutaneous cold) or MSA (inspiratory 
gasp).  The decreased responses in PAF may reflect the extensive postganglionic sympathetic 
denervation seen in this group. When inhaled CO2 was utilised instead of air, healthy controls 
showed a similar marked decrease in SkVR as with inhaled air. In MSA the SkVR responses 
to both air and CO2 were attenuated relative to controls. In PAF however, there was only 
minimal SkVR with inhaled air. Most interesting however was the response to inhaled CO2 
where a marked transient cutaneous vasodilatation. In this thesis I have suggested that this 
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novel finding may reflect the fact that the inhaled CO2 may act locally in the cutaneous 
vascular bed as a vasodilator with the normal vasoconstriction caused by inhalation itself 
being attenuated by the marked post-ganglionic sympathetic denervation in PAF. If confirmed 
in larger studies this could provide the basis for a rapid test to help differentiate MSA and 
PAF. Finally the Haemodynamic actions of inhaled CO2 were also explored. Both MSA and 
PAF subjects showed a pressor effect following a single breath of 35% CO2, although this 
was less marked and later in onset than in healthy controls. It is likely that the pressor action 
of CO2 requires both pre- and postganglionic pathways based on the results of this study. 
 
Overall I have aimed in this thesis to better delineate the pathophysiology of MSA and PAF 
based on their lesion site differences. In doing so I hope to have helped suggest improved 
testing for these conditions to help prognostication, clinical management and ultimately aid 
selection for future trials. I feel that of particular importance has been my systematic analysis 
of the differing responses to standard autonomic tests (such as pressor responses and 
intravenous Clonidine as well as the suggestion of more novel methods of distinguishing 
these patient groups (such as SBP overshoot on tilt reversal and with use of the Laser Doppler 
to assess finger pulp cutaneous blood flow). Finally I feel that the cardiovascular effects of 
water will be an exciting area of development over the next decade with possible implications 
for medicine beyond that of autonomic dysfunction. 
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          Appendix I: Summaries of Materials, Reagents and Suppliers 
 
 
 
 
                                           Multi-Purpose Tilt Table:  
 
 
 
An electronically operated, hydraulic 63 x 190 cm tilt table equiped with lockable casters and 
stabilisers for safety in use. Maximum load is 180Kg, distributed evenly. Additional security in upright 
positions provided by a foot rest and body belts (2X narrow Belts, 1X Wide Belt), secured by means of 
Velcro strips threaded through the side chrome rails of the table. Manually operated tilt and elevation 
controls allow raising or lowering of the table. In addition, these controls permit tilting upright and 
back to horizontal (degree of tilt estimated by means of dynamic scale under bed). 
 
 
 
Huntleigh Akron 
1 Farthing Road, 
Ipswich 
IP1 5AP 
 
Tel:   01473 461042 
Fax:  01473 462924 
 
 
 
 
 
 
 
 
                                                      
                                                  Portapres Model-II: 
 
 
 
Portpres is a class B equipment according to EN 60601-1. 
 
Dimensions: 
 
Main Unit:        140x90x40mm       weight 320 grams 
Pump Unit:        100x90x40mm    weight 345 grams 
Fronted Unit:       65x50x30mm              weight 350 grams (incuding fronted cable) 
Control Unit:     145x90x35/56mm      weight 590 grams 
Waist belt       1200x110x40mm         weight 270 grams 
AC adapter        125x75x40mm                weight 410 grams 
Finger Cuff……………………...            weight 25 grams 
 
 
Measurement Method:    Arterial volume-clamp (Penaz) and physiocal (Wesseling) methods 
Cuff Pressure:                 Maximum 350mmHg 
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BP accuracy:       Within 1% 
Data Storage:               In-built 10Mb Flash memory card (63.5 hours of recording) 
Height accuracy:                Within 1% 
Interbaet accuracy:        10ms 
Control Unit Display:     2X16 characters LCD 
Serial Port:                   RS232C 
Pump Unit:                   Maximum pressure 400mmHg; Maximum air flow 60litres/minute  
Environment limits:       0oC-35oC;  Humidity 5-90%; Atmospheric Pressure: 700-1100 hPa 
 
 
Electrical Specifications: 
 
Power Requirements:                                12 V DC, 0.2 A standby, 0.4 A measuring 
Main Unit and Poump Unit fueses:           Electronic  
AC adaptor:                                               100 to 240 V A; 47 to 65 Hz, 30 W 
Protection against water contamination:   IP20 
Power dissipation:   In main Unit 2 W; In Pump Unit 2 W; In fronted Unit 1 W; In Finger cuff  <50mW 
    
 
TNO-TPD Biomedical Instrumentation 
Attn. Mr. G.J. Langewouters, 
Academic Medical Centre K2-228 
Meibergdreerf 9 
1105 AZ Amsterdam 
The Netherlands 
 
Phone: + 31 20 566 3343 
Fax:     + 31 20 697 6424 
Email:  bmi@tpd.tno.nl 
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Appendix II: Consensus statement on the diagnosis of multiple system atrophy 
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Appendix III: Consensus statement on the diagnosing MSA, PAF & orthostatic 
hypotension 
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